TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
R-HSA-422475	Axon guidance	1.4369113344337e-06	-13.4530146546265	551	29	0.140096618357488	207	10391	3084,2042,8633,4747,2044,6197,9723,256076,3912,4897,2043,817,284,1293,220164,1272,3685,5362,137970,80031,3983,8829,4651,8911,285220,7204,3791,22866,1213	NRG1,EPHA3,UNC5C,NEFL,EPHA5,RPS6KA3,SEMA3E,COL6A5,LAMB1,NRCAM,EPHA4,CAMK2D,ANGPT1,COL6A3,DOK6,CNTN1,ITGAV,PLXNA2,UNC5D,SEMA6D,ABLIM1,NRP1,MYO10,CACNA1I,EPHA6,TRIO,KDR,CNKSR2,CLTC
R-HSA-3928663	EPHA-mediated growth cone collapse	0.000519597472117192	-7.56245613823511	34	5	0.0241545893719807	207	10391	2043,2042,2044,3791,285220	EPHA4,EPHA3,EPHA5,KDR,EPHA6
R-HSA-1266738	Developmental Biology	0.000655756376239334	-7.3297212156819	1078	37	0.178743961352657	207	10391	2043,1496,5915,4897,9314,220164,1272,284,1293,817,4651,8829,8911,3983,137970,10891,5362,80031,3685,7204,3791,22866,1213,285220,6197,2042,9211,4747,8633,2044,1825,3084,63978,688,3912,9723,256076	EPHA4,CTNNA2,RARB,NRCAM,KLF4,DOK6,CNTN1,ANGPT1,COL6A3,CAMK2D,MYO10,NRP1,CACNA1I,ABLIM1,UNC5D,PPARGC1A,PLXNA2,SEMA6D,ITGAV,TRIO,KDR,CNKSR2,CLTC,EPHA6,RPS6KA3,EPHA3,LGI1,NEFL,UNC5C,EPHA5,DSC3,NRG1,PRDM14,KLF5,LAMB1,SEMA3E,COL6A5
R-HSA-373752	Netrin-1 signaling	0.00139632071437571	-6.57391456293623	42	5	0.0241545893719807	207	10391	7204,137970,3983,8633,4651	TRIO,UNC5D,ABLIM1,UNC5C,MYO10
R-HSA-190828	Gap junction trafficking	0.00215257707654469	-6.14108951438492	28	4	0.0193236714975845	207	10391	1213,2702,84694,2697	CLTC,GJA5,GJA10,GJA1
R-HSA-194306	Neurophilin interactions with VEGF and VEGFR	0.00230793247646865	-6.07140318706033	4	2	0.00966183574879227	207	10391	8829,3791	NRP1,KDR
R-HSA-2408550	Metabolism of ingested H2SeO4 and H2SeO3 into H2Se	0.00230793247646865	-6.07140318706033	4	2	0.00966183574879227	207	10391	9060,2936	PAPSS2,GSR
R-HSA-8948216	Collagen chain trimerization	0.00232348557681293	-6.06468681698468	47	5	0.0241545893719807	207	10391	1293,84570,136227,256076,1295	COL6A3,COL25A1,COL26A1,COL6A5,COL8A1
R-HSA-3928665	EPH-ephrin mediated repulsion of cells	0.00255237232289411	-5.97073202959019	48	5	0.0241545893719807	207	10391	2043,2044,2042,1213,285220	EPHA4,EPHA5,EPHA3,CLTC,EPHA6
R-HSA-157858	Gap junction trafficking and regulation	0.00279308253223985	-5.88060944278155	30	4	0.0193236714975845	207	10391	1213,2697,84694,2702	CLTC,GJA1,GJA10,GJA5
R-HSA-418990	Adherens junctions interactions	0.00315753341181423	-5.75796412206506	31	4	0.0193236714975845	207	10391	1004,1016,1009,1006	CDH6,CDH18,CDH11,CDH8
R-HSA-373760	L1CAM interactions	0.00420646482487882	-5.4711326930959	102	7	0.0338164251207729	207	10391	1272,6197,1213,8829,3912,3685,4897	CNTN1,RPS6KA3,CLTC,NRP1,LAMB1,ITGAV,NRCAM
R-HSA-416476	G alpha (q) signalling events	0.00506147535360602	-5.28609726632268	192	10	0.0483091787439614	207	10391	1131,301,54331,3356,56923,886,5581,5583,7204,5028	CHRM3,ANXA1,GNG2,HTR2A,NMUR2,CCKAR,PRKCE,PRKCH,TRIO,P2RY1
R-HSA-190861	Gap junction assembly	0.0059661342075916	-5.1216560977367	19	3	0.0144927536231884	207	10391	2697,2702,84694	GJA1,GJA5,GJA10
R-HSA-416700	Other semaphorin interactions	0.0059661342075916	-5.1216560977367	19	3	0.0144927536231884	207	10391	9723,80031,5362	SEMA3E,SEMA6D,PLXNA2
R-HSA-421270	Cell-cell junction organization	0.00771132146975531	-4.86506570923824	62	5	0.0241545893719807	207	10391	101928583,1006,1004,1009,1016	SLC7A14-AS1,CDH8,CDH6,CDH11,CDH18
R-HSA-447043	Neurofascin interactions	0.00776464174993184	-4.85817495996457	7	2	0.00966183574879227	207	10391	1272,4897	CNTN1,NRCAM
R-HSA-381426	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)	0.00795308923923662	-4.83419484224316	21	3	0.0144927536231884	207	10391	1511,3486,5069	CTSG,IGFBP3,PAPPA
R-HSA-5365859	RA biosynthesis pathway	0.0102859226452843	-4.57697905204615	23	3	0.0144927536231884	207	10391	57665,216,195814	RDH14,ALDH1A1,SDR16C5
R-HSA-5362517	Signaling by Retinoic Acid	0.0102901072200708	-4.57657230935852	43	4	0.0193236714975845	207	10391	5915,57665,216,195814	RARB,RDH14,ALDH1A1,SDR16C5
R-HSA-2682334	EPH-Ephrin signaling	0.0116410428062677	-4.4532182525243	95	6	0.0289855072463768	207	10391	285220,1213,3791,2042,2044,2043	EPHA6,CLTC,KDR,EPHA3,EPHA5,EPHA4
R-HSA-1650814	Collagen biosynthesis and modifying enzymes	0.0127002700323239	-4.36613202335592	70	5	0.0241545893719807	207	10391	84570,1293,1295,256076,136227	COL25A1,COL6A3,COL8A1,COL6A5,COL26A1
R-HSA-196025	Formation of annular gap junctions	0.0129659643261259	-4.34542748357309	9	2	0.00966183574879227	207	10391	2697,1213	GJA1,CLTC
R-HSA-881907	Gastrin-CREB signalling pathway via PKC and MAPK	0.0156158967399628	-4.15946586178442	443	16	0.0772946859903382	207	10391	5581,817,284,3084,5028,4747,6197,886,1131,301,5583,7204,22866,3356,54331,56923	PRKCE,CAMK2D,ANGPT1,NRG1,P2RY1,NEFL,RPS6KA3,CCKAR,CHRM3,ANXA1,PRKCH,TRIO,CNKSR2,HTR2A,GNG2,NMUR2
R-HSA-937042	IRAK2 mediated activation of TAK1 complex	0.0159966490846639	-4.13537601088485	10	2	0.00966183574879227	207	10391	23118,6885	TAB2,MAP3K7
R-HSA-418886	Netrin mediated repulsion signals	0.0159966490846639	-4.13537601088485	10	2	0.00966183574879227	207	10391	8633,137970	UNC5C,UNC5D
R-HSA-190873	Gap junction degradation	0.0159966490846639	-4.13537601088485	10	2	0.00966183574879227	207	10391	1213,2697	CLTC,GJA1
R-HSA-442742	CREB phosphorylation through the activation of Ras	0.0194522394298807	-3.93979307776246	29	3	0.0144927536231884	207	10391	4747,6197,817	NEFL,RPS6KA3,CAMK2D
R-HSA-190840	Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane	0.0199210855548936	-3.91597653258293	1	1	0.00483091787439614	207	10391	2697	GJA1
R-HSA-390666	Serotonin receptors	0.0228568887284599	-3.77850273099531	12	2	0.00966183574879227	207	10391	3350,3356	HTR1A,HTR2A
R-HSA-8866427	VLDLR internalisation and degradation	0.0228568887284599	-3.77850273099531	12	2	0.00966183574879227	207	10391	1213,7436	CLTC,VLDLR
R-HSA-2559585	Oncogene Induced Senescence	0.0252847844822978	-3.67755246802625	32	3	0.0144927536231884	207	10391	7029,2113,1030	TFDP2,ETS1,CDKN2B
R-HSA-75205	Dissolution of Fibrin Clot	0.0266630807497924	-3.62447541390131	13	2	0.00966183574879227	207	10391	5270,6281	SERPINE2,S100A10
R-HSA-373076	Class A/1 (Rhodopsin-like receptors)	0.0275797616783557	-3.59067304775817	322	12	0.0579710144927536	207	10391	3350,5173,886,54886,5028,1131,6364,301,7852,3356,56923,6753	HTR1A,PDYN,CCKAR,PLPPR1,P2RY1,CHRM3,CCL20,ANXA1,CXCR4,HTR2A,NMUR2,SSTR3
R-HSA-5173105	O-linked glycosylation	0.0283009228607376	-3.56486086494458	116	6	0.0289855072463768	207	10391	84002,2650,80731,9215,56913,80070	B3GNT5,GCNT1,THSD7B,LARGE1,C1GALT1,ADAMTS20
R-HSA-109582	Hemostasis	0.029777884502093	-3.51398929178841	639	20	0.0966183574879227	207	10391	284,7534,5028,5581,4842,5874,5270,221037,6281,5627,5099,5139,5583,6694,55619,308,54331,3685,30845,483	ANGPT1,YWHAZ,P2RY1,PRKCE,NOS1,RAB27B,SERPINE2,JMJD1C,S100A10,PROS1,PCDH7,PDE3A,PRKCH,SPP2,DOCK10,ANXA5,GNG2,ITGAV,EHD3,ATP1B3
R-HSA-418885	DCC mediated attractive signaling	0.030705005080331	-3.48332960574464	14	2	0.00966183574879227	207	10391	3983,7204	ABLIM1,TRIO
R-HSA-446728	Cell junction organization	0.0322706528211004	-3.43359704315387	89	5	0.0241545893719807	207	10391	1006,101928583,1009,1016,1004	CDH8,SLC7A14-AS1,CDH11,CDH18,CDH6
R-HSA-399955	SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion	0.0349718552911622	-3.35321167552055	15	2	0.00966183574879227	207	10391	8829,5362	NRP1,PLXNA2
R-HSA-1474244	Extracellular matrix organization	0.0354378228883642	-3.33997558604745	297	11	0.0531400966183575	207	10391	4593,1511,1293,3685,84570,1295,256076,3912,136227,4325,3791	MUSK,CTSG,COL6A3,ITGAV,COL25A1,COL8A1,COL6A5,LAMB1,COL26A1,MMP16,KDR
R-HSA-438064	Post NMDA receptor activation events	0.036860328995575	-3.30061940123566	37	3	0.0144927536231884	207	10391	4747,6197,817	NEFL,RPS6KA3,CAMK2D
R-HSA-419037	NCAM1 interactions	0.036860328995575	-3.30061940123566	37	3	0.0144927536231884	207	10391	8911,256076,1293	CACNA1I,COL6A5,COL6A3
R-HSA-1474290	Collagen formation	0.0379491257441252	-3.2715088124513	93	5	0.0241545893719807	207	10391	136227,256076,1295,1293,84570	COL26A1,COL6A5,COL8A1,COL6A3,COL25A1
R-HSA-500792	GPCR ligand binding	0.03834480869272	-3.26113612688403	455	15	0.072463768115942	207	10391	2913,5173,886,54886,5028,3350,3356,54331,6753,56923,1131,80834,301,6364,7852	GRM3,PDYN,CCKAR,PLPPR1,P2RY1,HTR1A,HTR2A,GNG2,SSTR3,NMUR2,CHRM3,TAS1R2,ANXA1,CCL20,CXCR4
R-HSA-141333	Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB	0.03944720059667	-3.23279219500226	2	1	0.00483091787439614	207	10391	4129	MAOB
R-HSA-190872	Transport of connexons to the plasma membrane	0.03944720059667	-3.23279219500226	2	1	0.00483091787439614	207	10391	2697	GJA1
R-HSA-168275	Entry of Influenza Virion into Host Cell via Endocytosis	0.03944720059667	-3.23279219500226	2	1	0.00483091787439614	207	10391	1213	CLTC
R-HSA-3642279	TGFBR2 MSI Frameshift Mutants in Cancer	0.03944720059667	-3.23279219500226	2	1	0.00483091787439614	207	10391	7048	TGFBR2
R-HSA-6804754	Regulation of TP53 Expression	0.03944720059667	-3.23279219500226	2	1	0.00483091787439614	207	10391	639	PRDM1
R-HSA-399956	CRMPs in Sema3A signaling	0.0394531583137106	-3.23264117624558	16	2	0.00966183574879227	207	10391	8829,5362	NRP1,PLXNA2
R-HSA-975163	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	0.0394531583137106	-3.23264117624558	16	2	0.00966183574879227	207	10391	6885,23118	MAP3K7,TAB2
R-HSA-399954	Sema3A PAK dependent Axon repulsion	0.0394531583137106	-3.23264117624558	16	2	0.00966183574879227	207	10391	5362,8829	PLXNA2,NRP1
R-HSA-162582	Signal Transduction	0.0422322597701337	-3.16457090045365	2596	63	0.304347826086957	207	10391	301,27152,8829,144165,6753,7029,5583,3791,7204,56034,6014,658,5173,2913,11059,817,1293,5028,284,7534,23118,23081,56923,5139,5475,9734,127124,216,195814,6197,1131,6364,3685,7852,399,1030,26084,22866,7048,10395,1213,3350,219981,5915,54886,886,1272,5948,10928,6885,80834,256076,3912,9958,54331,3356,1894,57665,4747,55294,5581,51339,3084	ANXA1,INTU,NRP1,PRICKLE1,SSTR3,TFDP2,PRKCH,KDR,TRIO,PDGFC,RIT2,BMPR1B,PDYN,GRM3,WWP1,CAMK2D,COL6A3,P2RY1,ANGPT1,YWHAZ,TAB2,KDM4C,NMUR2,PDE3A,PPEF1,HDAC9,ATP6V1G3,ALDH1A1,SDR16C5,RPS6KA3,CHRM3,CCL20,ITGAV,CXCR4,RHOH,CDKN2B,ARHGEF26,CNKSR2,TGFBR2,DLC1,CLTC,HTR1A,OR5A2,RARB,PLPPR1,CCKAR,CNTN1,RBP2,RALBP1,MAP3K7,TAS1R2,COL6A5,LAMB1,USP15,GNG2,HTR2A,ECT2,RDH14,NEFL,FBXW7,PRKCE,DACT1,NRG1
R-HSA-438066	Unblocking of NMDA receptor, glutamate binding and activation	0.0441387655618224	-3.12041684497365	17	2	0.00966183574879227	207	10391	817,4747	CAMK2D,NEFL
R-HSA-442729	CREB phosphorylation through the activation of CaMKII	0.0441387655618224	-3.12041684497365	17	2	0.00966183574879227	207	10391	817,4747	CAMK2D,NEFL
R-HSA-937072	TRAF6 mediated induction of TAK1 complex	0.0441387655618224	-3.12041684497365	17	2	0.00966183574879227	207	10391	23118,6885	TAB2,MAP3K7
R-HSA-373755	Semaphorin interactions	0.04639841900434	-3.07048989351276	68	4	0.0193236714975845	207	10391	80031,5362,9723,8829	SEMA6D,PLXNA2,SEMA3E,NRP1
R-HSA-442755	Activation of NMDA receptor upon glutamate binding and postsynaptic events	0.0477557162303326	-3.04165650759026	41	3	0.0144927536231884	207	10391	4747,6197,817	NEFL,RPS6KA3,CAMK2D
R-HSA-1236394	Signaling by ERBB4	0.0537309489616125	-2.92376611272582	43	3	0.0144927536231884	207	10391	23118,11059,3084	TAB2,WWP1,NRG1
R-HSA-375280	Amine ligand-binding receptors	0.0537309489616125	-2.92376611272582	43	3	0.0144927536231884	207	10391	3356,3350,1131	HTR2A,HTR1A,CHRM3
R-HSA-442982	Ras activation uopn Ca2+ infux through NMDA receptor	0.0540838689650759	-2.91721930829242	19	2	0.00966183574879227	207	10391	4747,817	NEFL,CAMK2D
R-HSA-450321	JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	0.0540838689650759	-2.91721930829242	19	2	0.00966183574879227	207	10391	6885,23118	MAP3K7,TAB2
R-HSA-450604	KSRP (KHSRP) binds and destabilizes mRNA	0.0540838689650759	-2.91721930829242	19	2	0.00966183574879227	207	10391	23404,7534	EXOSC2,YWHAZ
R-HSA-422085	Synthesis, secretion, and deacylation of Ghrelin	0.0540838689650759	-2.91721930829242	19	2	0.00966183574879227	207	10391	9314,590	KLF4,BCHE
R-HSA-418594	G alpha (i) signalling events	0.0541480778954666	-2.91603280209373	243	9	0.0434782608695652	207	10391	301,6364,3350,7852,6753,56923,2913,54331,5173	ANXA1,CCL20,HTR1A,CXCR4,SSTR3,NMUR2,GRM3,GNG2,PDYN
R-HSA-76002	Platelet activation, signaling and aggregation	0.055665246686961	-2.88839926417631	282	10	0.0483091787439614	207	10391	5627,5099,5581,5583,6694,5028,7534,54331,5874,308	PROS1,PCDH7,PRKCE,PRKCH,SPP2,P2RY1,YWHAZ,GNG2,RAB27B,ANXA5
R-HSA-190827	Transport of connexins along the secretory pathway	0.0585861388468277	-2.83725714882884	3	1	0.00483091787439614	207	10391	2697	GJA1
R-HSA-191647	c-src mediated regulation of Cx43 function and closure of gap junctions	0.0585861388468277	-2.83725714882884	3	1	0.00483091787439614	207	10391	2697	GJA1
R-HSA-191650	Regulation of gap junction activity	0.0585861388468277	-2.83725714882884	3	1	0.00483091787439614	207	10391	2697	GJA1
R-HSA-190704	Oligomerization of connexins into connexons	0.0585861388468277	-2.83725714882884	3	1	0.00483091787439614	207	10391	2697	GJA1
R-HSA-450302	activated TAK1 mediates p38 MAPK activation	0.0593246133759115	-2.82473099373319	20	2	0.00966183574879227	207	10391	23118,6885	TAB2,MAP3K7
R-HSA-194840	Rho GTPase cycle	0.0643758652013559	-2.74301648006749	142	6	0.0289855072463768	207	10391	7204,10395,10928,26084,1894,399	TRIO,DLC1,RALBP1,ARHGEF26,ECT2,RHOH
R-HSA-445144	Signal transduction by L1	0.0647321422341203	-2.73749741205314	21	2	0.00966183574879227	207	10391	3685,8829	ITGAV,NRP1
R-HSA-170834	Signaling by TGF-beta Receptor Complex	0.0673429439475794	-2.69795714853953	77	4	0.0193236714975845	207	10391	7048,1030,9958,7029	TGFBR2,CDKN2B,USP15,TFDP2
R-HSA-418597	G alpha (z) signalling events	0.0701384200461563	-2.65728456024157	48	3	0.0144927536231884	207	10391	5581,5583,54331	PRKCE,PRKCH,GNG2
R-HSA-1250196	SHC1 events in ERBB2 signaling	0.0702978035026657	-2.65501472528144	22	2	0.00966183574879227	207	10391	5581,3084	PRKCE,NRG1
R-HSA-140875	Common Pathway of Fibrin Clot Formation	0.0702978035026657	-2.65501472528144	22	2	0.00966183574879227	207	10391	5270,5627	SERPINE2,PROS1
R-HSA-1474228	Degradation of the extracellular matrix	0.0728676832317327	-2.61911004097494	112	5	0.0241545893719807	207	10391	4325,84570,136227,1511,3912	MMP16,COL25A1,COL26A1,CTSG,LAMB1
R-HSA-8855121	VLDL interactions	0.0760132207269706	-2.57684799689074	23	2	0.00966183574879227	207	10391	7436,1213	VLDLR,CLTC
R-HSA-1855191	Synthesis of IPs in the nucleus	0.0773455409694874	-2.55947235107804	4	1	0.00483091787439614	207	10391	253430	IPMK
R-HSA-6783984	Glycine degradation	0.0773455409694874	-2.55947235107804	4	1	0.00483091787439614	207	10391	2731	GLDC
R-HSA-140179	Amine Oxidase reactions	0.0773455409694874	-2.55947235107804	4	1	0.00483091787439614	207	10391	4129	MAOB
R-HSA-112313	Neurotransmitter uptake and Metabolism In Glial Cells	0.0773455409694874	-2.55947235107804	4	1	0.00483091787439614	207	10391	6507	SLC1A3
R-HSA-173107	Binding and entry of HIV virion	0.0773455409694874	-2.55947235107804	4	1	0.00483091787439614	207	10391	7852	CXCR4
R-HSA-8848584	Wax biosynthesis	0.0773455409694874	-2.55947235107804	4	1	0.00483091787439614	207	10391	55711	FAR2
R-HSA-210455	Astrocytic Glutamate-Glutamine Uptake And Metabolism	0.0773455409694874	-2.55947235107804	4	1	0.00483091787439614	207	10391	6507	SLC1A3
R-HSA-73923	Lipid digestion, mobilization, and transport	0.0795832512934796	-2.53095161915721	115	5	0.0241545893719807	207	10391	9388,7436,19,646486,1213	LIPG,VLDLR,ABCA1,FABP12,CLTC
R-HSA-392154	Nitric oxide stimulates guanylate cyclase	0.0818702855620096	-2.50261916760659	24	2	0.00966183574879227	207	10391	4842,5139	NOS1,PDE3A
R-HSA-375276	Peptide ligand-binding receptors	0.0819221458789837	-2.5019859232222	188	7	0.0338164251207729	207	10391	5173,56923,886,6753,6364,301,7852	PDYN,NMUR2,CCKAR,SSTR3,CCL20,ANXA1,CXCR4
R-HSA-418592	ADP signalling through P2Y purinoceptor 1	0.0878611505120752	-2.4319975456867	25	2	0.00966183574879227	207	10391	5028,54331	P2RY1,GNG2
R-HSA-3000157	Laminin interactions	0.0878611505120752	-2.4319975456867	25	2	0.00966183574879227	207	10391	3685,3912	ITGAV,LAMB1
R-HSA-1251985	Nuclear signaling by ERBB4	0.0878611505120752	-2.4319975456867	25	2	0.00966183574879227	207	10391	23118,3084	TAB2,NRG1
R-HSA-112316	Neuronal System	0.089431762458911	-2.41427937512607	349	11	0.0531400966183575	207	10391	6507,56479,54331,84694,9369,23426,817,4747,347730,590,6197	SLC1A3,KCNQ5,GNG2,GJA10,NRXN3,GRIP1,CAMK2D,NEFL,LRRTM1,BCHE,RPS6KA3
R-HSA-5357956	TNFR1-induced NFkappaB signaling pathway	0.093978221818516	-2.36469220633648	26	2	0.00966183574879227	207	10391	23118,6885	TAB2,MAP3K7
R-HSA-3656535	TGFBR1 LBD Mutants in Cancer	0.0957328975706638	-2.34619328232501	5	1	0.00483091787439614	207	10391	7048	TGFBR2
R-HSA-112303	Electric Transmission Across Gap Junctions	0.0957328975706638	-2.34619328232501	5	1	0.00483091787439614	207	10391	84694	GJA10
R-HSA-390648	Muscarinic acetylcholine receptors	0.0957328975706638	-2.34619328232501	5	1	0.00483091787439614	207	10391	1131	CHRM3
R-HSA-111448	Activation of NOXA and translocation to mitochondria	0.0957328975706638	-2.34619328232501	5	1	0.00483091787439614	207	10391	7029	TFDP2
R-HSA-1306955	GRB7 events in ERBB2 signaling	0.0957328975706638	-2.34619328232501	5	1	0.00483091787439614	207	10391	3084	NRG1
R-HSA-3642278	Loss of Function of TGFBR2 in Cancer	0.0957328975706638	-2.34619328232501	5	1	0.00483091787439614	207	10391	7048	TGFBR2
R-HSA-70350	Fructose catabolism	0.0957328975706638	-2.34619328232501	5	1	0.00483091787439614	207	10391	216	ALDH1A1
R-HSA-8866376	Reelin signalling pathway	0.0957328975706638	-2.34619328232501	5	1	0.00483091787439614	207	10391	7436	VLDLR
R-HSA-2644605	FBXW7 Mutants and NOTCH1 in Cancer	0.0957328975706638	-2.34619328232501	5	1	0.00483091787439614	207	10391	55294	FBXW7
R-HSA-112307	Transmission across Electrical Synapses	0.0957328975706638	-2.34619328232501	5	1	0.00483091787439614	207	10391	84694	GJA10
R-HSA-3645790	TGFBR2 Kinase Domain Mutants in Cancer	0.0957328975706638	-2.34619328232501	5	1	0.00483091787439614	207	10391	7048	TGFBR2
R-HSA-2644607	Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling	0.0957328975706638	-2.34619328232501	5	1	0.00483091787439614	207	10391	55294	FBXW7
R-HSA-416482	G alpha (12/13) signalling events	0.0984864069539518	-2.31783674079453	88	4	0.0193236714975845	207	10391	26084,7204,54331,1894	ARHGEF26,TRIO,GNG2,ECT2
R-HSA-2173788	Downregulation of TGF-beta receptor signaling	0.100214152569772	-2.30044585709396	27	2	0.00966183574879227	207	10391	7048,9958	TGFBR2,USP15
R-HSA-114508	Effects of PIP2 hydrolysis	0.100214152569772	-2.30044585709396	27	2	0.00966183574879227	207	10391	5583,5581	PRKCH,PRKCE
R-HSA-5578775	Ion homeostasis	0.100412418147353	-2.29846939264645	56	3	0.0144927536231884	207	10391	483,4842,817	ATP1B3,NOS1,CAMK2D
R-HSA-3000178	ECM proteoglycans	0.104513809529515	-2.25843606770033	57	3	0.0144927536231884	207	10391	3912,4593,3685	LAMB1,MUSK,ITGAV
R-HSA-1368082	RORA activates gene expression	0.106561835951707	-2.23902984306195	28	2	0.00966183574879227	207	10391	10891,406	PPARGC1A,BMAL1
R-HSA-2980736	Peptide hormone metabolism	0.107969386414232	-2.22590755116753	91	4	0.0193236714975845	207	10391	9314,3670,1511,590	KLF4,ISL1,CTSG,BCHE
R-HSA-437239	Recycling pathway of L1	0.113014398656513	-2.1802400466482	29	2	0.00966183574879227	207	10391	1213,6197	CLTC,RPS6KA3
R-HSA-202040	G-protein activation	0.113014398656513	-2.1802400466482	29	2	0.00966183574879227	207	10391	5173,54331	PDYN,GNG2
R-HSA-445989	TAK1 activates NFkB by phosphorylation and activation of IKKs complex	0.113014398656513	-2.1802400466482	29	2	0.00966183574879227	207	10391	23118,6885	TAB2,MAP3K7
R-HSA-3304356	SMAD2/3 Phosphorylation Motif Mutants in Cancer	0.113755552125986	-2.17370341244346	6	1	0.00483091787439614	207	10391	7048	TGFBR2
R-HSA-6787639	GDP-fucose biosynthesis	0.113755552125986	-2.17370341244346	6	1	0.00483091787439614	207	10391	2762	GMDS
R-HSA-2142700	Synthesis of Lipoxins (LX)	0.113755552125986	-2.17370341244346	6	1	0.00483091787439614	207	10391	3248	HPGD
R-HSA-444257	RSK activation	0.113755552125986	-2.17370341244346	6	1	0.00483091787439614	207	10391	6197	RPS6KA3
R-HSA-193648	NRAGE signals death through JNK	0.117202878589407	-2.14384884079779	60	3	0.0144927536231884	207	10391	7204,26084,1894	TRIO,ARHGEF26,ECT2
R-HSA-2022090	Assembly of collagen fibrils and other multimeric structures	0.117202878589407	-2.14384884079779	60	3	0.0144927536231884	207	10391	1293,256076,1295	COL6A3,COL6A5,COL8A1
R-HSA-114608	Platelet degranulation	0.123522775436462	-2.09132972342716	132	5	0.0241545893719807	207	10391	308,5874,6694,5627,5099	ANXA5,RAB27B,SPP2,PROS1,PCDH7
R-HSA-352230	Amino acid transport across the plasma membrane	0.126207798150112	-2.06982553878635	31	2	0.00966183574879227	207	10391	6541,55117	SLC7A1,SLC6A15
R-HSA-114452	Activation of BH3-only proteins	0.126207798150112	-2.06982553878635	31	2	0.00966183574879227	207	10391	7534,7029	YWHAZ,TFDP2
R-HSA-1500931	Cell-Cell communication	0.129313540590159	-2.04551527641231	134	5	0.0241545893719807	207	10391	101928583,1006,1004,1009,1016	SLC7A14-AS1,CDH8,CDH6,CDH11,CDH18
R-HSA-447038	NrCAM interactions	0.13142070385673	-2.02935162174583	7	1	0.00483091787439614	207	10391	4897	NRCAM
R-HSA-6814848	Glycerophospholipid catabolism	0.13142070385673	-2.02935162174583	7	1	0.00483091787439614	207	10391	51573	GDE1
R-HSA-199920	CREB phosphorylation	0.13142070385673	-2.02935162174583	7	1	0.00483091787439614	207	10391	6197	RPS6KA3
R-HSA-174362	Transport and synthesis of PAPS	0.13142070385673	-2.02935162174583	7	1	0.00483091787439614	207	10391	9060	PAPSS2
R-HSA-3304349	Loss of Function of SMAD2/3 in Cancer	0.13142070385673	-2.02935162174583	7	1	0.00483091787439614	207	10391	7048	TGFBR2
R-HSA-2980767	Activation of NIMA Kinases NEK9, NEK6, NEK7	0.13142070385673	-2.02935162174583	7	1	0.00483091787439614	207	10391	140609	NEK7
R-HSA-5652084	Fructose metabolism	0.13142070385673	-2.02935162174583	7	1	0.00483091787439614	207	10391	216	ALDH1A1
R-HSA-3315487	SMAD2/3 MH2 Domain Mutants in Cancer	0.13142070385673	-2.02935162174583	7	1	0.00483091787439614	207	10391	7048	TGFBR2
R-HSA-2993913	Clearance of Nuclear Envelope Membranes from Chromatin	0.13142070385673	-2.02935162174583	7	1	0.00483091787439614	207	10391	7444	VRK2
R-HSA-399721	Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity	0.132935999063409	-2.01788747662866	32	2	0.00966183574879227	207	10391	23426,817	GRIP1,CAMK2D
R-HSA-399719	Trafficking of AMPA receptors	0.132935999063409	-2.01788747662866	32	2	0.00966183574879227	207	10391	23426,817	GRIP1,CAMK2D
R-HSA-168638	NOD1/2 Signaling Pathway	0.132935999063409	-2.01788747662866	32	2	0.00966183574879227	207	10391	23118,6885	TAB2,MAP3K7
R-HSA-450294	MAP kinase activation in TLR cascade	0.134958433577788	-2.00278844737826	64	3	0.0144927536231884	207	10391	6885,23118,6197	MAP3K7,TAB2,RPS6KA3
R-HSA-76005	Response to elevated platelet cytosolic Ca2+	0.138227316605683	-1.97885572722643	137	5	0.0241545893719807	207	10391	5099,5627,6694,5874,308	PCDH7,PROS1,SPP2,RAB27B,ANXA5
R-HSA-1592389	Activation of Matrix Metalloproteinases	0.139743795511563	-1.96794456498751	33	2	0.00966183574879227	207	10391	4325,1511	MMP16,CTSG
R-HSA-392518	Signal amplification	0.139743795511563	-1.96794456498751	33	2	0.00966183574879227	207	10391	5028,54331	P2RY1,GNG2
R-HSA-1222556	ROS, RNS production in phagocytes	0.139743795511563	-1.96794456498751	33	2	0.00966183574879227	207	10391	127124,4842	ATP6V1G3,NOS1
R-HSA-112315	Transmission across Chemical Synapses	0.142746486908041	-1.94668504085014	217	7	0.0338164251207729	207	10391	817,6197,590,4747,54331,6507,23426	CAMK2D,RPS6KA3,BCHE,NEFL,GNG2,SLC1A3,GRIP1
R-HSA-2173789	TGF-beta receptor signaling activates SMADs	0.146625388821111	-1.91987432020563	34	2	0.00966183574879227	207	10391	7048,9958	TGFBR2,USP15
R-HSA-2173796	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	0.146625388821111	-1.91987432020563	34	2	0.00966183574879227	207	10391	1030,7029	CDKN2B,TFDP2
R-HSA-444473	Formyl peptide receptors bind formyl peptides and many other ligands	0.148735410550213	-1.90558631970129	8	1	0.00483091787439614	207	10391	301	ANXA1
R-HSA-77111	Synthesis of Ketone Bodies	0.148735410550213	-1.90558631970129	8	1	0.00483091787439614	207	10391	79611	ACSS3
R-HSA-195399	VEGF binds to VEGFR leading to receptor dimerization	0.148735410550213	-1.90558631970129	8	1	0.00483091787439614	207	10391	3791	KDR
R-HSA-194313	VEGF ligand-receptor interactions	0.148735410550213	-1.90558631970129	8	1	0.00483091787439614	207	10391	3791	KDR
R-HSA-1253288	Downregulation of ERBB4 signaling	0.148735410550213	-1.90558631970129	8	1	0.00483091787439614	207	10391	11059	WWP1
R-HSA-3656532	TGFBR1 KD Mutants in Cancer	0.148735410550213	-1.90558631970129	8	1	0.00483091787439614	207	10391	7048	TGFBR2
R-HSA-3656534	Loss of Function of TGFBR1 in Cancer	0.148735410550213	-1.90558631970129	8	1	0.00483091787439614	207	10391	7048	TGFBR2
R-HSA-1236973	Cross-presentation of particulate exogenous antigens (phagosomes)	0.148735410550213	-1.90558631970129	8	1	0.00483091787439614	207	10391	3685	ITGAV
R-HSA-2142789	Ubiquinol biosynthesis	0.148735410550213	-1.90558631970129	8	1	0.00483091787439614	207	10391	57107	PDSS2
R-HSA-913709	O-linked glycosylation of mucins	0.148844565779272	-1.9048527002199	67	3	0.0144927536231884	207	10391	2650,84002,56913	GCNT1,B3GNT5,C1GALT1
R-HSA-5689603	UCH proteinases	0.157164092443016	-1.85046484465244	105	4	0.0193236714975845	207	10391	125476,9958,55252,7048	INO80C,USP15,ASXL2,TGFBR2
R-HSA-452723	Transcriptional regulation of pluripotent stem cells	0.160587752837501	-1.82891473917246	36	2	0.00966183574879227	207	10391	63978,9314	PRDM14,KLF4
R-HSA-445355	Smooth Muscle Contraction	0.160587752837501	-1.82891473917246	36	2	0.00966183574879227	207	10391	301,800	ANXA1,CALD1
R-HSA-6806003	Regulation of TP53 Expression and Degradation	0.160587752837501	-1.82891473917246	36	2	0.00966183574879227	207	10391	639,117584	PRDM1,RFFL
R-HSA-425393	Transport of inorganic cations/anions and amino acids/oligopeptides	0.164785799655939	-1.80310883235566	107	4	0.0193236714975845	207	10391	6541,55117,6507,6508	SLC7A1,SLC6A15,SLC1A3,SLC4A3
R-HSA-426486	Small interfering RNA (siRNA) biogenesis	0.165706591321968	-1.7975365766928	9	1	0.00483091787439614	207	10391	7247	TSN
R-HSA-74182	Ketone body metabolism	0.165706591321968	-1.7975365766928	9	1	0.00483091787439614	207	10391	79611	ACSS3
R-HSA-159763	Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus	0.165706591321968	-1.7975365766928	9	1	0.00483091787439614	207	10391	5627	PROS1
R-HSA-3304351	Signaling by TGF-beta Receptor Complex in Cancer	0.165706591321968	-1.7975365766928	9	1	0.00483091787439614	207	10391	7048	TGFBR2
R-HSA-447041	CHL1 interactions	0.165706591321968	-1.7975365766928	9	1	0.00483091787439614	207	10391	8829	NRP1
R-HSA-112314	Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell	0.166511020079566	-1.79269378508782	146	5	0.0241545893719807	207	10391	817,23426,6197,4747,54331	CAMK2D,GRIP1,RPS6KA3,NEFL,GNG2
R-HSA-5083635	Defective B3GALTL causes Peters-plus syndrome (PpS)	0.167657891342311	-1.78582973683881	37	2	0.00966183574879227	207	10391	80070,80731	ADAMTS20,THSD7B
R-HSA-3299685	Detoxification of Reactive Oxygen Species	0.174780551724106	-1.74422408211015	38	2	0.00966183574879227	207	10391	2936,50507	GSR,NOX4
R-HSA-69231	Cyclin D associated events in G1	0.181950868688036	-1.70401858061255	39	2	0.00966183574879227	207	10391	1030,7029	CDKN2B,TFDP2
R-HSA-140877	Formation of Fibrin Clot (Clotting Cascade)	0.181950868688036	-1.70401858061255	39	2	0.00966183574879227	207	10391	5270,5627	SERPINE2,PROS1
R-HSA-69236	G1 Phase	0.181950868688036	-1.70401858061255	39	2	0.00966183574879227	207	10391	1030,7029	CDKN2B,TFDP2
R-HSA-5173214	O-glycosylation of TSR domain-containing proteins	0.181950868688036	-1.70401858061255	39	2	0.00966183574879227	207	10391	80070,80731	ADAMTS20,THSD7B
R-HSA-442380	Zinc influx into cells by the SLC39 gene family	0.182341029354415	-1.70187655759389	10	1	0.00483091787439614	207	10391	64116	SLC39A8
R-HSA-159740	Gamma-carboxylation of protein precursors	0.182341029354415	-1.70187655759389	10	1	0.00483091787439614	207	10391	5627	PROS1
R-HSA-139915	Activation of PUMA and translocation to mitochondria	0.182341029354415	-1.70187655759389	10	1	0.00483091787439614	207	10391	7029	TFDP2
R-HSA-399997	Acetylcholine regulates insulin secretion	0.182341029354415	-1.70187655759389	10	1	0.00483091787439614	207	10391	1131	CHRM3
R-HSA-112311	Neurotransmitter Clearance In The Synaptic Cleft	0.182341029354415	-1.70187655759389	10	1	0.00483091787439614	207	10391	590	BCHE
R-HSA-1300644	Interaction With The Zona Pellucida	0.182341029354415	-1.70187655759389	10	1	0.00483091787439614	207	10391	57829	ZP4
R-HSA-425381	Bicarbonate transporters	0.182341029354415	-1.70187655759389	10	1	0.00483091787439614	207	10391	6508	SLC4A3
R-HSA-1250342	PI3K events in ERBB4 signaling	0.182341029354415	-1.70187655759389	10	1	0.00483091787439614	207	10391	3084	NRG1
R-HSA-430116	GP1b-IX-V activation signalling	0.182341029354415	-1.70187655759389	10	1	0.00483091787439614	207	10391	7534	YWHAZ
R-HSA-159782	Removal of aminoterminal propeptides from gamma-carboxylated proteins	0.182341029354415	-1.70187655759389	10	1	0.00483091787439614	207	10391	5627	PROS1
R-HSA-2151209	Activation of PPARGC1A (PGC-1alpha) by phosphorylation	0.182341029354415	-1.70187655759389	10	1	0.00483091787439614	207	10391	10891	PPARGC1A
R-HSA-1980143	Signaling by NOTCH1	0.182871946465006	-1.69896911717015	74	3	0.0144927536231884	207	10391	1272,9734,55294	CNTN1,HDAC9,FBXW7
R-HSA-174824	Lipoprotein metabolism	0.182871946465006	-1.69896911717015	74	3	0.0144927536231884	207	10391	19,1213,7436	ABCA1,CLTC,VLDLR
R-HSA-375165	NCAM signaling for neurite out-growth	0.185863518199952	-1.68274264773073	276	8	0.0386473429951691	207	10391	256076,8911,817,3084,284,22866,1293,4747	COL6A5,CACNA1I,CAMK2D,NRG1,ANGPT1,CNKSR2,COL6A3,NEFL
R-HSA-157118	Signaling by NOTCH	0.188410447735862	-1.66913246330387	113	4	0.0193236714975845	207	10391	9734,55294,1272,7029	HDAC9,FBXW7,CNTN1,TFDP2
R-HSA-420499	Class C/3 (Metabotropic glutamate/pheromone receptors)	0.189164148202603	-1.66514013184973	40	2	0.00966183574879227	207	10391	80834,2913	TAS1R2,GRM3
R-HSA-204998	Cell death signalling via NRAGE, NRIF and NADE	0.192953048090073	-1.6453083938179	76	3	0.0144927536231884	207	10391	1894,7204,26084	ECT2,TRIO,ARHGEF26
R-HSA-1442490	Collagen degradation	0.196415862659893	-1.62752111921586	41	2	0.00966183574879227	207	10391	84570,136227	COL25A1,COL26A1
R-HSA-159854	Gamma-carboxylation, transport, and amino-terminal cleavage of proteins	0.198645374495671	-1.61623408168595	11	1	0.00483091787439614	207	10391	5627	PROS1
R-HSA-380320	Recruitment of NuMA to mitotic centrosomes	0.198645374495671	-1.61623408168595	11	1	0.00483091787439614	207	10391	121441	NEDD1
R-HSA-1855183	Synthesis of IP2, IP, and Ins in the cytosol	0.198645374495671	-1.61623408168595	11	1	0.00483091787439614	207	10391	8821	INPP4B
R-HSA-549127	Organic cation transport	0.198645374495671	-1.61623408168595	11	1	0.00483091787439614	207	10391	100506403	LOC100506403
R-HSA-8866654	E3 ubiquitin ligases ubiquitinate target proteins	0.203701646167915	-1.59109887444715	42	2	0.00966183574879227	207	10391	8915,220441	BCL10,RNF152
R-HSA-1483255	PI Metabolism	0.208325551486035	-1.56865327147851	79	3	0.0144927536231884	207	10391	8821,54477,51573	INPP4B,PLEKHA5,GDE1
R-HSA-75893	TNF signaling	0.211017289936268	-1.55581520603728	43	2	0.00966183574879227	207	10391	23118,6885	TAB2,MAP3K7
R-HSA-6803211	TP53 Regulates Transcription of Death Receptors and Ligands	0.214626145933735	-1.53885762054178	12	1	0.00483091787439614	207	10391	3486	IGFBP3
R-HSA-417957	P2Y receptors	0.214626145933735	-1.53885762054178	12	1	0.00483091787439614	207	10391	5028	P2RY1
R-HSA-75035	Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex	0.214626145933735	-1.53885762054178	12	1	0.00483091787439614	207	10391	7534	YWHAZ
R-HSA-210990	PECAM1 interactions	0.214626145933735	-1.53885762054178	12	1	0.00483091787439614	207	10391	3685	ITGAV
R-HSA-71384	Ethanol oxidation	0.214626145933735	-1.53885762054178	12	1	0.00483091787439614	207	10391	216	ALDH1A1
R-HSA-109606	Intrinsic Pathway for Apoptosis	0.218358737817646	-1.52161598236718	44	2	0.00966183574879227	207	10391	7534,7029	YWHAZ,TFDP2
R-HSA-1660661	Sphingolipid de novo biosynthesis	0.218358737817646	-1.52161598236718	44	2	0.00966183574879227	207	10391	171546,130367	SPTSSA,SGPP2
R-HSA-3000171	Non-integrin membrane-ECM interactions	0.225722081945875	-1.48845076234641	45	2	0.00966183574879227	207	10391	3912,3685	LAMB1,ITGAV
R-HSA-400511	Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)	0.23028973469633	-1.46841704676452	13	1	0.00483091787439614	207	10391	3670	ISL1
R-HSA-2995383	Initiation of Nuclear Envelope Reformation	0.23028973469633	-1.46841704676452	13	1	0.00483091787439614	207	10391	7444	VRK2
R-HSA-1480926	O2/CO2 exchange in erythrocytes	0.23028973469633	-1.46841704676452	13	1	0.00483091787439614	207	10391	51700	CYB5R2
R-HSA-113501	Inhibition of replication initiation of damaged DNA by RB1/E2F1	0.23028973469633	-1.46841704676452	13	1	0.00483091787439614	207	10391	7029	TFDP2
R-HSA-1237044	Erythrocytes take up carbon dioxide and release oxygen	0.23028973469633	-1.46841704676452	13	1	0.00483091787439614	207	10391	51700	CYB5R2
R-HSA-71240	Tryptophan catabolism	0.23028973469633	-1.46841704676452	13	1	0.00483091787439614	207	10391	169355	IDO2
R-HSA-8847993	ERBB2 Activates PTK6 Signaling	0.23028973469633	-1.46841704676452	13	1	0.00483091787439614	207	10391	3084	NRG1
R-HSA-5140745	WNT5A-dependent internalization of FZD2, FZD5 and ROR2	0.23028973469633	-1.46841704676452	13	1	0.00483091787439614	207	10391	1213	CLTC
R-HSA-2995410	Nuclear Envelope Reassembly	0.23028973469633	-1.46841704676452	13	1	0.00483091787439614	207	10391	7444	VRK2
R-HSA-1358803	Downregulation of ERBB2:ERBB3 signaling	0.23028973469633	-1.46841704676452	13	1	0.00483091787439614	207	10391	3084	NRG1
R-HSA-446652	Interleukin-1 signaling	0.233103558493582	-1.45627246710422	46	2	0.00966183574879227	207	10391	23118,6885	TAB2,MAP3K7
R-HSA-2173793	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	0.233103558493582	-1.45627246710422	46	2	0.00966183574879227	207	10391	1030,7029	CDKN2B,TFDP2
R-HSA-1989781	PPARA activates gene expression	0.234218946326048	-1.4514989330289	124	4	0.0193236714975845	207	10391	406,23179,19,10891	BMAL1,RGL1,ABCA1,PPARGC1A
R-HSA-168142	Toll Like Receptor 10 (TLR10) Cascade	0.234511677826286	-1.45024989350295	84	3	0.0144927536231884	207	10391	6197,23118,6885	RPS6KA3,TAB2,MAP3K7
R-HSA-168176	Toll Like Receptor 5 (TLR5) Cascade	0.234511677826286	-1.45024989350295	84	3	0.0144927536231884	207	10391	23118,6197,6885	TAB2,RPS6KA3,MAP3K7
R-HSA-975871	MyD88 cascade initiated on plasma membrane	0.234511677826286	-1.45024989350295	84	3	0.0144927536231884	207	10391	6885,6197,23118	MAP3K7,RPS6KA3,TAB2
R-HSA-2871837	FCERI mediated NF-kB activation	0.239820095171896	-1.42786624018373	85	3	0.0144927536231884	207	10391	23118,6885,8915	TAB2,MAP3K7,BCL10
R-HSA-1483249	Inositol phosphate metabolism	0.240499543500394	-1.42503708756538	47	2	0.00966183574879227	207	10391	253430,8821	IPMK,INPP4B
R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	0.242830242339818	-1.41539267096429	126	4	0.0193236714975845	207	10391	23118,6197,6885,4064	TAB2,RPS6KA3,MAP3K7,CD180
R-HSA-166520	Signalling by NGF	0.244932768839535	-1.40677151899538	478	12	0.0579710144927536	207	10391	7204,22866,1213,26084,3084,284,5581,817,6197,4747,6014,1894	TRIO,CNKSR2,CLTC,ARHGEF26,NRG1,ANGPT1,PRKCE,CAMK2D,RPS6KA3,NEFL,RIT2,ECT2
R-HSA-1660516	Synthesis of PIPs at the early endosome membrane	0.245642406200392	-1.40387843393143	14	1	0.00483091787439614	207	10391	8821	INPP4B
R-HSA-419408	Lysosphingolipid and LPA receptors	0.245642406200392	-1.40387843393143	14	1	0.00483091787439614	207	10391	54886	PLPPR1
R-HSA-162594	Early Phase of HIV Life Cycle	0.245642406200392	-1.40387843393143	14	1	0.00483091787439614	207	10391	7852	CXCR4
R-HSA-177504	Retrograde neurotrophin signalling	0.245642406200392	-1.40387843393143	14	1	0.00483091787439614	207	10391	1213	CLTC
R-HSA-1250347	SHC1 events in ERBB4 signaling	0.245642406200392	-1.40387843393143	14	1	0.00483091787439614	207	10391	3084	NRG1
R-HSA-400206	Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)	0.247163020967134	-1.39770715614543	127	4	0.0193236714975845	207	10391	406,23179,19,10891	BMAL1,RGL1,ABCA1,PPARGC1A
R-HSA-168643	Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	0.247906548862595	-1.39470342293375	48	2	0.00966183574879227	207	10391	23118,6885	TAB2,MAP3K7
R-HSA-1368108	BMAL1:CLOCK,NPAS2 activates circadian gene expression	0.247906548862595	-1.39470342293375	48	2	0.00966183574879227	207	10391	406,10891	BMAL1,PPARGC1A
R-HSA-2122947	NOTCH1 Intracellular Domain Regulates Transcription	0.247906548862595	-1.39470342293375	48	2	0.00966183574879227	207	10391	9734,55294	HDAC9,FBXW7
R-HSA-380108	Chemokine receptors bind chemokines	0.247906548862595	-1.39470342293375	48	2	0.00966183574879227	207	10391	7852,6364	CXCR4,CCL20
R-HSA-381340	Transcriptional regulation of white adipocyte differentiation	0.255861473812499	-1.36311909887964	88	3	0.0144927536231884	207	10391	688,9314,10891	KLF5,KLF4,PPARGC1A
R-HSA-156581	Methylation	0.260690302696578	-1.34442215590913	15	1	0.00483091787439614	207	10391	27430	MAT2B
R-HSA-5099900	WNT5A-dependent internalization of FZD4	0.260690302696578	-1.34442215590913	15	1	0.00483091787439614	207	10391	1213	CLTC
R-HSA-6785631	ERBB2 Regulates Cell Motility	0.260690302696578	-1.34442215590913	15	1	0.00483091787439614	207	10391	3084	NRG1
R-HSA-5682910	LGI-ADAM interactions	0.260690302696578	-1.34442215590913	15	1	0.00483091787439614	207	10391	9211	LGI1
R-HSA-111447	Activation of BAD and translocation to mitochondria	0.260690302696578	-1.34442215590913	15	1	0.00483091787439614	207	10391	7534	YWHAZ
R-HSA-2162123	Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	0.260690302696578	-1.34442215590913	15	1	0.00483091787439614	207	10391	3248	HPGD
R-HSA-1660499	Synthesis of PIPs at the plasma membrane	0.262740324086779	-1.336589095453	50	2	0.00966183574879227	207	10391	8821,54477	INPP4B,PLEKHA5
R-HSA-73887	Death Receptor Signalling	0.262740324086779	-1.336589095453	50	2	0.00966183574879227	207	10391	23118,6885	TAB2,MAP3K7
R-HSA-383280	Nuclear Receptor transcription pathway	0.270160762159729	-1.30873808176678	51	2	0.00966183574879227	207	10391	5915,7181	RARB,NR2C1
R-HSA-1227986	Signaling by ERBB2	0.270160762159729	-1.30873808176678	51	2	0.00966183574879227	207	10391	3084,5581	NRG1,PRKCE
R-HSA-556833	Metabolism of lipids and lipoproteins	0.27131260978834	-1.30448358126601	816	19	0.0917874396135266	207	10391	590,3248,9388,646486,130367,406,7436,171546,19,8821,84803,1213,51573,23179,54477,57107,55711,10891,79611	BCHE,HPGD,LIPG,FABP12,SGPP2,BMAL1,VLDLR,SPTSSA,ABCA1,INPP4B,GPAT3,CLTC,GDE1,RGL1,PLEKHA5,PDSS2,FAR2,PPARGC1A,ACSS3
R-HSA-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	0.272047601259245	-1.30177822336808	91	3	0.0144927536231884	207	10391	23118,6197,6885	TAB2,RPS6KA3,MAP3K7
R-HSA-418346	Platelet homeostasis	0.272047601259245	-1.30177822336808	91	3	0.0144927536231884	207	10391	4842,54331,5139	NOS1,GNG2,PDE3A
R-HSA-549132	Organic cation/anion/zwitterion transport	0.275439445656548	-1.28938747252814	16	1	0.00483091787439614	207	10391	100506403	LOC100506403
R-HSA-418038	Nucleotide-like (purinergic) receptors	0.275439445656548	-1.28938747252814	16	1	0.00483091787439614	207	10391	5028	P2RY1
R-HSA-392517	Rap1 signalling	0.275439445656548	-1.28938747252814	16	1	0.00483091787439614	207	10391	7534	YWHAZ
R-HSA-1963642	PI3K events in ERBB2 signaling	0.275439445656548	-1.28938747252814	16	1	0.00483091787439614	207	10391	3084	NRG1
R-HSA-1963640	GRB2 events in ERBB2 signaling	0.275439445656548	-1.28938747252814	16	1	0.00483091787439614	207	10391	3084	NRG1
R-HSA-2980766	Nuclear Envelope Breakdown	0.2775795496463	-1.28164772148425	52	2	0.00966183574879227	207	10391	7444,140609	VRK2,NEK7
R-HSA-168181	Toll Like Receptor 7/8 (TLR7/8) Cascade	0.282900675793684	-1.26265941186982	93	3	0.0144927536231884	207	10391	6885,23118,6197	MAP3K7,TAB2,RPS6KA3
R-HSA-975155	MyD88 dependent cascade initiated on endosome	0.282900675793684	-1.26265941186982	93	3	0.0144927536231884	207	10391	6885,23118,6197	MAP3K7,TAB2,RPS6KA3
R-HSA-416993	Trafficking of GluR2-containing AMPA receptors	0.289895738165024	-1.23823394421459	17	1	0.00483091787439614	207	10391	23426	GRIP1
R-HSA-192456	Digestion of dietary lipid	0.289895738165024	-1.23823394421459	17	1	0.00483091787439614	207	10391	9388	LIPG
R-HSA-429958	mRNA decay by 3' to 5' exoribonuclease	0.289895738165024	-1.23823394421459	17	1	0.00483091787439614	207	10391	23404	EXOSC2
R-HSA-2173791	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	0.289895738165024	-1.23823394421459	17	1	0.00483091787439614	207	10391	7048	TGFBR2
R-HSA-435354	Zinc transporters	0.289895738165024	-1.23823394421459	17	1	0.00483091787439614	207	10391	64116	SLC39A8
R-HSA-166658	Complement cascade	0.292400823478052	-1.22962973483807	54	2	0.00966183574879227	207	10391	10584,5627	COLEC10,PROS1
R-HSA-166058	MyD88:Mal cascade initiated on plasma membrane	0.293791424829933	-1.22488520276861	95	3	0.0144927536231884	207	10391	6197,23118,6885	RPS6KA3,TAB2,MAP3K7
R-HSA-181438	Toll Like Receptor 2 (TLR2) Cascade	0.293791424829933	-1.22488520276861	95	3	0.0144927536231884	207	10391	6885,6197,23118	MAP3K7,RPS6KA3,TAB2
R-HSA-168188	Toll Like Receptor TLR6:TLR2 Cascade	0.293791424829933	-1.22488520276861	95	3	0.0144927536231884	207	10391	6197,23118,6885	RPS6KA3,TAB2,MAP3K7
R-HSA-168179	Toll Like Receptor TLR1:TLR2 Cascade	0.293791424829933	-1.22488520276861	95	3	0.0144927536231884	207	10391	6885,6197,23118	MAP3K7,RPS6KA3,TAB2
R-HSA-450513	Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA	0.304064967214357	-1.19051389246624	18	1	0.00483091787439614	207	10391	23404	EXOSC2
R-HSA-2022377	Metabolism of Angiotensinogen to Angiotensins	0.304064967214357	-1.19051389246624	18	1	0.00483091787439614	207	10391	1511	CTSG
R-HSA-450385	Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA	0.304064967214357	-1.19051389246624	18	1	0.00483091787439614	207	10391	23404	EXOSC2
R-HSA-210993	Tie2 Signaling	0.304064967214357	-1.19051389246624	18	1	0.00483091787439614	207	10391	284	ANGPT1
R-HSA-418457	cGMP effects	0.304064967214357	-1.19051389246624	18	1	0.00483091787439614	207	10391	5139	PDE3A
R-HSA-69205	G1/S-Specific Transcription	0.304064967214357	-1.19051389246624	18	1	0.00483091787439614	207	10391	7029	TFDP2
R-HSA-197264	Nicotinamide salvaging	0.304064967214357	-1.19051389246624	18	1	0.00483091787439614	207	10391	83594	NUDT12
R-HSA-168138	Toll Like Receptor 9 (TLR9) Cascade	0.304709786161502	-1.18839547613996	97	3	0.0144927536231884	207	10391	23118,6197,6885	TAB2,RPS6KA3,MAP3K7
R-HSA-193704	p75 NTR receptor-mediated signalling	0.310176271111183	-1.17061452661636	98	3	0.0144927536231884	207	10391	26084,7204,1894	ARHGEF26,TRIO,ECT2
R-HSA-202733	Cell surface interactions at the vascular wall	0.313780663695332	-1.1590610604182	142	4	0.0193236714975845	207	10391	483,3685,5627,284	ATP1B3,ITGAV,PROS1,ANGPT1
R-HSA-937061	TRIF-mediated TLR3/TLR4 signaling	0.315646042169	-1.15313381291653	99	3	0.0144927536231884	207	10391	6885,23118,6197	MAP3K7,TAB2,RPS6KA3
R-HSA-168164	Toll Like Receptor 3 (TLR3) Cascade	0.315646042169	-1.15313381291653	99	3	0.0144927536231884	207	10391	6197,23118,6885	RPS6KA3,TAB2,MAP3K7
R-HSA-166166	MyD88-independent TLR3/TLR4 cascade	0.315646042169	-1.15313381291653	99	3	0.0144927536231884	207	10391	6197,23118,6885	RPS6KA3,TAB2,MAP3K7
R-HSA-392851	Prostacyclin signalling through prostacyclin receptor	0.317952806004096	-1.14585231600778	19	1	0.00483091787439614	207	10391	54331	GNG2
R-HSA-442660	Na+/Cl- dependent neurotransmitter transporters	0.317952806004096	-1.14585231600778	19	1	0.00483091787439614	207	10391	55117	SLC6A15
R-HSA-5223345	Miscellaneous transport and binding events	0.317952806004096	-1.14585231600778	19	1	0.00483091787439614	207	10391	79815	NIPAL2
R-HSA-2168880	Scavenging of heme from plasma	0.317952806004096	-1.14585231600778	19	1	0.00483091787439614	207	10391	9332	CD163
R-HSA-6804114	TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest	0.317952806004096	-1.14585231600778	19	1	0.00483091787439614	207	10391	7029	TFDP2
R-HSA-156584	Cytosolic sulfonation of small molecules	0.317952806004096	-1.14585231600778	19	1	0.00483091787439614	207	10391	9060	PAPSS2
R-HSA-936837	Ion transport by P-type ATPases	0.321904905078751	-1.13349910289738	58	2	0.00966183574879227	207	10391	817,483	CAMK2D,ATP1B3
R-HSA-2894858	Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	0.321904905078751	-1.13349910289738	58	2	0.00966183574879227	207	10391	9734,55294	HDAC9,FBXW7
R-HSA-2644606	Constitutive Signaling by NOTCH1 PEST Domain Mutants	0.321904905078751	-1.13349910289738	58	2	0.00966183574879227	207	10391	55294,9734	FBXW7,HDAC9
R-HSA-2644603	Signaling by NOTCH1 in Cancer	0.321904905078751	-1.13349910289738	58	2	0.00966183574879227	207	10391	9734,55294	HDAC9,FBXW7
R-HSA-6794361	Interactions of neurexins and neuroligins at synapses	0.321904905078751	-1.13349910289738	58	2	0.00966183574879227	207	10391	9369,347730	NRXN3,LRRTM1
R-HSA-2644602	Signaling by NOTCH1 PEST Domain Mutants in Cancer	0.321904905078751	-1.13349910289738	58	2	0.00966183574879227	207	10391	9734,55294	HDAC9,FBXW7
R-HSA-2894862	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	0.321904905078751	-1.13349910289738	58	2	0.00966183574879227	207	10391	55294,9734	FBXW7,HDAC9
R-HSA-202424	Downstream TCR signaling	0.326590823431199	-1.11904719611179	101	3	0.0144927536231884	207	10391	23118,6885,8915	TAB2,MAP3K7,BCL10
R-HSA-5607764	CLEC7A (Dectin-1) signaling	0.326590823431199	-1.11904719611179	101	3	0.0144927536231884	207	10391	23118,6885,8915	TAB2,MAP3K7,BCL10
R-HSA-163560	Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis	0.331564816145278	-1.10393196465168	20	1	0.00483091787439614	207	10391	646486	FABP12
R-HSA-8874081	MET activates PTK2 signaling	0.331564816145278	-1.10393196465168	20	1	0.00483091787439614	207	10391	3912	LAMB1
R-HSA-194223	HDL-mediated lipid transport	0.331564816145278	-1.10393196465168	20	1	0.00483091787439614	207	10391	19	ABCA1
R-HSA-3000170	Syndecan interactions	0.331564816145278	-1.10393196465168	20	1	0.00483091787439614	207	10391	3685	ITGAV
R-HSA-418217	G beta:gamma signalling through PLC beta	0.331564816145278	-1.10393196465168	20	1	0.00483091787439614	207	10391	54331	GNG2
R-HSA-186797	Signaling by PDGF	0.334613033846115	-1.09478053767309	376	9	0.0434782608695652	207	10391	4747,817,5581,22866,1293,3084,284,256076,56034	NEFL,CAMK2D,PRKCE,CNKSR2,COL6A3,NRG1,ANGPT1,COL6A5,PDGFC
R-HSA-3906995	Diseases associated with O-glycosylation of proteins	0.336549593319211	-1.08900976090763	60	2	0.00966183574879227	207	10391	80070,80731	ADAMTS20,THSD7B
R-HSA-2454202	Fc epsilon receptor (FCERI) signaling	0.340233827634145	-1.07812216941297	378	9	0.0434782608695652	207	10391	7294,23118,4747,22866,3084,284,817,8915,6885	TXK,TAB2,NEFL,CNKSR2,NRG1,ANGPT1,CAMK2D,BCL10,MAP3K7
R-HSA-4086398	Ca2+ pathway	0.343837531500471	-1.0675860253236	61	2	0.00966183574879227	207	10391	54331,6885	GNG2,MAP3K7
R-HSA-500657	Presynaptic function of Kainate receptors	0.344906449846088	-1.06448205858767	21	1	0.00483091787439614	207	10391	54331	GNG2
R-HSA-2979096	NOTCH2 Activation and Transmission of Signal to the Nucleus	0.344906449846088	-1.06448205858767	21	1	0.00483091787439614	207	10391	1272	CNTN1
R-HSA-3858494	Beta-catenin independent WNT signaling	0.345485204109003	-1.06280546126738	149	4	0.0193236714975845	207	10391	1213,6885,144165,54331	CLTC,MAP3K7,PRICKLE1,GNG2
R-HSA-8852135	Protein ubiquitination	0.351099894870659	-1.04668449523628	62	2	0.00966183574879227	207	10391	8915,220441	BCL10,RNF152
R-HSA-1445148	Translocation of GLUT4 to the plasma membrane	0.351099894870659	-1.04668449523628	62	2	0.00966183574879227	207	10391	7534,9847	YWHAZ,C2CD5
R-HSA-425366	Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds	0.353931751864471	-1.0386511757783	106	3	0.0144927536231884	207	10391	55117,64116,100506403	SLC6A15,SLC39A8,LOC100506403
R-HSA-140837	Intrinsic Pathway of Fibrin Clot Formation	0.357983052042006	-1.02726963436683	22	1	0.00483091787439614	207	10391	5270	SERPINE2
R-HSA-198753	ERK/MAPK targets	0.357983052042006	-1.02726963436683	22	1	0.00483091787439614	207	10391	6197	RPS6KA3
R-HSA-194138	Signaling by VEGF	0.36048606684745	-1.02030197252568	338	8	0.0386473429951691	207	10391	817,22866,3791,3084,284,4747,3685,8829	CAMK2D,CNKSR2,KDR,NRG1,ANGPT1,NEFL,ITGAV,NRP1
R-HSA-168898	Toll-Like Receptors Cascades	0.363648541613085	-1.01156742280325	153	4	0.0193236714975845	207	10391	6197,23118,4064,6885	RPS6KA3,TAB2,CD180,MAP3K7
R-HSA-187037	NGF signalling via TRKA from the plasma membrane	0.365706517861719	-1.00592413101128	387	9	0.0434782608695652	207	10391	4747,6197,817,5581,22866,1213,284,3084,6014	NEFL,RPS6KA3,CAMK2D,PRKCE,CNKSR2,CLTC,ANGPT1,NRG1,RIT2
R-HSA-428930	Thromboxane signalling through TP receptor	0.370799862559148	-0.992092815950839	23	1	0.00483091787439614	207	10391	54331	GNG2
R-HSA-5620922	BBSome-mediated cargo-targeting to cilium	0.370799862559148	-0.992092815950839	23	1	0.00483091787439614	207	10391	6753	SSTR3
R-HSA-392170	ADP signalling through P2Y purinoceptor 12	0.370799862559148	-0.992092815950839	23	1	0.00483091787439614	207	10391	54331	GNG2
R-HSA-400508	Incretin synthesis, secretion, and inactivation	0.370799862559148	-0.992092815950839	23	1	0.00483091787439614	207	10391	3670	ISL1
R-HSA-3371571	HSF1-dependent transactivation	0.370799862559148	-0.992092815950839	23	1	0.00483091787439614	207	10391	817	CAMK2D
R-HSA-382551	Transmembrane transport of small molecules	0.372794698207524	-0.986727417818169	677	15	0.072463768115942	207	10391	79815,6541,54331,64116,6507,483,79139,6508,4308,817,1244,11059,55117,127124,100506403	NIPAL2,SLC7A1,GNG2,SLC39A8,SLC1A3,ATP1B3,DERL1,SLC4A3,TRPM1,CAMK2D,ABCC2,WWP1,SLC6A15,ATP6V1G3,LOC100506403
R-HSA-187706	Signalling to p38 via RIT and RIN	0.376868976076146	-0.975857695505987	249	6	0.0289855072463768	207	10391	22866,3084,284,817,6014,4747	CNKSR2,NRG1,ANGPT1,CAMK2D,RIT2,NEFL
R-HSA-171052	LDL-mediated lipid transport	0.38336201808167	-0.958775519314288	24	1	0.00483091787439614	207	10391	1213	CLTC
R-HSA-210500	Glutamate Neurotransmitter Release Cycle	0.38336201808167	-0.958775519314288	24	1	0.00483091787439614	207	10391	6507	SLC1A3
R-HSA-201451	Signaling by BMP	0.38336201808167	-0.958775519314288	24	1	0.00483091787439614	207	10391	658	BMPR1B
R-HSA-397014	Muscle contraction	0.383845197021153	-0.95751594043168	204	5	0.0241545893719807	207	10391	800,817,4842,301,483	CALD1,CAMK2D,NOS1,ANXA1,ATP1B3
R-HSA-535734	Fatty acid, triacylglycerol, and ketone body metabolism	0.391164550820165	-0.938626961440269	253	6	0.0289855072463768	207	10391	23179,84803,79611,19,10891,406	RGL1,GPAT3,ACSS3,ABCA1,PPARGC1A,BMAL1
R-HSA-216083	Integrin cell surface interactions	0.394038051680814	-0.931307796477459	68	2	0.00966183574879227	207	10391	3685,3791	ITGAV,KDR
R-HSA-1169091	Activation of NF-kappaB in B cells	0.394038051680814	-0.931307796477459	68	2	0.00966183574879227	207	10391	6885,8915	MAP3K7,BCL10
R-HSA-997272	Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits	0.395674554245735	-0.927163238330088	25	1	0.00483091787439614	207	10391	54331	GNG2
R-HSA-203927	MicroRNA (miRNA) biogenesis	0.395674554245735	-0.927163238330088	25	1	0.00483091787439614	207	10391	29102	DROSHA
R-HSA-425410	Metal ion SLC transporters	0.395674554245735	-0.927163238330088	25	1	0.00483091787439614	207	10391	64116	SLC39A8
R-HSA-1296059	G protein gated Potassium channels	0.395674554245735	-0.927163238330088	25	1	0.00483091787439614	207	10391	54331	GNG2
R-HSA-1538133	G0 and Early G1	0.395674554245735	-0.927163238330088	25	1	0.00483091787439614	207	10391	7029	TFDP2
R-HSA-982772	Growth hormone receptor signaling	0.395674554245735	-0.927163238330088	25	1	0.00483091787439614	207	10391	8835	SOCS2
R-HSA-389661	Glyoxylate metabolism and glycine degradation	0.395674554245735	-0.927163238330088	25	1	0.00483091787439614	207	10391	2731	GLDC
R-HSA-198725	Nuclear Events (kinase and transcription factor activation)	0.395674554245735	-0.927163238330088	25	1	0.00483091787439614	207	10391	6197	RPS6KA3
R-HSA-3295583	TRP channels	0.395674554245735	-0.927163238330088	25	1	0.00483091787439614	207	10391	4308	TRPM1
R-HSA-1296041	Activation of G protein gated Potassium channels	0.395674554245735	-0.927163238330088	25	1	0.00483091787439614	207	10391	54331	GNG2
R-HSA-499943	Synthesis and interconversion of nucleotide di- and triphosphates	0.395674554245735	-0.927163238330088	25	1	0.00483091787439614	207	10391	2936	GSR
R-HSA-1483257	Phospholipid metabolism	0.399709073235855	-0.91701831340778	208	5	0.0241545893719807	207	10391	51573,84803,54477,590,8821	GDE1,GPAT3,PLEKHA5,BCHE,INPP4B
R-HSA-909733	Interferon alpha/beta signaling	0.401073571316198	-0.913610398887607	69	2	0.00966183574879227	207	10391	3433,3454	IFIT2,IFNAR1
R-HSA-166054	Activated TLR4 signalling	0.40272956527299	-0.909489996206085	115	3	0.0144927536231884	207	10391	6885,6197,23118	MAP3K7,RPS6KA3,TAB2
R-HSA-983712	Ion channel transport	0.403669878440878	-0.907157867627872	209	5	0.0241545893719807	207	10391	483,11059,4308,817,127124	ATP1B3,WWP1,TRPM1,CAMK2D,ATP6V1G3
R-HSA-210991	Basigin interactions	0.407742407525657	-0.897119658069687	26	1	0.00483091787439614	207	10391	483	ATP1B3
R-HSA-912694	Regulation of IFNA signaling	0.407742407525657	-0.897119658069687	26	1	0.00483091787439614	207	10391	3454	IFNAR1
R-HSA-1187000	Fertilization	0.407742407525657	-0.897119658069687	26	1	0.00483091787439614	207	10391	57829	ZP4
R-HSA-1474165	Reproduction	0.407742407525657	-0.897119658069687	26	1	0.00483091787439614	207	10391	57829	ZP4
R-HSA-5218921	VEGFR2 mediated cell proliferation	0.409026703878718	-0.893974834413666	258	6	0.0289855072463768	207	10391	4747,3084,284,3791,22866,817	NEFL,NRG1,ANGPT1,KDR,CNKSR2,CAMK2D
R-HSA-400253	Circadian Clock	0.415028383347387	-0.879408367482013	71	2	0.00966183574879227	207	10391	406,10891	BMAL1,PPARGC1A
R-HSA-977606	Regulation of Complement cascade	0.419570417339218	-0.868523906996817	27	1	0.00483091787439614	207	10391	5627	PROS1
R-HSA-380994	ATF4 activates genes	0.419570417339218	-0.868523906996817	27	1	0.00483091787439614	207	10391	23404	EXOSC2
R-HSA-77387	Insulin receptor recycling	0.419570417339218	-0.868523906996817	27	1	0.00483091787439614	207	10391	127124	ATP6V1G3
R-HSA-5693554	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	0.419570417339218	-0.868523906996817	27	1	0.00483091787439614	207	10391	7486	WRN
R-HSA-380259	Loss of Nlp from mitotic centrosomes	0.421945207632273	-0.862879813109983	72	2	0.00966183574879227	207	10391	121441,55755	NEDD1,CDK5RAP2
R-HSA-380284	Loss of proteins required for interphase microtubule organization from the centrosome	0.421945207632273	-0.862879813109983	72	2	0.00966183574879227	207	10391	55755,121441	CDK5RAP2,NEDD1
R-HSA-6794362	Protein-protein interactions at synapses	0.421945207632273	-0.862879813109983	72	2	0.00966183574879227	207	10391	347730,9369	LRRTM1,NRXN3
R-HSA-187687	Signalling to ERKs	0.426847447915355	-0.851328594423032	263	6	0.0289855072463768	207	10391	817,3084,284,22866,4747,6014	CAMK2D,NRG1,ANGPT1,CNKSR2,NEFL,RIT2
R-HSA-1483191	Synthesis of PC	0.431163327767985	-0.841268309924302	28	1	0.00483091787439614	207	10391	590	BCHE
R-HSA-400042	Adrenaline,noradrenaline inhibits insulin secretion	0.431163327767985	-0.841268309924302	28	1	0.00483091787439614	207	10391	54331	GNG2
R-HSA-372790	Signaling by GPCR	0.431748343482082	-0.83991239871527	1345	28	0.135265700483092	207	10391	5139,3356,54331,56923,80834,5581,3084,4747,6197,1894,26084,5583,22866,7204,6753,7852,1131,6364,301,817,5028,284,5173,2913,54886,886,219981,3350	PDE3A,HTR2A,GNG2,NMUR2,TAS1R2,PRKCE,NRG1,NEFL,RPS6KA3,ECT2,ARHGEF26,PRKCH,CNKSR2,TRIO,SSTR3,CXCR4,CHRM3,CCL20,ANXA1,CAMK2D,P2RY1,ANGPT1,PDYN,GRM3,PLPPR1,CCKAR,OR5A2,HTR1A
R-HSA-2408522	Selenoamino acid metabolism	0.439965414497039	-0.82105915857506	122	3	0.0144927536231884	207	10391	6235,9060,2936	RPS29,PAPSS2,GSR
R-HSA-202403	TCR signaling	0.439965414497039	-0.82105915857506	122	3	0.0144927536231884	207	10391	6885,8915,23118	MAP3K7,BCL10,TAB2
R-HSA-8854518	AURKA Activation by TPX2	0.442439869193102	-0.815450712597023	75	2	0.00966183574879227	207	10391	55755,121441	CDK5RAP2,NEDD1
R-HSA-196807	Nicotinate metabolism	0.442525789520667	-0.815256534829811	29	1	0.00483091787439614	207	10391	83594	NUDT12
R-HSA-525793	Myogenesis	0.442525789520667	-0.815256534829811	29	1	0.00483091787439614	207	10391	1496	CTNNA2
R-HSA-375170	CDO in myogenesis	0.442525789520667	-0.815256534829811	29	1	0.00483091787439614	207	10391	1496	CTNNA2
R-HSA-8853659	RET signaling	0.451662210822265	-0.794820699723266	270	6	0.0289855072463768	207	10391	220164,4747,22866,3084,284,817	DOK6,NEFL,CNKSR2,NRG1,ANGPT1,CAMK2D
R-HSA-381042	PERK regulates gene expression	0.453662361756214	-0.790402054192485	30	1	0.00483091787439614	207	10391	23404	EXOSC2
R-HSA-5669034	TNFs bind their physiological receptors	0.453662361756214	-0.790402054192485	30	1	0.00483091787439614	207	10391	7292	TNFSF4
R-HSA-445095	Interaction between L1 and Ankyrins	0.453662361756214	-0.790402054192485	30	1	0.00483091787439614	207	10391	4897	NRCAM
R-HSA-917977	Transferrin endocytosis and recycling	0.453662361756214	-0.790402054192485	30	1	0.00483091787439614	207	10391	127124	ATP6V1G3
R-HSA-1912408	Pre-NOTCH Transcription and Translation	0.453662361756214	-0.790402054192485	30	1	0.00483091787439614	207	10391	7029	TFDP2
R-HSA-420092	Glucagon-type ligand receptors	0.453662361756214	-0.790402054192485	30	1	0.00483091787439614	207	10391	54331	GNG2
R-HSA-8863795	Downregulation of ERBB2 signaling	0.453662361756214	-0.790402054192485	30	1	0.00483091787439614	207	10391	3084	NRG1
R-HSA-512988	Interleukin-3, 5 and GM-CSF signaling	0.455189885565673	-0.787040616175945	271	6	0.0289855072463768	207	10391	7534,284,3084,22866,817,4747	YWHAZ,ANGPT1,NRG1,CNKSR2,CAMK2D,NEFL
R-HSA-2129379	Molecules associated with elastic fibres	0.46457751387744	-0.766626858703359	31	1	0.00483091787439614	207	10391	3685	ITGAV
R-HSA-166663	Initial triggering of complement	0.46457751387744	-0.766626858703359	31	1	0.00483091787439614	207	10391	10584	COLEC10
R-HSA-1296065	Inwardly rectifying K+ channels	0.46457751387744	-0.766626858703359	31	1	0.00483091787439614	207	10391	54331	GNG2
R-HSA-8875878	MET promotes cell motility	0.46457751387744	-0.766626858703359	31	1	0.00483091787439614	207	10391	3912	LAMB1
R-HSA-420029	Tight junction interactions	0.46457751387744	-0.766626858703359	31	1	0.00483091787439614	207	10391	101928583	SLC7A14-AS1
R-HSA-2122948	Activated NOTCH1 Transmits Signal to the Nucleus	0.46457751387744	-0.766626858703359	31	1	0.00483091787439614	207	10391	1272	CNTN1
R-HSA-450282	MAPK targets/ Nuclear events mediated by MAP kinases	0.46457751387744	-0.766626858703359	31	1	0.00483091787439614	207	10391	6197	RPS6KA3
R-HSA-70263	Gluconeogenesis	0.475275627259248	-0.743860375323617	32	1	0.00483091787439614	207	10391	10165	SLC25A13
R-HSA-456926	Thrombin signalling through proteinase activated receptors (PARs)	0.475275627259248	-0.743860375323617	32	1	0.00483091787439614	207	10391	54331	GNG2
R-HSA-451326	Activation of Kainate Receptors upon glutamate binding	0.475275627259248	-0.743860375323617	32	1	0.00483091787439614	207	10391	54331	GNG2
R-HSA-422356	Regulation of insulin secretion	0.47568714281456	-0.742994903837353	80	2	0.00966183574879227	207	10391	54331,1131	GNG2,CHRM3
R-HSA-392499	Metabolism of proteins	0.480076656525873	-0.733809486735495	1624	33	0.159420289855072	207	10391	7486,54331,125476,6235,27430,80070,3670,220441,2762,53942,9958,590,5874,55294,6622,56913,9215,55252,5069,80731,3486,2650,7048,84002,8915,79139,5067,6885,1511,10165,23404,9314,5627	WRN,GNG2,INO80C,RPS29,MAT2B,ADAMTS20,ISL1,RNF152,GMDS,CNTN5,USP15,BCHE,RAB27B,FBXW7,SNCA,C1GALT1,LARGE1,ASXL2,PAPPA,THSD7B,IGFBP3,GCNT1,TGFBR2,B3GNT5,BCL10,DERL1,CNTN3,MAP3K7,CTSG,SLC25A13,EXOSC2,KLF4,PROS1
R-HSA-70326	Glucose metabolism	0.482192567990575	-0.729411726065219	81	2	0.00966183574879227	207	10391	132789,10165	GNPDA2,SLC25A13
R-HSA-1980145	Signaling by NOTCH2	0.485760996994946	-0.722038551773551	33	1	0.00483091787439614	207	10391	1272	CNTN1
R-HSA-163359	Glucagon signaling in metabolic regulation	0.485760996994946	-0.722038551773551	33	1	0.00483091787439614	207	10391	54331	GNG2
R-HSA-4420097	VEGFA-VEGFR2 Pathway	0.48740489520145	-0.718660094342389	330	7	0.0338164251207729	207	10391	3685,817,3084,284,22866,3791,4747	ITGAV,CAMK2D,NRG1,ANGPT1,CNKSR2,KDR,NEFL
R-HSA-380287	Centrosome maturation	0.488648342750735	-0.716112183688287	82	2	0.00966183574879227	207	10391	121441,55755	NEDD1,CDK5RAP2
R-HSA-380270	Recruitment of mitotic centrosome proteins and complexes	0.488648342750735	-0.716112183688287	82	2	0.00966183574879227	207	10391	55755,121441	CDK5RAP2,NEDD1
R-HSA-5693568	Resolution of D-loop Structures through Holliday Junction Intermediates	0.496037833605428	-0.701103077735886	34	1	0.00483091787439614	207	10391	7486	WRN
R-HSA-1483166	Synthesis of PA	0.496037833605428	-0.701103077735886	34	1	0.00483091787439614	207	10391	84803	GPAT3
R-HSA-1489509	DAG and IP3 signaling	0.496037833605428	-0.701103077735886	34	1	0.00483091787439614	207	10391	5581	PRKCE
R-HSA-113510	E2F mediated regulation of DNA replication	0.496037833605428	-0.701103077735886	34	1	0.00483091787439614	207	10391	7029	TFDP2
R-HSA-597592	Post-translational protein modification	0.502731241835207	-0.687699562143887	1037	21	0.101449275362319	207	10391	7486,8915,125476,84002,7048,2650,80070,79139,27430,53942,9958,5067,2762,220441,5874,6885,56913,80731,5627,9215,55252	WRN,BCL10,INO80C,B3GNT5,TGFBR2,GCNT1,ADAMTS20,DERL1,MAT2B,CNTN5,USP15,CNTN3,GMDS,RNF152,RAB27B,MAP3K7,C1GALT1,THSD7B,PROS1,LARGE1,ASXL2
R-HSA-2514859	Inactivation, recovery and regulation of the phototransduction cascade	0.506110264661673	-0.681000719083422	35	1	0.00483091787439614	207	10391	5475	PPEF1
R-HSA-5693537	Resolution of D-Loop Structures	0.506110264661673	-0.681000719083422	35	1	0.00483091787439614	207	10391	7486	WRN
R-HSA-2029485	Role of phospholipids in phagocytosis	0.506110264661673	-0.681000719083422	35	1	0.00483091787439614	207	10391	5581	PRKCE
R-HSA-3301854	Nuclear Pore Complex (NPC) Disassembly	0.506110264661673	-0.681000719083422	35	1	0.00483091787439614	207	10391	140609	NEK7
R-HSA-6804757	Regulation of TP53 Degradation	0.506110264661673	-0.681000719083422	35	1	0.00483091787439614	207	10391	117584	RFFL
R-HSA-6802948	Signaling by high-kinase activity BRAF mutants	0.506110264661673	-0.681000719083422	35	1	0.00483091787439614	207	10391	22866	CNKSR2
R-HSA-111885	Opioid Signalling	0.507711880417465	-0.677841156834849	85	2	0.00966183574879227	207	10391	5173,54331	PDYN,GNG2
R-HSA-5628897	TP53 Regulates Metabolic Genes	0.507711880417465	-0.677841156834849	85	2	0.00966183574879227	207	10391	7534,2936	YWHAZ,GSR
R-HSA-425407	SLC-mediated transmembrane transport	0.510784697583399	-0.671807113018385	287	6	0.0289855072463768	207	10391	6541,6507,55117,100506403,64116,6508	SLC7A1,SLC1A3,SLC6A15,LOC100506403,SLC39A8,SLC4A3
R-HSA-3781865	Diseases of glycosylation	0.513963381901732	-0.665603257501083	86	2	0.00966183574879227	207	10391	80731,80070	THSD7B,ADAMTS20
R-HSA-167021	PLC-gamma1 signalling	0.515982336427897	-0.661682745815375	36	1	0.00483091787439614	207	10391	5581	PRKCE
R-HSA-532668	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	0.515982336427897	-0.661682745815375	36	1	0.00483091787439614	207	10391	79139	DERL1
R-HSA-2514856	The phototransduction cascade	0.515982336427897	-0.661682745815375	36	1	0.00483091787439614	207	10391	5475	PPEF1
R-HSA-212718	EGFR interacts with phospholipase C-gamma	0.515982336427897	-0.661682745815375	36	1	0.00483091787439614	207	10391	5581	PRKCE
R-HSA-432720	Lysosome Vesicle Biogenesis	0.515982336427897	-0.661682745815375	36	1	0.00483091787439614	207	10391	1213	CLTC
R-HSA-2871809	FCERI mediated Ca+2 mobilization	0.515982336427897	-0.661682745815375	36	1	0.00483091787439614	207	10391	7294	TXK
R-HSA-211000	Gene Silencing by RNA	0.521342532003369	-0.651348002192912	138	3	0.0144927536231884	207	10391	10526,7247,29102	IPO8,TSN,DROSHA
R-HSA-5685938	HDR through Single Strand Annealing (SSA)	0.535141190165783	-0.625224660051487	38	1	0.00483091787439614	207	10391	7486	WRN
R-HSA-2565942	Regulation of PLK1 Activity at G2/M Transition	0.538442721654458	-0.619074154515695	90	2	0.00966183574879227	207	10391	121441,55755	NEDD1,CDK5RAP2
R-HSA-428157	Sphingolipid metabolism	0.538442721654458	-0.619074154515695	90	2	0.00966183574879227	207	10391	171546,130367	SPTSSA,SGPP2
R-HSA-5576891	Cardiac conduction	0.540683859604888	-0.614920533964661	142	3	0.0144927536231884	207	10391	817,483,4842	CAMK2D,ATP1B3,NOS1
R-HSA-112412	SOS-mediated signalling	0.541779749807441	-0.612895725800322	245	5	0.0241545893719807	207	10391	4747,3084,284,22866,817	NEFL,NRG1,ANGPT1,CNKSR2,CAMK2D
R-HSA-179812	GRB2 events in EGFR signaling	0.541779749807441	-0.612895725800322	245	5	0.0241545893719807	207	10391	4747,22866,284,3084,817	NEFL,CNKSR2,ANGPT1,NRG1,CAMK2D
R-HSA-180336	SHC1 events in EGFR signaling	0.541779749807441	-0.612895725800322	245	5	0.0241545893719807	207	10391	4747,22866,3084,284,817	NEFL,CNKSR2,NRG1,ANGPT1,CAMK2D
R-HSA-5673001	RAF/MAP kinase cascade	0.541779749807441	-0.612895725800322	245	5	0.0241545893719807	207	10391	4747,817,22866,3084,284	NEFL,CAMK2D,CNKSR2,NRG1,ANGPT1
R-HSA-450531	Regulation of mRNA stability by proteins that bind AU-rich elements	0.544429128859206	-0.608017503282078	91	2	0.00966183574879227	207	10391	23404,7534	EXOSC2,YWHAZ
R-HSA-6802946	Signaling by moderate kinase activity BRAF mutants	0.544435672309885	-0.608005484433325	39	1	0.00483091787439614	207	10391	22866	CNKSR2
R-HSA-5674135	MAP2K and MAPK activation	0.544435672309885	-0.608005484433325	39	1	0.00483091787439614	207	10391	22866	CNKSR2
R-HSA-5696394	DNA Damage Recognition in GG-NER	0.544435672309885	-0.608005484433325	39	1	0.00483091787439614	207	10391	125476	INO80C
R-HSA-6802955	Paradoxical activation of RAF signaling by kinase inactive BRAF	0.544435672309885	-0.608005484433325	39	1	0.00483091787439614	207	10391	22866	CNKSR2
R-HSA-163841	Gamma carboxylation, hypusine formation and arylsulfatase activation	0.544435672309885	-0.608005484433325	39	1	0.00483091787439614	207	10391	5627	PROS1
R-HSA-163125	Post-translational modification: synthesis of GPI-anchored proteins	0.550361580892581	-0.597179796956661	92	2	0.00966183574879227	207	10391	5067,53942	CNTN3,CNTN5
R-HSA-977444	GABA B receptor activation	0.553545198564024	-0.591411870611806	40	1	0.00483091787439614	207	10391	54331	GNG2
R-HSA-5693616	Presynaptic phase of homologous DNA pairing and strand exchange	0.553545198564024	-0.591411870611806	40	1	0.00483091787439614	207	10391	7486	WRN
R-HSA-991365	Activation of GABAB receptors	0.553545198564024	-0.591411870611806	40	1	0.00483091787439614	207	10391	54331	GNG2
R-HSA-390471	Association of TriC/CCT with target proteins during biosynthesis	0.553545198564024	-0.591411870611806	40	1	0.00483091787439614	207	10391	55294	FBXW7
R-HSA-5621481	C-type lectin receptors (CLRs)	0.554894015393382	-0.588978146726675	145	3	0.0144927536231884	207	10391	23118,8915,6885	TAB2,BCL10,MAP3K7
R-HSA-2559583	Cellular Senescence	0.555226932018742	-0.58837836228676	197	4	0.0193236714975845	207	10391	7029,6197,2113,1030	TFDP2,RPS6KA3,ETS1,CDKN2B
R-HSA-170984	ARMS-mediated activation	0.556272380059114	-0.586497212496908	249	5	0.0241545893719807	207	10391	817,22866,284,3084,4747	CAMK2D,CNKSR2,ANGPT1,NRG1,NEFL
R-HSA-5688426	Deubiquitination	0.55766379078986	-0.583999023658441	301	6	0.0289855072463768	207	10391	55252,7048,6885,125476,9958,27430	ASXL2,TGFBR2,MAP3K7,INO80C,USP15,MAT2B
R-HSA-170968	Frs2-mediated activation	0.559860751384184	-0.580067184416058	250	5	0.0241545893719807	207	10391	4747,817,284,3084,22866	NEFL,CAMK2D,ANGPT1,NRG1,CNKSR2
R-HSA-5625740	RHO GTPases activate PKNs	0.56206370917107	-0.576140073999018	94	2	0.00966183574879227	207	10391	23081,7534	KDM4C,YWHAZ
R-HSA-388396	GPCR downstream signaling	0.563174542445447	-0.57416567678378	1019	20	0.0966183574879227	207	10391	5581,5028,5173,2913,886,219981,3350,1894,26084,5583,7204,5139,54331,3356,56923,6753,7852,1131,6364,301	PRKCE,P2RY1,PDYN,GRM3,CCKAR,OR5A2,HTR1A,ECT2,ARHGEF26,PRKCH,TRIO,PDE3A,GNG2,HTR2A,NMUR2,SSTR3,CXCR4,CHRM3,CCL20,ANXA1
R-HSA-5684996	MAPK1/MAPK3 signaling	0.563434830711723	-0.573703603101262	251	5	0.0241545893719807	207	10391	817,3084,284,22866,4747	CAMK2D,NRG1,ANGPT1,CNKSR2,NEFL
R-HSA-169893	Prolonged ERK activation events	0.566994437216961	-0.567405786207343	252	5	0.0241545893719807	207	10391	4747,817,3084,284,22866	NEFL,CAMK2D,NRG1,ANGPT1,CNKSR2
R-HSA-2029480	Fcgamma receptor (FCGR) dependent phagocytosis	0.567833005603537	-0.565927907707825	95	2	0.00966183574879227	207	10391	4651,5581	MYO10,PRKCE
R-HSA-2586552	Signaling by Leptin	0.570539394605075	-0.561173059294407	253	5	0.0241545893719807	207	10391	4747,22866,284,3084,817	NEFL,CNKSR2,ANGPT1,NRG1,CAMK2D
R-HSA-381676	Glucagon-like Peptide-1 (GLP1) regulates insulin secretion	0.571223963331459	-0.559973916225652	42	1	0.00483091787439614	207	10391	54331	GNG2
R-HSA-1566948	Elastic fibre formation	0.571223963331459	-0.559973916225652	42	1	0.00483091787439614	207	10391	3685	ITGAV
R-HSA-69473	G2/M DNA damage checkpoint	0.573547585090241	-0.555914372724466	96	2	0.00966183574879227	207	10391	7486,7534	WRN,YWHAZ
R-HSA-4086400	PCP/CE pathway	0.573547585090241	-0.555914372724466	96	2	0.00966183574879227	207	10391	1213,144165	CLTC,PRICKLE1
R-HSA-912526	Interleukin receptor SHC signaling	0.577584679096293	-0.548900216865613	255	5	0.0241545893719807	207	10391	4747,817,284,3084,22866	NEFL,CAMK2D,ANGPT1,NRG1,CNKSR2
R-HSA-6814122	Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding	0.579800312697076	-0.545071523175865	43	1	0.00483091787439614	207	10391	54331	GNG2
R-HSA-3769402	Deactivation of the beta-catenin transactivating complex	0.579800312697076	-0.545071523175865	43	1	0.00483091787439614	207	10391	7534	YWHAZ
R-HSA-432040	Vasopressin regulates renal water homeostasis via Aquaporins	0.579800312697076	-0.545071523175865	43	1	0.00483091787439614	207	10391	54331	GNG2
R-HSA-5693579	Homologous DNA Pairing and Strand Exchange	0.579800312697076	-0.545071523175865	43	1	0.00483091787439614	207	10391	7486	WRN
R-HSA-167044	Signalling to RAS	0.581084675792834	-0.542858791281609	256	5	0.0241545893719807	207	10391	817,3084,284,22866,4747	CAMK2D,NRG1,ANGPT1,CNKSR2,NEFL
R-HSA-1296072	Voltage gated Potassium channels	0.588205930715449	-0.53067817009184	44	1	0.00483091787439614	207	10391	56479	KCNQ5
R-HSA-917937	Iron uptake and transport	0.588205930715449	-0.53067817009184	44	1	0.00483091787439614	207	10391	127124	ATP6V1G3
R-HSA-6788656	Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism	0.588205930715449	-0.53067817009184	44	1	0.00483091787439614	207	10391	169355	IDO2
R-HSA-975634	Retinoid metabolism and transport	0.588205930715449	-0.53067817009184	44	1	0.00483091787439614	207	10391	5948	RBP2
R-HSA-390466	Chaperonin-mediated protein folding	0.590361958398304	-0.527019441379018	99	2	0.00966183574879227	207	10391	55294,54331	FBXW7,GNG2
R-HSA-5620912	Anchoring of the basal body to the plasma membrane	0.595856734305155	-0.517755019495	100	2	0.00966183574879227	207	10391	121441,55755	NEDD1,CDK5RAP2
R-HSA-1296071	Potassium Channels	0.595856734305155	-0.517755019495	100	2	0.00966183574879227	207	10391	56479,54331	KCNQ5,GNG2
R-HSA-5633008	TP53 Regulates Transcription of Cell Death Genes	0.596444199990465	-0.516769587518975	45	1	0.00483091787439614	207	10391	3486	IGFBP3
R-HSA-2151201	Transcriptional activation of mitochondrial biogenesis	0.596444199990465	-0.516769587518975	45	1	0.00483091787439614	207	10391	10891	PPARGC1A
R-HSA-2187338	Visual phototransduction	0.601296449676992	-0.508667205366165	101	2	0.00966183574879227	207	10391	5475,5948	PPEF1,RBP2
R-HSA-451927	Interleukin-2 signaling	0.601757897953616	-0.507900077430237	262	5	0.0241545893719807	207	10391	4747,22866,284,3084,817	NEFL,CNKSR2,ANGPT1,NRG1,CAMK2D
R-HSA-983231	Factors involved in megakaryocyte development and platelet production	0.60904229530608	-0.495867563263316	157	3	0.0144927536231884	207	10391	55619,221037,30845	DOCK10,JMJD1C,EHD3
R-HSA-3700989	Transcriptional Regulation by TP53	0.609367122576733	-0.495334364367148	370	7	0.0338164251207729	207	10391	639,2936,7534,7486,3486,117584,7029	PRDM1,GSR,YWHAZ,WRN,IGFBP3,RFFL,TFDP2
R-HSA-449147	Signaling by Interleukins	0.611472046561279	-0.491886037800383	528	10	0.0483091787439614	207	10391	6364,301,23118,4747,22866,284,7534,3084,817,6885	CCL20,ANXA1,TAB2,NEFL,CNKSR2,ANGPT1,YWHAZ,NRG1,CAMK2D,MAP3K7
R-HSA-5576892	Phase 0 - rapid depolarisation	0.612431890684228	-0.490317541629203	47	1	0.00483091787439614	207	10391	817	CAMK2D
R-HSA-1912422	Pre-NOTCH Expression and Processing	0.612431890684228	-0.490317541629203	47	1	0.00483091787439614	207	10391	7029	TFDP2
R-HSA-8854214	TBC/RABGAPs	0.612431890684228	-0.490317541629203	47	1	0.00483091787439614	207	10391	23637	RABGAP1
R-HSA-2672351	Stimuli-sensing channels	0.617285365772094	-0.482423856696128	104	2	0.00966183574879227	207	10391	11059,4308	WWP1,TRPM1
R-HSA-392451	G beta:gamma signalling through PI3Kgamma	0.620187749010345	-0.477733025799593	48	1	0.00483091787439614	207	10391	54331	GNG2
R-HSA-194315	Signaling by Rho GTPases	0.621262733589182	-0.476001205058324	427	8	0.0386473429951691	207	10391	7204,7534,10395,26084,10928,1894,23081,399	TRIO,YWHAZ,DLC1,ARHGEF26,RALBP1,ECT2,KDM4C,RHOH
R-HSA-391251	Protein folding	0.622505077004439	-0.474003494846109	105	2	0.00966183574879227	207	10391	54331,55294	GNG2,FBXW7
R-HSA-74752	Signaling by Insulin receptor	0.623823381017984	-0.471887993917417	322	6	0.0289855072463768	207	10391	4747,22866,3084,284,817,127124	NEFL,CNKSR2,NRG1,ANGPT1,CAMK2D,ATP6V1G3
R-HSA-6783783	Interleukin-10 signaling	0.62778913505091	-0.465550941109976	49	1	0.00483091787439614	207	10391	6364	CCL20
R-HSA-6791312	TP53 Regulates Transcription of Cell Cycle Genes	0.62778913505091	-0.465550941109976	49	1	0.00483091787439614	207	10391	7029	TFDP2
R-HSA-2173782	Binding and Uptake of Ligands by Scavenger Receptors	0.62778913505091	-0.465550941109976	49	1	0.00483091787439614	207	10391	9332	CD163
R-HSA-5633007	Regulation of TP53 Activity	0.630276693598335	-0.46159635982714	162	3	0.0144927536231884	207	10391	639,7486,117584	PRDM1,WRN,RFFL
R-HSA-2871796	FCERI mediated MAPK activation	0.631668753908492	-0.459390145798559	271	5	0.0241545893719807	207	10391	817,284,3084,22866,4747	CAMK2D,ANGPT1,NRG1,CNKSR2,NEFL
R-HSA-382556	ABC-family proteins mediated transport	0.632780083177878	-0.457632337142412	107	2	0.00966183574879227	207	10391	79139,1244	DERL1,ABCC2
R-HSA-6802949	Signaling by RAS mutants	0.635239110795136	-0.453753798534235	50	1	0.00483091787439614	207	10391	22866	CNKSR2
R-HSA-156580	Phase II conjugation	0.637835600753345	-0.449674707912295	108	2	0.00966183574879227	207	10391	27430,9060	MAT2B,PAPSS2
R-HSA-112310	Neurotransmitter Release Cycle	0.642540677777457	-0.442325152500978	51	1	0.00483091787439614	207	10391	6507	SLC1A3
R-HSA-397795	G-protein beta:gamma signalling	0.642540677777457	-0.442325152500978	51	1	0.00483091787439614	207	10391	54331	GNG2
R-HSA-3214842	HDMs demethylate histones	0.649696778323629	-0.431249519821769	52	1	0.00483091787439614	207	10391	23081	KDM4C
R-HSA-445717	Aquaporin-mediated transport	0.649696778323629	-0.431249519821769	52	1	0.00483091787439614	207	10391	54331	GNG2
R-HSA-2559582	Senescence-Associated Secretory Phenotype (SASP)	0.652675901834717	-0.426674594759925	111	2	0.00966183574879227	207	10391	6197,1030	RPS6KA3,CDKN2B
R-HSA-211945	Phase 1 - Functionalization of compounds	0.652675901834717	-0.426674594759925	111	2	0.00966183574879227	207	10391	216,4129	ALDH1A1,MAOB
R-HSA-163685	Integration of energy metabolism	0.652675901834717	-0.426674594759925	111	2	0.00966183574879227	207	10391	1131,54331	CHRM3,GNG2
R-HSA-5620920	Cargo trafficking to the periciliary membrane	0.656710296748614	-0.420512306376209	53	1	0.00483091787439614	207	10391	6753	SSTR3
R-HSA-72695	Formation of the ternary complex, and subsequently, the 43S complex	0.656710296748614	-0.420512306376209	53	1	0.00483091787439614	207	10391	6235	RPS29
R-HSA-6806667	Metabolism of fat-soluble vitamins	0.656710296748614	-0.420512306376209	53	1	0.00483091787439614	207	10391	5948	RBP2
R-HSA-1280215	Cytokine Signaling in Immune system	0.659737388829698	-0.415913418855749	760	14	0.0676328502415459	207	10391	4747,8835,817,6885,3454,284,3084,7534,7292,22866,23118,6364,301,3433	NEFL,SOCS2,CAMK2D,MAP3K7,IFNAR1,ANGPT1,NRG1,YWHAZ,TNFSF4,CNKSR2,TAB2,CCL20,ANXA1,IFIT2
R-HSA-211859	Biological oxidations	0.663390631066852	-0.410391275169374	226	4	0.0193236714975845	207	10391	9060,216,4129,27430	PAPSS2,ALDH1A1,MAOB,MAT2B
R-HSA-1592230	Mitochondrial biogenesis	0.663584060382981	-0.410099740871478	54	1	0.00483091787439614	207	10391	10891	PPARGC1A
R-HSA-195721	Signaling by Wnt	0.67027141884163	-0.400072545880388	338	6	0.0289855072463768	207	10391	1213,7534,51339,6885,54331,144165	CLTC,YWHAZ,DACT1,MAP3K7,GNG2,PRICKLE1
R-HSA-977443	GABA receptor activation	0.676923354951338	-0.390197225253892	56	1	0.00483091787439614	207	10391	54331	GNG2
R-HSA-429914	Deadenylation-dependent mRNA decay	0.683394265983034	-0.380683329761907	57	1	0.00483091787439614	207	10391	23404	EXOSC2
R-HSA-432722	Golgi Associated Vesicle Biogenesis	0.683394265983034	-0.380683329761907	57	1	0.00483091787439614	207	10391	1213	CLTC
R-HSA-5683057	MAPK family signaling cascades	0.690179994664009	-0.370802853577466	290	5	0.0241545893719807	207	10391	22866,284,3084,817,4747	CNKSR2,ANGPT1,NRG1,CAMK2D,NEFL
R-HSA-4641258	Degradation of DVL	0.695951669900796	-0.362475060856478	59	1	0.00483091787439614	207	10391	51339	DACT1
R-HSA-112399	IRS-mediated signalling	0.701664503463596	-0.354299904488262	294	5	0.0241545893719807	207	10391	817,3084,284,22866,4747	CAMK2D,NRG1,ANGPT1,CNKSR2,NEFL
R-HSA-6802952	Signaling by BRAF and RAF fusions	0.70204323053446	-0.353760294894497	60	1	0.00483091787439614	207	10391	22866	CNKSR2
R-HSA-1500620	Meiosis	0.70298134851623	-0.352424918794798	122	2	0.00966183574879227	207	10391	56979,23345	PRDM9,SYNE1
R-HSA-186763	Downstream signal transduction	0.707831593500591	-0.345549075869438	352	6	0.0289855072463768	207	10391	4747,22866,3084,284,817,5581	NEFL,CNKSR2,NRG1,ANGPT1,CAMK2D,PRKCE
R-HSA-2142753	Arachidonic acid metabolism	0.708013325533565	-0.345292364090446	61	1	0.00483091787439614	207	10391	3248	HPGD
R-HSA-72702	Ribosomal scanning and start codon recognition	0.708013325533565	-0.345292364090446	61	1	0.00483091787439614	207	10391	6235	RPS29
R-HSA-74751	Insulin receptor signalling cascade	0.71008424578938	-0.342371659944466	297	5	0.0241545893719807	207	10391	4747,3084,284,22866,817	NEFL,NRG1,ANGPT1,CNKSR2,CAMK2D
R-HSA-2428928	IRS-related events triggered by IGF1R	0.712853854845495	-0.338478851743713	298	5	0.0241545893719807	207	10391	4747,284,3084,22866,817	NEFL,ANGPT1,NRG1,CNKSR2,CAMK2D
R-HSA-2428924	IGF1R signaling cascade	0.712853854845495	-0.338478851743713	298	5	0.0241545893719807	207	10391	22866,3084,284,817,4747	CNKSR2,NRG1,ANGPT1,CAMK2D,NEFL
R-HSA-1268020	Mitochondrial protein import	0.71386436538228	-0.337062299138673	62	1	0.00483091787439614	207	10391	10165	SLC25A13
R-HSA-5678895	Defective CFTR causes cystic fibrosis	0.71386436538228	-0.337062299138673	62	1	0.00483091787439614	207	10391	79139	DERL1
R-HSA-72649	Translation initiation complex formation	0.71386436538228	-0.337062299138673	62	1	0.00483091787439614	207	10391	6235	RPS29
R-HSA-2404192	Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	0.715604960902605	-0.334626994863771	299	5	0.0241545893719807	207	10391	22866,3084,284,817,4747	CNKSR2,NRG1,ANGPT1,CAMK2D,NEFL
R-HSA-2424491	DAP12 signaling	0.718017418024513	-0.331261451141095	356	6	0.0289855072463768	207	10391	817,5581,22866,284,3084,4747	CAMK2D,PRKCE,CNKSR2,ANGPT1,NRG1,NEFL
R-HSA-446219	Synthesis of substrates in N-glycan biosythesis	0.71959871297884	-0.329061565430372	63	1	0.00483091787439614	207	10391	2762	GMDS
R-HSA-72662	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	0.71959871297884	-0.329061565430372	63	1	0.00483091787439614	207	10391	6235	RPS29
R-HSA-2559580	Oxidative Stress Induced Senescence	0.723779172731119	-0.323268943161334	127	2	0.00966183574879227	207	10391	7029,1030	TFDP2,CDKN2B
R-HSA-8873719	RAB geranylgeranylation	0.730726550547217	-0.313715965074986	65	1	0.00483091787439614	207	10391	5874	RAB27B
R-HSA-2219530	Constitutive Signaling by Aberrant PI3K in Cancer	0.730726550547217	-0.313715965074986	65	1	0.00483091787439614	207	10391	3084	NRG1
R-HSA-1483206	Glycerophospholipid biosynthesis	0.735661193586996	-0.306985601040129	130	2	0.00966183574879227	207	10391	590,84803	BCHE,GPAT3
R-HSA-177929	Signaling by EGFR	0.737653346049786	-0.304281285534785	364	6	0.0289855072463768	207	10391	3084,284,22866,5581,817,4747	NRG1,ANGPT1,CNKSR2,PRKCE,CAMK2D,NEFL
R-HSA-5617833	Cilium Assembly	0.740720685149435	-0.300131667865137	192	3	0.0144927536231884	207	10391	121441,55755,6753	NEDD1,CDK5RAP2,SSTR3
R-HSA-4608870	Asymmetric localization of PCP proteins	0.741414824369615	-0.299194993362067	67	1	0.00483091787439614	207	10391	144165	PRICKLE1
R-HSA-8848021	Signaling by PTK6	0.741414824369615	-0.299194993362067	67	1	0.00483091787439614	207	10391	3084	NRG1
R-HSA-5685942	HDR through Homologous Recombination (HRR)	0.746599552308531	-0.292226312142162	68	1	0.00483091787439614	207	10391	7486	WRN
R-HSA-5625886	Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3	0.746599552308531	-0.292226312142162	68	1	0.00483091787439614	207	10391	23081	KDM4C
R-HSA-6806834	Signaling by MET	0.751680816743767	-0.28544349095438	69	1	0.00483091787439614	207	10391	3912	LAMB1
R-HSA-5619084	ABC transporter disorders	0.751680816743767	-0.28544349095438	69	1	0.00483091787439614	207	10391	79139	DERL1
R-HSA-2172127	DAP12 interactions	0.754028836494526	-0.28232466701779	371	6	0.0289855072463768	207	10391	284,3084,22866,5581,817,4747	ANGPT1,NRG1,CNKSR2,PRKCE,CAMK2D,NEFL
R-HSA-1168372	Downstream signaling events of B Cell Receptor (BCR)	0.756341779730805	-0.279261915373302	197	3	0.0144927536231884	207	10391	8915,6885,3084	BCL10,MAP3K7,NRG1
R-HSA-2029482	Regulation of actin dynamics for phagocytic cup formation	0.756660672476316	-0.278840379043644	70	1	0.00483091787439614	207	10391	4651	MYO10
R-HSA-6809371	Formation of the cornified envelope	0.761541133738231	-0.272411091377957	71	1	0.00483091787439614	207	10391	1825	DSC3
R-HSA-3214841	PKMTs methylate histone lysines	0.771011731487557	-0.2600516895974	73	1	0.00483091787439614	207	10391	56979	PRDM9
R-HSA-421837	Clathrin derived vesicle budding	0.771011731487557	-0.2600516895974	73	1	0.00483091787439614	207	10391	1213	CLTC
R-HSA-6807505	RNA polymerase II transcribes snRNA genes	0.771011731487557	-0.2600516895974	73	1	0.00483091787439614	207	10391	23379	ICE1
R-HSA-199992	trans-Golgi Network Vesicle Budding	0.771011731487557	-0.2600516895974	73	1	0.00483091787439614	207	10391	1213	CLTC
R-HSA-913531	Interferon Signaling	0.771200400113703	-0.259807016866301	202	3	0.0144927536231884	207	10391	3454,817,3433	IFNAR1,CAMK2D,IFIT2
R-HSA-6802957	Oncogenic MAPK signaling	0.7756057004278	-0.25411100594003	74	1	0.00483091787439614	207	10391	22866	CNKSR2
R-HSA-68875	Mitotic Prophase	0.778932215311	-0.249831251902548	142	2	0.00966183574879227	207	10391	7444,140609	VRK2,NEK7
R-HSA-453279	Mitotic G1-G1/S phases	0.782244029825442	-0.245588528516675	143	2	0.00966183574879227	207	10391	1030,7029	CDKN2B,TFDP2
R-HSA-5619115	Disorders of transmembrane transporters	0.784520277189256	-0.242682859865512	76	1	0.00483091787439614	207	10391	79139	DERL1
R-HSA-418555	G alpha (s) signalling events	0.791920733413585	-0.233293976250212	146	2	0.00966183574879227	207	10391	5139,54331	PDE3A,GNG2
R-HSA-168255	Influenza Life Cycle	0.791920733413585	-0.233293976250212	146	2	0.00966183574879227	207	10391	1213,6235	CLTC,RPS29
R-HSA-3108214	SUMOylation of DNA damage response and repair proteins	0.793082345047215	-0.231828222830063	78	1	0.00483091787439614	207	10391	7486	WRN
R-HSA-446193	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	0.793082345047215	-0.231828222830063	78	1	0.00483091787439614	207	10391	2762	GMDS
R-HSA-1640170	Cell Cycle	0.800992636919629	-0.221903524316042	622	10	0.0483091787439614	207	10391	55755,7486,7029,23345,121441,7534,7444,56979,1030,140609	CDK5RAP2,WRN,TFDP2,SYNE1,NEDD1,YWHAZ,VRK2,PRDM9,CDKN2B,NEK7
R-HSA-1221632	Meiotic synapsis	0.801305778293993	-0.22151265907474	80	1	0.00483091787439614	207	10391	23345	SYNE1
R-HSA-2262752	Cellular responses to stress	0.802396800638242	-0.220152029582837	452	7	0.0338164251207729	207	10391	817,2936,7029,6197,2113,1030,50507	CAMK2D,GSR,TFDP2,RPS6KA3,ETS1,CDKN2B,NOX4
R-HSA-1433557	Signaling by SCF-KIT	0.806587011621582	-0.214943499298873	337	5	0.0241545893719807	207	10391	817,3084,284,22866,4747	CAMK2D,NRG1,ANGPT1,CNKSR2,NEFL
R-HSA-75109	Triglyceride Biosynthesis	0.809203907633124	-0.211704344692391	82	1	0.00483091787439614	207	10391	84803	GPAT3
R-HSA-1852241	Organelle biogenesis and maintenance	0.812676099827245	-0.207422650013669	340	5	0.0241545893719807	207	10391	10891,121441,11222,55755,6753	PPARGC1A,NEDD1,MRPL3,CDK5RAP2,SSTR3
R-HSA-5696399	Global Genome Nucleotide Excision Repair (GG-NER)	0.820469037451984	-0.197879105359042	85	1	0.00483091787439614	207	10391	125476	INO80C
R-HSA-168254	Influenza Infection	0.824238184828297	-0.193295731584601	157	2	0.00966183574879227	207	10391	1213,6235	CLTC,RPS29
R-HSA-5689880	Ub-specific processing proteases	0.825729492742194	-0.191488049724809	223	3	0.0144927536231884	207	10391	27430,6885,9958	MAT2B,MAP3K7,USP15
R-HSA-168249	Innate Immune System	0.826062870844568	-0.191084393533813	1302	22	0.106280193236715	207	10391	6197,4842,10584,84443,4747,284,3084,387921,6885,5581,817,1511,7294,127124,5627,22866,8915,4651,23118,4064,11240,3685	RPS6KA3,NOS1,COLEC10,FRMPD3,NEFL,ANGPT1,NRG1,NHLRC3,MAP3K7,PRKCE,CAMK2D,CTSG,TXK,ATP6V1G3,PROS1,CNKSR2,BCL10,MYO10,TAB2,CD180,PADI2,ITGAV
R-HSA-5368286	Mitochondrial translation initiation	0.827608851239657	-0.189214638098274	87	1	0.00483091787439614	207	10391	11222	MRPL3
R-HSA-6811558	PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling	0.827608851239657	-0.189214638098274	87	1	0.00483091787439614	207	10391	3084	NRG1
R-HSA-5419276	Mitochondrial translation termination	0.827608851239657	-0.189214638098274	87	1	0.00483091787439614	207	10391	11222	MRPL3
R-HSA-5389840	Mitochondrial translation elongation	0.831072066290133	-0.185038765516059	88	1	0.00483091787439614	207	10391	11222	MRPL3
R-HSA-912446	Meiotic recombination	0.834466037190908	-0.180963235101609	89	1	0.00483091787439614	207	10391	56979	PRDM9
R-HSA-3371556	Cellular response to heat stress	0.834466037190908	-0.180963235101609	89	1	0.00483091787439614	207	10391	817	CAMK2D
R-HSA-8876198	RAB GEFs exchange GTP for GDP on RABs	0.837792141873182	-0.176985249991368	90	1	0.00483091787439614	207	10391	5874	RAB27B
R-HSA-2219528	PI3K/AKT Signaling in Cancer	0.837792141873182	-0.176985249991368	90	1	0.00483091787439614	207	10391	3084	NRG1
R-HSA-192823	Viral mRNA Translation	0.844246128158472	-0.169311205858488	92	1	0.00483091787439614	207	10391	6235	RPS29
R-HSA-156902	Peptide chain elongation	0.844246128158472	-0.169311205858488	92	1	0.00483091787439614	207	10391	6235	RPS29
R-HSA-381119	Unfolded Protein Response (UPR)	0.844246128158472	-0.169311205858488	92	1	0.00483091787439614	207	10391	23404	EXOSC2
R-HSA-71387	Metabolism of carbohydrates	0.84594590174056	-0.167299867353686	296	4	0.0193236714975845	207	10391	9060,216,10165,132789	PAPSS2,ALDH1A1,SLC25A13,GNPDA2
R-HSA-6804756	Regulation of TP53 Activity through Phosphorylation	0.847376631257947	-0.165610018160788	93	1	0.00483091787439614	207	10391	7486	WRN
R-HSA-373080	Class B/2 (Secretin family receptors)	0.847376631257947	-0.165610018160788	93	1	0.00483091787439614	207	10391	54331	GNG2
R-HSA-983705	Signaling by the B Cell Receptor (BCR)	0.849607332689401	-0.162980997776763	234	3	0.0144927536231884	207	10391	3084,6885,8915	NRG1,MAP3K7,BCL10
R-HSA-199418	Negative regulation of the PI3K/AKT network	0.850444512154216	-0.161996110715787	94	1	0.00483091787439614	207	10391	3084	NRG1
R-HSA-5368287	Mitochondrial translation	0.850444512154216	-0.161996110715787	94	1	0.00483091787439614	207	10391	11222	MRPL3
R-HSA-877300	Interferon gamma signaling	0.850444512154216	-0.161996110715787	94	1	0.00483091787439614	207	10391	817	CAMK2D
R-HSA-71291	Metabolism of amino acids and derivatives	0.852792767479405	-0.159238706517162	362	5	0.0241545893719807	207	10391	169355,6235,9060,2731,2936	IDO2,RPS29,PAPSS2,GLDC,GSR
R-HSA-2408557	Selenocysteine synthesis	0.853451017538001	-0.158467128508166	95	1	0.00483091787439614	207	10391	6235	RPS29
R-HSA-72764	Eukaryotic Translation Termination	0.85639736944351	-0.15502079391599	96	1	0.00483091787439614	207	10391	6235	RPS29
R-HSA-69481	G2/M Checkpoints	0.85659177268784	-0.154793818460767	170	2	0.00966183574879227	207	10391	7486,7534	WRN,YWHAZ
R-HSA-15869	Metabolism of nucleotides	0.859284765715501	-0.151654903534766	97	1	0.00483091787439614	207	10391	2936	GSR
R-HSA-156842	Eukaryotic Translation Elongation	0.859284765715501	-0.151654903534766	97	1	0.00483091787439614	207	10391	6235	RPS29
R-HSA-109581	Apoptosis	0.861059591636741	-0.149591564827805	172	2	0.00966183574879227	207	10391	7029,7534	TFDP2,YWHAZ
R-HSA-5663202	Diseases of signal transduction	0.863969131632336	-0.146218238093705	369	5	0.0241545893719807	207	10391	9734,55294,3084,7048,22866	HDAC9,FBXW7,NRG1,TGFBR2,CNKSR2
R-HSA-8856825	Cargo recognition for clathrin-mediated endocytosis	0.864887364282372	-0.145155995231388	99	1	0.00483091787439614	207	10391	1213	CLTC
R-HSA-975956	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	0.864887364282372	-0.145155995231388	99	1	0.00483091787439614	207	10391	6235	RPS29
R-HSA-6803157	Antimicrobial peptides	0.864887364282372	-0.145155995231388	99	1	0.00483091787439614	207	10391	1511	CTSG
R-HSA-5693607	Processing of DNA double-strand break ends	0.864887364282372	-0.145155995231388	99	1	0.00483091787439614	207	10391	7486	WRN
R-HSA-196854	Metabolism of vitamins and cofactors	0.867523898256971	-0.142112219117553	175	2	0.00966183574879227	207	10391	83594,5948	NUDT12,RBP2
R-HSA-5357801	Programmed Cell Death	0.867523898256971	-0.142112219117553	175	2	0.00966183574879227	207	10391	7534,7029	YWHAZ,TFDP2
R-HSA-1236975	Antigen processing-Cross presentation	0.870267929351432	-0.138954149973163	101	1	0.00483091787439614	207	10391	3685	ITGAV
R-HSA-5610787	Hedgehog 'off' state	0.872877699864788	-0.135959824749219	102	1	0.00483091787439614	207	10391	27152	INTU
R-HSA-977225	Amyloid fiber formation	0.872877699864788	-0.135959824749219	102	1	0.00483091787439614	207	10391	6622	SNCA
R-HSA-2132295	MHC class II antigen presentation	0.875435219200146	-0.133034122912007	103	1	0.00483091787439614	207	10391	1213	CLTC
R-HSA-6791226	Major pathway of rRNA processing in the nucleolus and cytosol	0.877689552463501	-0.130462332766405	180	2	0.00966183574879227	207	10391	23404,6235	EXOSC2,RPS29
R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	0.877941528450767	-0.130175283862184	104	1	0.00483091787439614	207	10391	7292	TNFSF4
R-HSA-3108232	SUMO E3 ligases SUMOylate target proteins	0.877941528450767	-0.130175283862184	104	1	0.00483091787439614	207	10391	7486	WRN
R-HSA-72689	Formation of a pool of free 40S subunits	0.880397648171862	-0.127381600651138	105	1	0.00483091787439614	207	10391	6235	RPS29
R-HSA-69275	G2/M Transition	0.881551498405414	-0.126071857517247	182	2	0.00966183574879227	207	10391	55755,121441	CDK5RAP2,NEDD1
R-HSA-5578749	Transcriptional regulation by small RNAs	0.885163300290283	-0.121983130893933	107	1	0.00483091787439614	207	10391	10526	IPO8
R-HSA-453274	Mitotic G2-G2/M phases	0.885300994935401	-0.121827584525936	184	2	0.00966183574879227	207	10391	121441,55755	NEDD1,CDK5RAP2
R-HSA-2990846	SUMOylation	0.891959727310455	-0.114334296176459	110	1	0.00483091787439614	207	10391	7486	WRN
R-HSA-5696398	Nucleotide Excision Repair	0.896266751496417	-0.109517196591464	112	1	0.00483091787439614	207	10391	125476	INO80C
R-HSA-8868773	rRNA processing in the nucleus and cytosol	0.899229958096886	-0.106216484008804	192	2	0.00966183574879227	207	10391	6235,23404	RPS29,EXOSC2
R-HSA-6785807	Interleukin-4 and 13 signaling	0.900402872739533	-0.104912979439842	114	1	0.00483091787439614	207	10391	301	ANXA1
R-HSA-1799339	SRP-dependent cotranslational protein targeting to membrane	0.902408964538033	-0.102687464180822	115	1	0.00483091787439614	207	10391	6235	RPS29
R-HSA-156827	L13a-mediated translational silencing of Ceruloplasmin expression	0.906301303828125	-0.0983834632949118	117	1	0.00483091787439614	207	10391	6235	RPS29
R-HSA-72706	GTP hydrolysis and joining of the 60S ribosomal subunit	0.906301303828125	-0.0983834632949118	117	1	0.00483091787439614	207	10391	6235	RPS29
R-HSA-69206	G1/S Transition	0.910039120484438	-0.0942676908519273	119	1	0.00483091787439614	207	10391	7029	TFDP2
R-HSA-927802	Nonsense-Mediated Decay (NMD)	0.911852000352592	-0.0922775823918215	120	1	0.00483091787439614	207	10391	6235	RPS29
R-HSA-975957	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)	0.911852000352592	-0.0922775823918215	120	1	0.00483091787439614	207	10391	6235	RPS29
R-HSA-69620	Cell Cycle Checkpoints	0.914434264079836	-0.0894496955502169	202	2	0.00966183574879227	207	10391	7486,7534	WRN,YWHAZ
R-HSA-72312	rRNA processing	0.914434264079836	-0.0894496955502169	202	2	0.00966183574879227	207	10391	6235,23404	RPS29,EXOSC2
R-HSA-5653656	Vesicle-mediated transport	0.915272495298764	-0.0885334489732469	659	9	0.0434782608695652	207	10391	84694,2702,9847,2697,5874,23637,7534,1213,9332	GJA10,GJA5,C2CD5,GJA1,RAB27B,RABGAP1,YWHAZ,CLTC,CD163
R-HSA-196849	Metabolism of water-soluble vitamins and cofactors	0.917075368862714	-0.0865656194131598	123	1	0.00483091787439614	207	10391	83594	NUDT12
R-HSA-1630316	Glycosaminoglycan metabolism	0.918747106178436	-0.0847443781978074	124	1	0.00483091787439614	207	10391	9060	PAPSS2
R-HSA-4839726	Chromatin organization	0.920076545825306	-0.0832984104161157	279	3	0.0144927536231884	207	10391	11240,56979,23081	PADI2,PRDM9,KDM4C
R-HSA-3247509	Chromatin modifying enzymes	0.920076545825306	-0.0832984104161157	279	3	0.0144927536231884	207	10391	56979,23081,11240	PRDM9,KDM4C,PADI2
R-HSA-72613	Eukaryotic Translation Initiation	0.920385301267577	-0.0829628908880631	125	1	0.00483091787439614	207	10391	6235	RPS29
R-HSA-72737	Cap-dependent Translation Initiation	0.920385301267577	-0.0829628908880631	125	1	0.00483091787439614	207	10391	6235	RPS29
R-HSA-1257604	PIP3 activates AKT signaling	0.920385301267577	-0.0829628908880631	125	1	0.00483091787439614	207	10391	3084	NRG1
R-HSA-5619507	Activation of HOX genes during differentiation	0.923563730706664	-0.079515471754604	127	1	0.00483091787439614	207	10391	5915	RARB
R-HSA-5617472	Activation of anterior HOX genes in hindbrain development during early embryogenesis	0.923563730706664	-0.079515471754604	127	1	0.00483091787439614	207	10391	5915	RARB
R-HSA-198203	PI3K/AKT activation	0.92510526498071	-0.0778477479652921	128	1	0.00483091787439614	207	10391	3084	NRG1
R-HSA-180292	GAB1 signalosome	0.92510526498071	-0.0778477479652921	128	1	0.00483091787439614	207	10391	3084	NRG1
R-HSA-199991	Membrane Trafficking	0.927535082992412	-0.0752246598871605	613	8	0.0386473429951691	207	10391	9847,2702,84694,5874,2697,23637,1213,7534	C2CD5,GJA5,GJA10,RAB27B,GJA1,RABGAP1,CLTC,YWHAZ
R-HSA-5693567	HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)	0.932360988142201	-0.0700352129551932	133	1	0.00483091787439614	207	10391	7486	WRN
R-HSA-2730905	Role of LAT2/NTAL/LAB on calcium mobilization	0.937658344005927	-0.0643696351266279	137	1	0.00483091787439614	207	10391	3084	NRG1
R-HSA-8856828	Clathrin-mediated endocytosis	0.937658344005927	-0.0643696351266279	137	1	0.00483091787439614	207	10391	1213	CLTC
R-HSA-168273	Influenza Viral RNA Transcription and Replication	0.937658344005927	-0.0643696351266279	137	1	0.00483091787439614	207	10391	6235	RPS29
R-HSA-212436	Generic Transcription Pathway	0.939097702873742	-0.062835755267903	874	12	0.0579710144927536	207	10391	1030,7029,117584,7486,3486,7761,126375,5915,639,7181,7534,2936	CDKN2B,TFDP2,RFFL,WRN,IGFBP3,ZNF214,ZNF792,RARB,PRDM1,NR2C1,YWHAZ,GSR
R-HSA-1430728	Metabolism	0.939965085129249	-0.0619125478874458	2177	35	0.169082125603865	207	10391	169355,8821,84803,1213,23179,9060,1131,10891,79611,5948,9388,646486,130367,10165,7436,171546,253430,19,54331,132789,51573,57107,54477,27430,6235,55711,590,3248,216,2731,2936,406,83594,4129,51700	IDO2,INPP4B,GPAT3,CLTC,RGL1,PAPSS2,CHRM3,PPARGC1A,ACSS3,RBP2,LIPG,FABP12,SGPP2,SLC25A13,VLDLR,SPTSSA,IPMK,ABCA1,GNG2,GNPDA2,GDE1,PDSS2,PLEKHA5,MAT2B,RPS29,FAR2,BCHE,HPGD,ALDH1A1,GLDC,GSR,BMAL1,NUDT12,MAOB,CYB5R2
R-HSA-5693538	Homology Directed Repair	0.94015007094047	-0.0617157665241126	139	1	0.00483091787439614	207	10391	7486	WRN
R-HSA-5358351	Signaling by Hedgehog	0.94015007094047	-0.0617157665241126	139	1	0.00483091787439614	207	10391	27152	INTU
R-HSA-983169	Class I MHC mediated antigen processing & presentation	0.94383723688598	-0.0578015462554108	374	4	0.0193236714975845	207	10391	3685,55294,158506,11059	ITGAV,FBXW7,CBLL2,WWP1
R-HSA-69278	Cell Cycle, Mitotic	0.948106917133369	-0.0532880013002482	515	6	0.0289855072463768	207	10391	1030,140609,7444,121441,7029,55755	CDKN2B,NEK7,VRK2,NEDD1,TFDP2,CDK5RAP2
R-HSA-983168	Antigen processing: Ubiquitination & Proteasome degradation	0.950997755539036	-0.0502435765456976	312	3	0.0144927536231884	207	10391	11059,158506,55294	WWP1,CBLL2,FBXW7
R-HSA-162587	HIV Life Cycle	0.954097857238702	-0.0469890370724701	152	1	0.00483091787439614	207	10391	7852	CXCR4
R-HSA-201681	TCF dependent signaling in response to WNT	0.954738894888508	-0.0463173843780319	240	2	0.00966183574879227	207	10391	51339,7534	DACT1,YWHAZ
R-HSA-168256	Immune System	0.959484722993731	-0.0413588855019584	2124	33	0.159420289855072	207	10391	10584,4747,8835,6197,4842,5581,55294,3084,3454,127124,23118,3433,11240,84443,11059,6885,817,158506,387921,7534,284,1511,7294,7292,5627,8915,22866,1213,301,4651,6364,3685,4064	COLEC10,NEFL,SOCS2,RPS6KA3,NOS1,PRKCE,FBXW7,NRG1,IFNAR1,ATP6V1G3,TAB2,IFIT2,PADI2,FRMPD3,WWP1,MAP3K7,CAMK2D,CBLL2,NHLRC3,YWHAZ,ANGPT1,CTSG,TXK,TNFSF4,PROS1,BCL10,CNKSR2,CLTC,ANXA1,MYO10,CCL20,ITGAV,CD180
R-HSA-1643685	Disease	0.96125412717497	-0.0395164646214662	859	11	0.0531400966183575	207	10391	1213,7048,22866,80070,79139,6235,7852,55294,3084,80731,9734	CLTC,TGFBR2,CNKSR2,ADAMTS20,DERL1,RPS29,CXCR4,FBXW7,NRG1,THSD7B,HDAC9
R-HSA-72766	Translation	0.963338133197796	-0.0373508039979161	163	1	0.00483091787439614	207	10391	6235	RPS29
R-HSA-5693532	DNA Double-Strand Break Repair	0.966901560740336	-0.0336585873245969	168	1	0.00483091787439614	207	10391	7486	WRN
R-HSA-1280218	Adaptive Immune System	0.970796031905878	-0.029638892585636	823	10	0.0483091787439614	207	10391	23118,3685,11059,158506,7534,3084,1213,6885,55294,8915	TAB2,ITGAV,WWP1,CBLL2,YWHAZ,NRG1,CLTC,MAP3K7,FBXW7,BCL10
R-HSA-6798695	Neutrophil degranulation	0.970814917629522	-0.029619438921503	492	5	0.0241545893719807	207	10391	387921,11240,3685,1511,84443	NHLRC3,PADI2,ITGAV,CTSG,FRMPD3
R-HSA-68882	Mitotic Anaphase	0.97357380113927	-0.0267816469362157	179	1	0.00483091787439614	207	10391	7444	VRK2
R-HSA-2555396	Mitotic Metaphase and Anaphase	0.974109467322411	-0.0262315922067627	180	1	0.00483091787439614	207	10391	7444	VRK2
R-HSA-72163	mRNA Splicing - Major Pathway	0.978023446399231	-0.0222216354113427	188	1	0.00483091787439614	207	10391	57703	CWC22
R-HSA-446203	Asparagine N-linked glycosylation	0.978886248955871	-0.0213398342586422	284	2	0.00966183574879227	207	10391	2762,79139	GMDS,DERL1
R-HSA-72172	mRNA Splicing	0.981348155761644	-0.0188279835388747	196	1	0.00483091787439614	207	10391	57703	CWC22
R-HSA-195258	RHO GTPase Effectors	0.982612515949465	-0.0175404217452952	295	2	0.00966183574879227	207	10391	7534,23081	YWHAZ,KDM4C
R-HSA-5663205	Infectious disease	0.985114811174505	-0.0149970850345611	388	3	0.0144927536231884	207	10391	6235,1213,7852	RPS29,CLTC,CXCR4
R-HSA-68886	M Phase	0.986444509637475	-0.0136482048354758	309	2	0.00966183574879227	207	10391	7444,140609	VRK2,NEK7
R-HSA-6805567	Keratinization	0.987110679840902	-0.0129731082055167	214	1	0.00483091787439614	207	10391	1825	DSC3
R-HSA-73894	DNA Repair	0.988252335731204	-0.0118172133057786	317	2	0.00966183574879227	207	10391	7486,125476	WRN,INO80C
R-HSA-162906	HIV Infection	0.991802460967991	-0.00823132361540992	236	1	0.00483091787439614	207	10391	7852	CXCR4
R-HSA-72203	Processing of Capped Intron-Containing Pre-mRNA	0.993598306132351	-0.00642227258260531	248	1	0.00483091787439614	207	10391	57703	CWC22
R-HSA-74160	Gene Expression	0.999826089585471	-0.00017392553869816	1834	19	0.0917874396135266	207	10391	10526,7247,7181,57703,7534,23379,2936,23404,29102,5915,639,7029,117584,7486,3486,7761,126375,6235,1030	IPO8,TSN,NR2C1,CWC22,YWHAZ,ICE1,GSR,EXOSC2,DROSHA,RARB,PRDM1,TFDP2,RFFL,WRN,IGFBP3,ZNF214,ZNF792,RPS29,CDKN2B
R-HSA-381753	Olfactory Signaling Pathway	0.99986937354362	-0.000130634988758079	435	1	0.00483091787439614	207	10391	219981	OR5A2
R-HSA-444209	Free fatty acid receptors	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-77352	Beta oxidation of butanoyl-CoA to acetyl-CoA	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-8849468	PTK6 Regulates Proteins Involved in RNA Processing	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-77346	Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-71262	Carnitine synthesis	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-8866911	TFAP2 (AP-2) family regulates transcription of cell cycle factors	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-180689	APOBEC3G mediated resistance to HIV-1 infection	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-1614517	Sulfide oxidation to sulfate	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-209931	Serotonin and melatonin biosynthesis	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-77310	Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-2161541	Abacavir metabolism	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-111469	SMAC-mediated apoptotic response	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-77350	Beta oxidation of hexanoyl-CoA to butanoyl-CoA	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-8853383	Lysosomal oligosaccharide catabolism	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-167826	The fatty acid cycling model	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-74713	IRS activation	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-69478	G2/M DNA replication checkpoint	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-433137	Sodium-coupled sulphate, di- and tri-carboxylate transporters	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-111461	Cytochrome c-mediated apoptotic response	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-203641	NOSTRIN mediated eNOS trafficking	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-380095	Tachykinin receptors bind tachykinins	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-196819	Vitamin B1 (thiamin) metabolism	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-1300652	Sperm:Oocyte Membrane Binding	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-68911	G2 Phase	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-389599	Alpha-oxidation of phytanate	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-163358	PKA-mediated phosphorylation of key metabolic factors	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-561048	Organic anion transport	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-8875513	MET interacts with TNS proteins	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-427652	Sodium-coupled phosphate cotransporters	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-6785470	tRNA processing in the mitochondrion	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-8849473	PTK6 Expression	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-2142850	Hyaluronan biosynthesis and export	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-1169092	Activation of RAS in B cells	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-8866423	VLDL biosynthesis	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-1606341	IRF3 mediated activation of type 1 IFN	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-187024	NGF-independant TRKA activation	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-111463	SMAC binds to IAPs	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-210746	Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-2855086	Ficolins bind to repetitive carbohydrate structures on the target cell surface	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-5661270	Catabolism of glucuronate to xylulose-5-phosphate	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-111464	SMAC-mediated dissociation of IAP:caspase complexes	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-111932	CaMK IV-mediated phosphorylation of CREB	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-426048	Arachidonate production from DAG	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-71032	Propionyl-CoA catabolism	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-75157	FasL/ CD95L signaling	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-5683678	Defective ABCA3 causes pulmonary surfactant metabolism dysfunction type 3 (SMDP3)	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-391906	Leukotriene receptors	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-2161517	Abacavir transmembrane transport	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-8865999	MET activates PTPN11	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-1483226	Synthesis of PI	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-111459	Activation of caspases through apoptosome-mediated cleavage	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-70370	Galactose catabolism	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-140834	Extrinsic Pathway of Fibrin Clot Formation	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-5250955	Toxicity of botulinum toxin type D (BoNT/D)	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-3065676	SUMO is conjugated to E1 (UBA2:SAE1)	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-446205	Synthesis of GDP-mannose	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-5662702	Melanin biosynthesis	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-167827	The proton buffering model	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-390651	Dopamine receptors	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-5250981	Toxicity of botulinum toxin type F (BoNT/F)	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-8869496	TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-157881	Cyclin B2 mediated events	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-166187	Mitochondrial Uncoupling Proteins	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-8852405	Signaling by MST1	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-114516	Disinhibition of SNARE formation	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-77348	Beta oxidation of octanoyl-CoA to hexanoyl-CoA	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-964739	N-glycan trimming and elongation in the cis-Golgi	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-3000471	Scavenging by Class B Receptors	0.999999999975649	-2.43509194752546e-11	5	0	0	207	10391
R-HSA-1482801	Acyl chain remodelling of PS	0.999999999977961	-2.20390993010971e-11	22	0	0	207	10391
R-HSA-373753	Nephrin interactions	0.999999999977961	-2.20390993010971e-11	22	0	0	207	10391
R-HSA-202430	Translocation of ZAP-70 to Immunological synapse	0.999999999977961	-2.20390993010971e-11	22	0	0	207	10391
R-HSA-8853338	Signaling by FGFR3 point mutants in cancer	0.999999999977961	-2.20390993010971e-11	22	0	0	207	10391
R-HSA-166208	mTORC1-mediated signalling	0.999999999977961	-2.20390993010971e-11	22	0	0	207	10391
R-HSA-69273	Cyclin A/B1 associated events during G2/M transition	0.999999999977961	-2.20390993010971e-11	22	0	0	207	10391
R-HSA-77595	Processing of Intronless Pre-mRNAs	0.999999999977961	-2.20390993010971e-11	22	0	0	207	10391
R-HSA-389357	CD28 dependent PI3K/Akt signaling	0.999999999977961	-2.20390993010971e-11	22	0	0	207	10391
R-HSA-5621575	CD209 (DC-SIGN) signaling	0.999999999977961	-2.20390993010971e-11	22	0	0	207	10391
R-HSA-901032	ER Quality Control Compartment (ERQC)	0.999999999977961	-2.20390993010971e-11	22	0	0	207	10391
R-HSA-2029481	FCGR activation	0.999999999977961	-2.20390993010971e-11	22	0	0	207	10391
R-HSA-4641263	Regulation of FZD by ubiquitination	0.999999999977961	-2.20390993010971e-11	22	0	0	207	10391
R-HSA-5620916	VxPx cargo-targeting to cilium	0.999999999977961	-2.20390993010971e-11	22	0	0	207	10391
R-HSA-77289	Mitochondrial Fatty Acid Beta-Oxidation	0.999999999977961	-2.20390993010971e-11	22	0	0	207	10391
R-HSA-389513	CTLA4 inhibitory signaling	0.999999999977961	-2.20390993010971e-11	22	0	0	207	10391
R-HSA-202131	Metabolism of nitric oxide	0.999999999977961	-2.20390993010971e-11	22	0	0	207	10391
R-HSA-5654712	FRS-mediated FGFR4 signaling	0.999999999977961	-2.20390993010971e-11	22	0	0	207	10391
R-HSA-203765	eNOS activation and regulation	0.999999999977961	-2.20390993010971e-11	22	0	0	207	10391
R-HSA-5655332	Signaling by FGFR3 in disease	0.999999999977961	-2.20390993010971e-11	22	0	0	207	10391
R-HSA-164938	Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters	0.999999999977961	-2.20390993010971e-11	22	0	0	207	10391
R-HSA-428543	Inactivation of Cdc42 and Rac	0.999999999979383	-2.06173523423788e-11	9	0	0	207	10391
R-HSA-194002	Glucocorticoid biosynthesis	0.999999999979383	-2.06173523423788e-11	9	0	0	207	10391
R-HSA-198693	AKT phosphorylates targets in the nucleus	0.999999999979383	-2.06173523423788e-11	9	0	0	207	10391
R-HSA-1482883	Acyl chain remodeling of DAG and TAG	0.999999999979383	-2.06173523423788e-11	9	0	0	207	10391
R-HSA-629597	Highly calcium permeable nicotinic acetylcholine receptors	0.999999999979383	-2.06173523423788e-11	9	0	0	207	10391
R-HSA-159424	Conjugation of carboxylic acids	0.999999999979383	-2.06173523423788e-11	9	0	0	207	10391
R-HSA-111453	BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members	0.999999999979383	-2.06173523423788e-11	9	0	0	207	10391
R-HSA-5666185	RHO GTPases Activate Rhotekin and Rhophilins	0.999999999979383	-2.06173523423788e-11	9	0	0	207	10391
R-HSA-428890	Role of Abl in Robo-Slit signaling	0.999999999979383	-2.06173523423788e-11	9	0	0	207	10391
R-HSA-2408508	Metabolism of ingested SeMet, Sec, MeSec into H2Se	0.999999999979383	-2.06173523423788e-11	9	0	0	207	10391
R-HSA-2142816	Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)	0.999999999979383	-2.06173523423788e-11	9	0	0	207	10391
R-HSA-2214320	Anchoring fibril formation	0.999999999979383	-2.06173523423788e-11	9	0	0	207	10391
R-HSA-5340588	RNF mutants show enhanced WNT signaling and proliferation	0.999999999979383	-2.06173523423788e-11	9	0	0	207	10391
R-HSA-8849469	PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1	0.999999999979383	-2.06173523423788e-11	9	0	0	207	10391
R-HSA-156587	Amino Acid conjugation	0.999999999979383	-2.06173523423788e-11	9	0	0	207	10391
R-HSA-112411	MAPK1 (ERK2) activation	0.999999999979383	-2.06173523423788e-11	9	0	0	207	10391
R-HSA-2428933	SHC-related events triggered by IGF1R	0.999999999979383	-2.06173523423788e-11	9	0	0	207	10391
R-HSA-1296052	Ca2+ activated K+ channels	0.999999999979383	-2.06173523423788e-11	9	0	0	207	10391
R-HSA-419771	Opsins	0.999999999979383	-2.06173523423788e-11	9	0	0	207	10391
R-HSA-2474795	Diseases associated with visual transduction	0.999999999979383	-2.06173523423788e-11	9	0	0	207	10391
R-HSA-163765	ChREBP activates metabolic gene expression	0.999999999979383	-2.06173523423788e-11	9	0	0	207	10391
R-HSA-71336	Pentose phosphate pathway (hexose monophosphate shunt)	0.999999999979383	-2.06173523423788e-11	9	0	0	207	10391
R-HSA-2243919	Crosslinking of collagen fibrils	0.999999999979383	-2.06173523423788e-11	9	0	0	207	10391
R-HSA-1614558	Degradation of cysteine and homocysteine	0.999999999979383	-2.06173523423788e-11	9	0	0	207	10391
R-HSA-2453864	Retinoid cycle disease events	0.999999999979383	-2.06173523423788e-11	9	0	0	207	10391
R-HSA-189085	Digestion of dietary carbohydrate	0.999999999979383	-2.06173523423788e-11	9	0	0	207	10391
R-HSA-390696	Adrenoceptors	0.999999999979383	-2.06173523423788e-11	9	0	0	207	10391
R-HSA-72200	mRNA Editing: C to U Conversion	0.999999999979383	-2.06173523423788e-11	9	0	0	207	10391
R-HSA-2179392	EGFR Transactivation by Gastrin	0.999999999979383	-2.06173523423788e-11	9	0	0	207	10391
R-HSA-193634	Axonal growth inhibition (RHOA activation)	0.999999999979383	-2.06173523423788e-11	9	0	0	207	10391
R-HSA-1247673	Erythrocytes take up oxygen and release carbon dioxide	0.999999999979383	-2.06173523423788e-11	9	0	0	207	10391
R-HSA-110357	Displacement of DNA glycosylase by APEX1	0.999999999979383	-2.06173523423788e-11	9	0	0	207	10391
R-HSA-8854691	Interleukin-19, 20, 22, 24	0.999999999979383	-2.06173523423788e-11	9	0	0	207	10391
R-HSA-162592	Integration of provirus	0.999999999979383	-2.06173523423788e-11	9	0	0	207	10391
R-HSA-8876493	InlA-mediated entry of Listeria monocytogenes into host cells	0.999999999979383	-2.06173523423788e-11	9	0	0	207	10391
R-HSA-425986	Sodium/Proton exchangers	0.999999999979383	-2.06173523423788e-11	9	0	0	207	10391
R-HSA-75094	Formation of the Editosome	0.999999999979383	-2.06173523423788e-11	9	0	0	207	10391
R-HSA-391908	Prostanoid ligand receptors	0.999999999979383	-2.06173523423788e-11	9	0	0	207	10391
R-HSA-166665	Terminal pathway of complement	0.999999999979383	-2.06173523423788e-11	9	0	0	207	10391
R-HSA-1362409	Mitochondrial iron-sulfur cluster biogenesis	0.999999999979383	-2.06173523423788e-11	9	0	0	207	10391
R-HSA-1300642	Sperm Motility And Taxes	0.999999999979383	-2.06173523423788e-11	9	0	0	207	10391
R-HSA-2142688	Synthesis of 5-eicosatetraenoic acids	0.999999999979383	-2.06173523423788e-11	9	0	0	207	10391
R-HSA-4839748	AMER1 mutants destabilize the destruction complex	0.999999999981399	-1.86013458606374e-11	14	0	0	207	10391
R-HSA-4839744	truncated APC mutants destabilize the destruction complex	0.999999999981399	-1.86013458606374e-11	14	0	0	207	10391
R-HSA-1483213	Synthesis of PE	0.999999999981399	-1.86013458606374e-11	14	0	0	207	10391
R-HSA-428790	Facilitative Na+-independent glucose transporters	0.999999999981399	-1.86013458606374e-11	14	0	0	207	10391
R-HSA-181431	Acetylcholine Binding And Downstream Events	0.999999999981399	-1.86013458606374e-11	14	0	0	207	10391
R-HSA-209560	NF-kB is activated and signals survival	0.999999999981399	-1.86013458606374e-11	14	0	0	207	10391
R-HSA-190322	FGFR4 ligand binding and activation	0.999999999981399	-1.86013458606374e-11	14	0	0	207	10391
R-HSA-162658	Golgi Cisternae Pericentriolar Stack Reorganization	0.999999999981399	-1.86013458606374e-11	14	0	0	207	10391
R-HSA-5467340	AXIN missense mutants destabilize the destruction complex	0.999999999981399	-1.86013458606374e-11	14	0	0	207	10391
R-HSA-69109	Leading Strand Synthesis	0.999999999981399	-1.86013458606374e-11	14	0	0	207	10391
R-HSA-418359	Reduction of cytosolic Ca++ levels	0.999999999981399	-1.86013458606374e-11	14	0	0	207	10391
R-HSA-5467337	APC truncation mutants have impaired AXIN binding	0.999999999981399	-1.86013458606374e-11	14	0	0	207	10391
R-HSA-6803205	TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain	0.999999999981399	-1.86013458606374e-11	14	0	0	207	10391
R-HSA-877312	Regulation of IFNG signaling	0.999999999981399	-1.86013458606374e-11	14	0	0	207	10391
R-HSA-5358606	Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)	0.999999999981399	-1.86013458606374e-11	14	0	0	207	10391
R-HSA-622327	Postsynaptic nicotinic acetylcholine receptors	0.999999999981399	-1.86013458606374e-11	14	0	0	207	10391
R-HSA-5467348	Truncations of AMER1 destabilize the destruction complex	0.999999999981399	-1.86013458606374e-11	14	0	0	207	10391
R-HSA-209952	Peptide hormone biosynthesis	0.999999999981399	-1.86013458606374e-11	14	0	0	207	10391
R-HSA-204174	Regulation of pyruvate dehydrogenase (PDH) complex	0.999999999981399	-1.86013458606374e-11	14	0	0	207	10391
R-HSA-5358565	Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)	0.999999999981399	-1.86013458606374e-11	14	0	0	207	10391
R-HSA-4839735	AXIN mutants destabilize the destruction complex, activating WNT signaling	0.999999999981399	-1.86013458606374e-11	14	0	0	207	10391
R-HSA-211958	Miscellaneous substrates	0.999999999981399	-1.86013458606374e-11	14	0	0	207	10391
R-HSA-174411	Polymerase switching on the C-strand of the telomere	0.999999999981399	-1.86013458606374e-11	14	0	0	207	10391
R-HSA-209543	p75NTR recruits signalling complexes	0.999999999981399	-1.86013458606374e-11	14	0	0	207	10391
R-HSA-193775	Synthesis of bile acids and bile salts via 24-hydroxycholesterol	0.999999999981399	-1.86013458606374e-11	14	0	0	207	10391
R-HSA-69091	Polymerase switching	0.999999999981399	-1.86013458606374e-11	14	0	0	207	10391
R-HSA-5675482	Regulation of necroptotic cell death	0.999999999981399	-1.86013458606374e-11	14	0	0	207	10391
R-HSA-629602	Activation of Nicotinic Acetylcholine Receptors	0.999999999981399	-1.86013458606374e-11	14	0	0	207	10391
R-HSA-1679131	Trafficking and processing of endosomal TLR	0.999999999981399	-1.86013458606374e-11	14	0	0	207	10391
R-HSA-69166	Removal of the Flap Intermediate	0.999999999981399	-1.86013458606374e-11	14	0	0	207	10391
R-HSA-2024101	CS/DS degradation	0.999999999981399	-1.86013458606374e-11	14	0	0	207	10391
R-HSA-6804759	Regulation of TP53 Activity through Association with Co-factors	0.999999999981399	-1.86013458606374e-11	14	0	0	207	10391
R-HSA-1839126	FGFR2 mutant receptor activation	0.99999999998382	-1.61796128153193e-11	33	0	0	207	10391
R-HSA-4085001	Sialic acid metabolism	0.99999999998382	-1.61796128153193e-11	33	0	0	207	10391
R-HSA-5357905	Regulation of TNFR1 signaling	0.99999999998382	-1.61796128153193e-11	33	0	0	207	10391
R-HSA-1638074	Keratan sulfate/keratin metabolism	0.99999999998382	-1.61796128153193e-11	33	0	0	207	10391
R-HSA-5654726	Negative regulation of FGFR1 signaling	0.99999999998382	-1.61796128153193e-11	33	0	0	207	10391
R-HSA-180746	Nuclear import of Rev protein	0.99999999998382	-1.61796128153193e-11	33	0	0	207	10391
R-HSA-376176	Signaling by Robo receptor	0.99999999998382	-1.61796128153193e-11	33	0	0	207	10391
R-HSA-389356	CD28 co-stimulation	0.99999999998382	-1.61796128153193e-11	33	0	0	207	10391
R-HSA-180910	Vpr-mediated nuclear import of PICs	0.99999999998382	-1.61796128153193e-11	33	0	0	207	10391
R-HSA-186712	Regulation of beta-cell development	0.99999999998382	-1.61796128153193e-11	33	0	0	207	10391
R-HSA-933541	TRAF6 mediated IRF7 activation	0.999999999984903	-1.50966037229999e-11	35	0	0	207	10391
R-HSA-167158	Formation of the HIV-1 Early Elongation Complex	0.999999999984903	-1.50966037229999e-11	35	0	0	207	10391
R-HSA-159230	Transport of the SLBP Dependant Mature mRNA	0.999999999984903	-1.50966037229999e-11	35	0	0	207	10391
R-HSA-4791275	Signaling by WNT in cancer	0.999999999984903	-1.50966037229999e-11	35	0	0	207	10391
R-HSA-113418	Formation of the Early Elongation Complex	0.999999999984903	-1.50966037229999e-11	35	0	0	207	10391
R-HSA-6811440	Retrograde transport at the Trans-Golgi-Network	0.999999999986421	-1.35792929012214e-11	49	0	0	207	10391
R-HSA-71406	Pyruvate metabolism and Citric Acid (TCA) cycle	0.999999999986421	-1.35792929012214e-11	49	0	0	207	10391
R-HSA-199977	ER to Golgi Anterograde Transport	0.99999999998914	-1.08595483794807e-11	133	0	0	207	10391
R-HSA-6811438	Intra-Golgi traffic	0.999999999990865	-9.13480301434606e-12	45	0	0	207	10391
R-HSA-379724	tRNA Aminoacylation	0.999999999990865	-9.13480301434606e-12	45	0	0	207	10391
R-HSA-159234	Transport of Mature mRNAs Derived from Intronless Transcripts	0.999999999990865	-9.13480301434606e-12	45	0	0	207	10391
R-HSA-1912420	Pre-NOTCH Processing in Golgi	0.999999999991812	-8.18792956523408e-12	18	0	0	207	10391
R-HSA-5083632	Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)	0.999999999991812	-8.18792956523408e-12	18	0	0	207	10391
R-HSA-5083625	Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)	0.999999999991812	-8.18792956523408e-12	18	0	0	207	10391
R-HSA-5654704	SHC-mediated cascade:FGFR3	0.999999999991812	-8.18792956523408e-12	18	0	0	207	10391
R-HSA-73780	RNA Polymerase III Chain Elongation	0.999999999991812	-8.18792956523408e-12	18	0	0	207	10391
R-HSA-912631	Regulation of signaling by CBL	0.999999999991812	-8.18792956523408e-12	18	0	0	207	10391
R-HSA-5635838	Activation of SMO	0.999999999991812	-8.18792956523408e-12	18	0	0	207	10391
R-HSA-5654221	Phospholipase C-mediated cascade; FGFR2	0.999999999991812	-8.18792956523408e-12	18	0	0	207	10391
R-HSA-181430	Norepinephrine Neurotransmitter Release Cycle	0.999999999991812	-8.18792956523408e-12	18	0	0	207	10391
R-HSA-5083636	Defective GALNT12 causes colorectal cancer 1 (CRCS1)	0.999999999991812	-8.18792956523408e-12	18	0	0	207	10391
R-HSA-5654710	PI-3K cascade:FGFR3	0.999999999991812	-8.18792956523408e-12	18	0	0	207	10391
R-HSA-196757	Metabolism of folate and pterines	0.999999999991812	-8.18792956523408e-12	18	0	0	207	10391
R-HSA-181429	Serotonin Neurotransmitter Release Cycle	0.999999999991812	-8.18792956523408e-12	18	0	0	207	10391
R-HSA-209776	Amine-derived hormones	0.999999999991812	-8.18792956523408e-12	18	0	0	207	10391
R-HSA-5676594	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	0.999999999991812	-8.18792956523408e-12	18	0	0	207	10391
R-HSA-163210	Formation of ATP by chemiosmotic coupling	0.999999999991812	-8.18792956523408e-12	18	0	0	207	10391
R-HSA-1369062	ABC transporters in lipid homeostasis	0.999999999991812	-8.18792956523408e-12	18	0	0	207	10391
R-HSA-936964	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	0.999999999991812	-8.18792956523408e-12	18	0	0	207	10391
R-HSA-1839117	Signaling by cytosolic FGFR1 fusion mutants	0.999999999991812	-8.18792956523408e-12	18	0	0	207	10391
R-HSA-1482925	Acyl chain remodelling of PG	0.999999999991812	-8.18792956523408e-12	18	0	0	207	10391
R-HSA-5603027	IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)	0.999999999992186	-7.81422322232873e-12	8	0	0	207	10391
R-HSA-2142670	Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)	0.999999999992186	-7.81422322232873e-12	8	0	0	207	10391
R-HSA-70921	Histidine catabolism	0.999999999992186	-7.81422322232873e-12	8	0	0	207	10391
R-HSA-5688890	Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4)	0.999999999992186	-7.81422322232873e-12	8	0	0	207	10391
R-HSA-5576890	Phase 3 - rapid repolarisation	0.999999999992186	-7.81422322232873e-12	8	0	0	207	10391
R-HSA-5632681	Ligand-receptor interactions	0.999999999992186	-7.81422322232873e-12	8	0	0	207	10391
R-HSA-68952	DNA replication initiation	0.999999999992186	-7.81422322232873e-12	8	0	0	207	10391
R-HSA-196836	Vitamin C (ascorbate) metabolism	0.999999999992186	-7.81422322232873e-12	8	0	0	207	10391
R-HSA-977347	Serine biosynthesis	0.999999999992186	-7.81422322232873e-12	8	0	0	207	10391
R-HSA-6787450	tRNA modification in the mitochondrion	0.999999999992186	-7.81422322232873e-12	8	0	0	207	10391
R-HSA-450520	HuR (ELAVL1) binds and stabilizes mRNA	0.999999999992186	-7.81422322232873e-12	8	0	0	207	10391
R-HSA-110329	Cleavage of the damaged pyrimidine	0.999999999992186	-7.81422322232873e-12	8	0	0	207	10391
R-HSA-444821	Relaxin receptors	0.999999999992186	-7.81422322232873e-12	8	0	0	207	10391
R-HSA-446210	Synthesis of UDP-N-acetyl-glucosamine	0.999999999992186	-7.81422322232873e-12	8	0	0	207	10391
R-HSA-210747	Regulation of gene expression in early pancreatic precursor cells	0.999999999992186	-7.81422322232873e-12	8	0	0	207	10391
R-HSA-448424	Interleukin-17 signaling	0.999999999992186	-7.81422322232873e-12	8	0	0	207	10391
R-HSA-163680	AMPK inhibits chREBP transcriptional activation activity	0.999999999992186	-7.81422322232873e-12	8	0	0	207	10391
R-HSA-5362798	Release of Hh-Np from the secreting cell	0.999999999992186	-7.81422322232873e-12	8	0	0	207	10391
R-HSA-196783	Coenzyme A biosynthesis	0.999999999992186	-7.81422322232873e-12	8	0	0	207	10391
R-HSA-446388	Regulation of cytoskeletal remodeling and cell spreading by IPP complex components	0.999999999992186	-7.81422322232873e-12	8	0	0	207	10391
R-HSA-434316	Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion	0.999999999992186	-7.81422322232873e-12	8	0	0	207	10391
R-HSA-1483115	Hydrolysis of LPC	0.999999999992186	-7.81422322232873e-12	8	0	0	207	10391
R-HSA-110328	Recognition and association of DNA glycosylase with site containing an affected pyrimidine	0.999999999992186	-7.81422322232873e-12	8	0	0	207	10391
R-HSA-8850843	Phosphate bond hydrolysis by NTPDase proteins	0.999999999992186	-7.81422322232873e-12	8	0	0	207	10391
R-HSA-5358493	Synthesis of diphthamide-EEF2	0.999999999992186	-7.81422322232873e-12	8	0	0	207	10391
R-HSA-72731	Recycling of eIF2:GDP	0.999999999992186	-7.81422322232873e-12	8	0	0	207	10391
R-HSA-73928	Depyrimidination	0.999999999992186	-7.81422322232873e-12	8	0	0	207	10391
R-HSA-5688849	Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5)	0.999999999992186	-7.81422322232873e-12	8	0	0	207	10391
R-HSA-73942	DNA Damage Reversal	0.999999999992186	-7.81422322232873e-12	8	0	0	207	10391
R-HSA-416550	Sema4D mediated inhibition of cell attachment and migration	0.999999999992186	-7.81422322232873e-12	8	0	0	207	10391
R-HSA-804914	Transport of fatty acids	0.999999999992186	-7.81422322232873e-12	8	0	0	207	10391
R-HSA-400451	Free fatty acids regulate insulin secretion	0.999999999992186	-7.81422322232873e-12	8	0	0	207	10391
R-HSA-389397	Orexin and neuropeptides FF and QRFP bind to their respective receptors	0.999999999992186	-7.81422322232873e-12	8	0	0	207	10391
R-HSA-8937144	Aryl hydrocarbon receptor signalling	0.999999999992186	-7.81422322232873e-12	8	0	0	207	10391
R-HSA-164944	Nef and signal transduction	0.999999999992186	-7.81422322232873e-12	8	0	0	207	10391
R-HSA-174430	Telomere C-strand synthesis initiation	0.999999999992186	-7.81422322232873e-12	8	0	0	207	10391
R-HSA-177128	Conjugation of salicylate with glycine	0.999999999992186	-7.81422322232873e-12	8	0	0	207	10391
R-HSA-1483148	Synthesis of PG	0.999999999992186	-7.81422322232873e-12	8	0	0	207	10391
R-HSA-5693606	DNA Double Strand Break Response	0.999999999993465	-6.53541235708112e-12	77	0	0	207	10391
R-HSA-167172	Transcription of the HIV genome	0.999999999993465	-6.53541235708112e-12	77	0	0	207	10391
R-HSA-2262749	Cellular response to hypoxia	0.999999999993465	-6.53541235708112e-12	77	0	0	207	10391
R-HSA-176814	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins	0.999999999993465	-6.53541235708112e-12	77	0	0	207	10391
R-HSA-1169410	Antiviral mechanism by IFN-stimulated genes	0.999999999993465	-6.53541235708112e-12	77	0	0	207	10391
R-HSA-1234174	Regulation of Hypoxia-inducible Factor (HIF) by oxygen	0.999999999993465	-6.53541235708112e-12	77	0	0	207	10391
R-HSA-1169408	ISG15 antiviral mechanism	0.999999999993465	-6.53541235708112e-12	77	0	0	207	10391
R-HSA-69304	Regulation of DNA replication	0.999999999993465	-6.53541235708112e-12	77	0	0	207	10391
R-HSA-427389	ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression	0.999999999993465	-6.53541235708112e-12	77	0	0	207	10391
R-HSA-975298	Ligand-gated ion channel transport	0.999999999993622	-6.37799055338305e-12	26	0	0	207	10391
R-HSA-3560782	Diseases associated with glycosaminoglycan metabolism	0.999999999993622	-6.37799055338305e-12	26	0	0	207	10391
R-HSA-389948	PD-1 signaling	0.999999999993622	-6.37799055338305e-12	26	0	0	207	10391
R-HSA-379716	Cytosolic tRNA aminoacylation	0.999999999993622	-6.37799055338305e-12	26	0	0	207	10391
R-HSA-73848	Pyrimidine metabolism	0.999999999993622	-6.37799055338305e-12	26	0	0	207	10391
R-HSA-389960	Formation of tubulin folding intermediates by CCT/TriC	0.999999999993622	-6.37799055338305e-12	26	0	0	207	10391
R-HSA-1971475	A tetrasaccharide linker sequence is required for GAG synthesis	0.999999999993622	-6.37799055338305e-12	26	0	0	207	10391
R-HSA-975576	N-glycan antennae elongation in the medial/trans-Golgi	0.999999999993622	-6.37799055338305e-12	26	0	0	207	10391
R-HSA-977068	Termination of O-glycan biosynthesis	0.999999999993622	-6.37799055338305e-12	26	0	0	207	10391
R-HSA-1614635	Sulfur amino acid metabolism	0.999999999993622	-6.37799055338305e-12	26	0	0	207	10391
R-HSA-190236	Signaling by FGFR	0.999999999994579	-5.42140608933057e-12	89	0	0	207	10391
R-HSA-8876384	Listeria monocytogenes entry into host cells	0.999999999995122	-4.87771242817774e-12	20	0	0	207	10391
R-HSA-1643713	Signaling by EGFR in Cancer	0.999999999995122	-4.87771242817774e-12	20	0	0	207	10391
R-HSA-6804760	Regulation of TP53 Activity through Methylation	0.999999999995122	-4.87771242817774e-12	20	0	0	207	10391
R-HSA-381771	Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)	0.999999999995122	-4.87771242817774e-12	20	0	0	207	10391
R-HSA-5637815	Signaling by Ligand-Responsive EGFR Variants in Cancer	0.999999999995122	-4.87771242817774e-12	20	0	0	207	10391
R-HSA-6788467	IL-6-type cytokine receptor ligand interactions	0.999999999995122	-4.87771242817774e-12	20	0	0	207	10391
R-HSA-5654719	SHC-mediated cascade:FGFR4	0.999999999995122	-4.87771242817774e-12	20	0	0	207	10391
R-HSA-5654706	FRS-mediated FGFR3 signaling	0.999999999995122	-4.87771242817774e-12	20	0	0	207	10391
R-HSA-5654720	PI-3K cascade:FGFR4	0.999999999995122	-4.87771242817774e-12	20	0	0	207	10391
R-HSA-141430	Inactivation of APC/C via direct inhibition of the APC/C complex	0.999999999995122	-4.87771242817774e-12	20	0	0	207	10391
R-HSA-1236382	Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	0.999999999995122	-4.87771242817774e-12	20	0	0	207	10391
R-HSA-190241	FGFR2 ligand binding and activation	0.999999999995122	-4.87771242817774e-12	20	0	0	207	10391
R-HSA-69186	Lagging Strand Synthesis	0.999999999995122	-4.87771242817774e-12	20	0	0	207	10391
R-HSA-141405	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components	0.999999999995122	-4.87771242817774e-12	20	0	0	207	10391
R-HSA-611105	Respiratory electron transport	0.999999999995142	-4.85824316876017e-12	102	0	0	207	10391
R-HSA-5221030	TET1,2,3 and TDG demethylate DNA	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-6802953	RAS signaling downstream of NF1 loss-of-function variants	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-204626	Hypusine synthesis from eIF5A-lysine	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-6803544	Ion influx/efflux at host-pathogen interface	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-2473224	Antagonism of Activin by Follistatin	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-1251932	PLCG1 events in ERBB2 signaling	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-176034	Interactions of Tat with host cellular proteins	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-75108	Activation, myristolyation of BID and translocation to mitochondria	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-1296053	Classical Kir channels	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-165158	Activation of AKT2	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-379401	Dopamine clearance from the synaptic cleft	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-173736	Alternative complement activation	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-8866906	TFAP2 (AP-2) family regulates transcription of other transcription factors	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-8847453	Synthesis of PIPs in the nucleus	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-5619099	Defective AVP causes neurohypophyseal diabetes insipidus (NDI)	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-209563	Axonal growth stimulation	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-428776	Class II GLUTs	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-390650	Histamine receptors	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-69560	Transcriptional activation of p53 responsive genes	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-211163	AKT-mediated inactivation of FOXO1A	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-69200	Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-4551638	SUMOylation of chromatin organization proteins	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-417973	Adenosine P1 receptors	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-5083630	Defective LFNG causes SCDO3	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-447115	Interleukin-12 signaling	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-3878781	Glycogen storage disease type IV (GBE1)	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-69895	Transcriptional  activation of  cell cycle inhibitor p21	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-75944	Transcription from mitochondrial promoters	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-1296061	HCN channels	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-167060	NGF processing	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-5579026	Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-427975	Proton/oligopeptide cotransporters	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-1369007	Mitochondrial ABC transporters	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-5603037	IRAK4 deficiency (TLR5)	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-428542	Regulation of Commissural axon pathfinding by Slit and Robo	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-442745	Activation of CaMK IV	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-209905	Catecholamine biosynthesis	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-110381	Resolution of AP sites via the single-nucleotide replacement pathway	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-8935690	Miscellaneous digestion events	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-3000497	Scavenging by Class H Receptors	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-446343	Localization of the PINCH-ILK-PARVIN complex to focal adhesions	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-6807062	Cholesterol biosynthesis via lathosterol	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-888593	Reuptake of GABA	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-112126	ALKBH3 mediated reversal of alkylation damage	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-399710	Activation of AMPA receptors	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-964975	Vitamins B6 activation to pyridoxal phosphate	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-8849474	PTK6 Activates STAT3	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-1296025	ATP sensitive Potassium channels	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-5250968	Toxicity of botulinum toxin type A (BoNT/A)	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-6807047	Cholesterol biosynthesis via desmosterol	0.999999999995285	-4.71508169736424e-12	4	0	0	207	10391
R-HSA-4641262	Disassembly of the destruction complex and recruitment of AXIN to the membrane	0.99999999999549	-4.51014098834146e-12	32	0	0	207	10391
R-HSA-69190	DNA strand elongation	0.99999999999549	-4.51014098834146e-12	32	0	0	207	10391
R-HSA-73863	RNA Polymerase I Transcription Termination	0.99999999999549	-4.51014098834146e-12	32	0	0	207	10391
R-HSA-68962	Activation of the pre-replicative complex	0.99999999999549	-4.51014098834146e-12	32	0	0	207	10391
R-HSA-196071	Metabolism of steroid hormones	0.99999999999549	-4.51014098834146e-12	32	0	0	207	10391
R-HSA-168274	Export of Viral Ribonucleoproteins from Nucleus	0.99999999999549	-4.51014098834146e-12	32	0	0	207	10391
R-HSA-70171	Glycolysis	0.99999999999549	-4.51014098834146e-12	32	0	0	207	10391
R-HSA-3928664	Ephrin signaling	0.999999999995669	-4.33113504812361e-12	19	0	0	207	10391
R-HSA-176407	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	0.999999999995669	-4.33113504812361e-12	19	0	0	207	10391
R-HSA-176412	Phosphorylation of the APC/C	0.999999999995669	-4.33113504812361e-12	19	0	0	207	10391
R-HSA-5576886	Phase 4 - resting membrane potential	0.999999999995669	-4.33113504812361e-12	19	0	0	207	10391
R-HSA-8851708	Signaling by FGFR2 IIIa TM	0.999999999995669	-4.33113504812361e-12	19	0	0	207	10391
R-HSA-71403	Citric acid cycle (TCA cycle)	0.999999999995669	-4.33113504812361e-12	19	0	0	207	10391
R-HSA-3560783	Defective B4GALT7 causes EDS, progeroid type	0.999999999995669	-4.33113504812361e-12	19	0	0	207	10391
R-HSA-110320	Translesion Synthesis by POLH	0.999999999995669	-4.33113504812361e-12	19	0	0	207	10391
R-HSA-888590	GABA synthesis, release, reuptake and degradation	0.999999999995669	-4.33113504812361e-12	19	0	0	207	10391
R-HSA-1660514	Synthesis of PIPs at the Golgi membrane	0.999999999995669	-4.33113504812361e-12	19	0	0	207	10391
R-HSA-3560801	Defective B3GAT3 causes JDSSDHD	0.999999999995669	-4.33113504812361e-12	19	0	0	207	10391
R-HSA-4420332	Defective B3GALT6 causes EDSP2 and SEMDJL1	0.999999999995669	-4.33113504812361e-12	19	0	0	207	10391
R-HSA-8876725	Protein methylation	0.999999999995669	-4.33113504812361e-12	19	0	0	207	10391
R-HSA-379726	Mitochondrial tRNA aminoacylation	0.999999999996025	-3.97504808175246e-12	23	0	0	207	10391
R-HSA-8863678	Neurodegenerative Diseases	0.999999999996025	-3.97504808175246e-12	23	0	0	207	10391
R-HSA-389977	Post-chaperonin tubulin folding pathway	0.999999999996025	-3.97504808175246e-12	23	0	0	207	10391
R-HSA-112409	RAF-independent MAPK1/3 activation	0.999999999996025	-3.97504808175246e-12	23	0	0	207	10391
R-HSA-2173795	Downregulation of SMAD2/3:SMAD4 transcriptional activity	0.999999999996025	-3.97504808175246e-12	23	0	0	207	10391
R-HSA-8862803	Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models	0.999999999996025	-3.97504808175246e-12	23	0	0	207	10391
R-HSA-5205685	Pink/Parkin Mediated Mitophagy	0.999999999996025	-3.97504808175246e-12	23	0	0	207	10391
R-HSA-5654695	PI-3K cascade:FGFR2	0.999999999996025	-3.97504808175246e-12	23	0	0	207	10391
R-HSA-73980	RNA Polymerase III Transcription Termination	0.999999999996025	-3.97504808175246e-12	23	0	0	207	10391
R-HSA-5423646	Aflatoxin activation and detoxification	0.999999999996025	-3.97504808175246e-12	23	0	0	207	10391
R-HSA-5205647	Mitophagy	0.999999999996025	-3.97504808175246e-12	23	0	0	207	10391
R-HSA-5627123	RHO GTPases activate PAKs	0.999999999996025	-3.97504808175246e-12	23	0	0	207	10391
R-HSA-212676	Dopamine Neurotransmitter Release Cycle	0.999999999996025	-3.97504808175246e-12	23	0	0	207	10391
R-HSA-5654693	FRS-mediated FGFR1 signaling	0.999999999996025	-3.97504808175246e-12	23	0	0	207	10391
R-HSA-2453902	The canonical retinoid cycle in rods (twilight vision)	0.999999999996025	-3.97504808175246e-12	23	0	0	207	10391
R-HSA-174048	APC/C:Cdc20 mediated degradation of Cyclin B	0.999999999996025	-3.97504808175246e-12	23	0	0	207	10391
R-HSA-5654699	SHC-mediated cascade:FGFR2	0.999999999996025	-3.97504808175246e-12	23	0	0	207	10391
R-HSA-193368	Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol	0.999999999996142	-3.85799524285357e-12	24	0	0	207	10391
R-HSA-5260271	Diseases of Immune System	0.999999999996142	-3.85799524285357e-12	24	0	0	207	10391
R-HSA-2142691	Synthesis of Leukotrienes (LT) and Eoxins (EX)	0.999999999996142	-3.85799524285357e-12	24	0	0	207	10391
R-HSA-191273	Cholesterol biosynthesis	0.999999999996142	-3.85799524285357e-12	24	0	0	207	10391
R-HSA-416572	Sema4D induced cell migration and growth-cone collapse	0.999999999996142	-3.85799524285357e-12	24	0	0	207	10391
R-HSA-174417	Telomere C-strand (Lagging Strand) Synthesis	0.999999999996142	-3.85799524285357e-12	24	0	0	207	10391
R-HSA-156588	Glucuronidation	0.999999999996142	-3.85799524285357e-12	24	0	0	207	10391
R-HSA-70895	Branched-chain amino acid catabolism	0.999999999996142	-3.85799524285357e-12	24	0	0	207	10391
R-HSA-5602358	Diseases associated with the TLR signaling cascade	0.999999999996142	-3.85799524285357e-12	24	0	0	207	10391
R-HSA-937041	IKK complex recruitment mediated by RIP1	0.999999999996142	-3.85799524285357e-12	24	0	0	207	10391
R-HSA-110373	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	0.999999999996142	-3.85799524285357e-12	24	0	0	207	10391
R-HSA-176033	Interactions of Vpr with host cellular proteins	0.999999999996364	-3.63638563589097e-12	36	0	0	207	10391
R-HSA-936440	Negative regulators of RIG-I/MDA5 signaling	0.999999999996364	-3.63638563589097e-12	36	0	0	207	10391
R-HSA-5663213	RHO GTPases Activate WASPs and WAVEs	0.999999999996364	-3.63638563589097e-12	36	0	0	207	10391
R-HSA-202433	Generation of second messenger molecules	0.999999999996364	-3.63638563589097e-12	36	0	0	207	10391
R-HSA-177243	Interactions of Rev with host cellular proteins	0.999999999996364	-3.63638563589097e-12	36	0	0	207	10391
R-HSA-76046	RNA Polymerase III Transcription Initiation	0.999999999996364	-3.63638563589097e-12	36	0	0	207	10391
R-HSA-69656	Cyclin A:Cdk2-associated events at S phase entry	0.99999999999697	-3.03039373894008e-12	71	0	0	207	10391
R-HSA-5334118	DNA methylation	0.999999999997399	-2.60062209427256e-12	66	0	0	207	10391
R-HSA-6782135	Dual incision in TC-NER	0.999999999997399	-2.60062209427256e-12	66	0	0	207	10391
R-HSA-75105	Fatty Acyl-CoA Biosynthesis	0.999999999997534	-2.46598741061126e-12	55	0	0	207	10391
R-HSA-1655829	Regulation of cholesterol biosynthesis by SREBP (SREBF)	0.999999999997534	-2.46598741061126e-12	55	0	0	207	10391
R-HSA-180585	Vif-mediated degradation of APOBEC3G	0.999999999997534	-2.46598741061126e-12	55	0	0	207	10391
R-HSA-948021	Transport to the Golgi and subsequent modification	0.999999999997578	-2.42219552057265e-12	164	0	0	207	10391
R-HSA-69580	p53-Dependent G1/S DNA damage checkpoint	0.999999999997829	-2.17146879295368e-12	65	0	0	207	10391
R-HSA-112382	Formation of RNA Pol II elongation complex	0.999999999997829	-2.17146879295368e-12	65	0	0	207	10391
R-HSA-6782210	Gap-filling DNA repair synthesis and ligation in TC-NER	0.999999999997829	-2.17146879295368e-12	65	0	0	207	10391
R-HSA-69563	p53-Dependent G1 DNA Damage Response	0.999999999997829	-2.17146879295368e-12	65	0	0	207	10391
R-HSA-75955	RNA Polymerase II Transcription Elongation	0.999999999997829	-2.17146879295368e-12	65	0	0	207	10391
R-HSA-453276	Regulation of mitotic cell cycle	0.999999999997858	-2.14224266261773e-12	87	0	0	207	10391
R-HSA-5632684	Hedgehog 'on' state	0.999999999997858	-2.14224266261773e-12	87	0	0	207	10391
R-HSA-351202	Metabolism of polyamines	0.999999999997858	-2.14224266261773e-12	87	0	0	207	10391
R-HSA-174143	APC/C-mediated degradation of cell cycle proteins	0.999999999997858	-2.14224266261773e-12	87	0	0	207	10391
R-HSA-73930	Abasic sugar-phosphate removal via the single-nucleotide replacement pathway	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-916853	Degradation of GABA	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-3359469	Defective MTR causes methylmalonic aciduria and homocystinuria type cblG	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-164939	Nef mediated downregulation of CD28 cell surface expression	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-177162	Conjugation of phenylacetate with glutamine	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-5688354	Defective pro-SFTPC causes pulmonary surfactant metabolism dysfunction 2 (SMDP2) and respiratory distress syndrome (RDS)	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-111995	phospho-PLA2 pathway	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-8854521	Interaction between PHLDA1 and AURKA	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-141334	PAOs oxidise polyamines to amines	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-3814836	Glycogen storage disease type XV (GYG1)	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-114294	Activation, translocation and oligomerization of BAX	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-844623	The IPAF inflammasome	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-3359467	Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-192905	vRNP Assembly	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-168277	Influenza Virus Induced Apoptosis	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-211994	Sterols are 12-hydroxylated by CYP8B1	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-5652227	Fructose biosynthesis	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-211736	Stimulation of the cell death response by PAK-2p34	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-68881	Mitotic Metaphase/Anaphase Transition	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-156582	Acetylation	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-1483152	Hydrolysis of LPE	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-5602636	IKBKB deficiency causes SCID	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-3359475	Defective MMAA causes methylmalonic aciduria type cblA	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-141424	Amplification of signal from the kinetochores	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-168315	Inhibition of Host mRNA Processing and RNA Silencing	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-351143	Agmatine biosynthesis	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-75064	mRNA Editing: A to I Conversion	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-163754	Insulin effects increased synthesis of Xylulose-5-Phosphate	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-141444	Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-211728	Regulation of PAK-2p34 activity by PS-GAP/RHG10	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-71737	Pyrophosphate hydrolysis	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-5638303	Inhibition of Signaling by Overexpressed EGFR	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-3858516	Glycogen storage disease type 0 (liver GYS2)	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-198765	Signalling to ERK5	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-1299361	TWIK-related alkaline pH activated K+ channel (TALK)	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-8942233	Intestinal infectious diseases	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-451307	Activation of Na-permeable Kainate Receptors	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-3828062	Glycogen storage disease type 0 (muscle GYS1)	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-888568	GABA synthesis	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-70688	Proline catabolism	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-168268	Virus Assembly and Release	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-1299316	TWIK-releated acid-sensitive K+ channel (TASK)	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-3359473	Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-111452	Activation and oligomerization of BAK protein	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-5579031	Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-75896	Plasmalogen biosynthesis	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-77042	Formation of editosomes by ADAR proteins	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-75102	C6 deamination of adenosine	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-480985	Synthesis of dolichyl-phosphate-glucose	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-166020	Transfer of LPS from LBP carrier to CD14	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-111457	Release of apoptotic factors from the mitochondria	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-5619107	Defective TRP may confer susceptibility towards thyroid papillary carcinoma (TPC)	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-428559	Proton-coupled neutral amino acid transporters	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-3359478	Defective MUT causes methylmalonic aciduria mut type	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-1483101	Synthesis of PS	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-187042	TRKA activation by NGF	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-5545619	XAV939 inhibits tankyrase, stabilizing AXIN	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-165160	PDE3B signalling	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-5602566	TICAM1 deficiency - HSE	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-5683177	Defective ABCC8 can cause hypoglycemias and hyperglycemias	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-5357609	Glycogen storage disease type II (GAA)	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-3359485	Defective CD320 causes methylmalonic aciduria	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-203754	NOSIP mediated eNOS trafficking	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-205017	NFG and proNGF binds to p75NTR	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-8849175	Threonine catabolism	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-168316	Assembly of Viral Components at the Budding Site	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-5638302	Signaling by Overexpressed Wild-Type EGFR in Cancer	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-380612	Metabolism of serotonin	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-432030	Transport of glycerol from adipocytes to the liver by Aquaporins	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-5687868	Defective SFTPA2 causes idiopathic pulmonary fibrosis (IPF)	0.99999999999795	-2.05005429949542e-12	2	0	0	207	10391
R-HSA-162909	Host Interactions of HIV factors	0.999999999998265	-1.73534578556583e-12	134	0	0	207	10391
R-HSA-2033519	Activated point mutants of FGFR2	0.999999999998325	-1.67450061934433e-12	17	0	0	207	10391
R-HSA-432142	Platelet sensitization by LDL	0.999999999998325	-1.67450061934433e-12	17	0	0	207	10391
R-HSA-264642	Acetylcholine Neurotransmitter Release Cycle	0.999999999998325	-1.67450061934433e-12	17	0	0	207	10391
R-HSA-193639	p75NTR signals via NF-kB	0.999999999998325	-1.67450061934433e-12	17	0	0	207	10391
R-HSA-196299	Beta-catenin phosphorylation cascade	0.999999999998325	-1.67450061934433e-12	17	0	0	207	10391
R-HSA-156711	Polo-like kinase mediated events	0.999999999998325	-1.67450061934433e-12	17	0	0	207	10391
R-HSA-3296482	Defects in vitamin and cofactor metabolism	0.999999999998325	-1.67450061934433e-12	17	0	0	207	10391
R-HSA-1482922	Acyl chain remodelling of PI	0.999999999998325	-1.67450061934433e-12	17	0	0	207	10391
R-HSA-140534	Ligand-dependent caspase activation	0.999999999998325	-1.67450061934433e-12	17	0	0	207	10391
R-HSA-5656121	Translesion synthesis by POLI	0.999999999998325	-1.67450061934433e-12	17	0	0	207	10391
R-HSA-622312	Inflammasomes	0.999999999998325	-1.67450061934433e-12	17	0	0	207	10391
R-HSA-211935	Fatty acids	0.999999999998325	-1.67450061934433e-12	17	0	0	207	10391
R-HSA-5625900	RHO GTPases activate CIT	0.999999999998325	-1.67450061934433e-12	17	0	0	207	10391
R-HSA-70221	Glycogen breakdown (glycogenolysis)	0.999999999998325	-1.67450061934433e-12	17	0	0	207	10391
R-HSA-5627117	RHO GTPases Activate ROCKs	0.999999999998325	-1.67450061934433e-12	17	0	0	207	10391
R-HSA-5655862	Translesion synthesis by POLK	0.999999999998325	-1.67450061934433e-12	17	0	0	207	10391
R-HSA-139853	Elevation of cytosolic Ca2+ levels	0.999999999998325	-1.67450061934433e-12	17	0	0	207	10391
R-HSA-3232118	SUMOylation of transcription factors	0.999999999998325	-1.67450061934433e-12	17	0	0	207	10391
R-HSA-164378	PKA activation in glucagon signalling	0.999999999998325	-1.67450061934433e-12	17	0	0	207	10391
R-HSA-199220	Vitamin B5 (pantothenate) metabolism	0.999999999998325	-1.67450061934433e-12	17	0	0	207	10391
R-HSA-2142845	Hyaluronan metabolism	0.999999999998325	-1.67450061934433e-12	17	0	0	207	10391
R-HSA-189445	Metabolism of porphyrins	0.999999999998325	-1.67450061934433e-12	17	0	0	207	10391
R-HSA-111931	PKA-mediated phosphorylation of CREB	0.999999999998325	-1.67450061934433e-12	17	0	0	207	10391
R-HSA-209968	Thyroxine biosynthesis	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-8868766	rRNA processing in the mitochondrion	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-3215018	Processing and activation of SUMO	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-3229121	Glycogen storage diseases	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-8853334	Signaling by FGFR3 fusions in cancer	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-113507	E2F-enabled inhibition of pre-replication complex formation	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-196108	Pregnenolone biosynthesis	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-389887	Beta-oxidation of pristanoyl-CoA	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-174437	Removal of the Flap Intermediate from the C-strand	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-419812	Calcitonin-like ligand receptors	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-727802	Transport of nucleotide sugars	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-418890	Role of second messengers in netrin-1 signaling	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-427601	Multifunctional anion exchangers	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-8875656	MET receptor recycling	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-190377	FGFR2b ligand binding and activation	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-168799	Neurotoxicity of clostridium toxins	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-73929	Base-Excision Repair, AP Site Formation	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-74259	Purine catabolism	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-6811555	PI5P Regulates TP53 Acetylation	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-170660	Adenylate cyclase activating pathway	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-2562578	TRIF-mediated programmed cell death	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-5687613	Diseases associated with surfactant metabolism	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-77286	mitochondrial fatty acid beta-oxidation of saturated fatty acids	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-201688	WNT mediated activation of DVL	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-164940	Nef mediated downregulation of MHC class I complex cell surface expression	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-193692	Regulated proteolysis of p75NTR	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-2465910	MASTL Facilitates Mitotic Progression	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-3785653	Myoclonic epilepsy of Lafora	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-975578	Reactions specific to the complex N-glycan synthesis pathway	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-428643	Organic anion transporters	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-70635	Urea cycle	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-111367	SLBP independent Processing of Histone Pre-mRNAs	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-1660517	Synthesis of PIPs at the late endosome membrane	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-74749	Signal attenuation	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-5663084	Diseases of carbohydrate metabolism	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-2161522	Abacavir transport and metabolism	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-390450	Folding of actin by CCT/TriC	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-110056	MAPK3 (ERK1) activation	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-1855167	Synthesis of pyrophosphates in the cytosol	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-167590	Nef Mediated CD4 Down-regulation	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-2046105	Linoleic acid (LA) metabolism	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-193697	p75NTR regulates axonogenesis	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-1462054	Alpha-defensins	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-450341	Activation of the AP-1 family of transcription factors	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-8866904	Negative regulation of activity of TFAP2 (AP-2) family transcription factors	0.99999999999872	-1.2795406331003e-12	10	0	0	207	10391
R-HSA-69239	Synthesis of DNA	0.99999999999937	-6.30000748909759e-13	101	0	0	207	10391
R-HSA-73762	RNA Polymerase I Transcription Initiation	0.999999999999694	-3.05511313818939e-13	48	0	0	207	10391
R-HSA-112040	G-protein mediated events	0.999999999999694	-3.05511313818939e-13	48	0	0	207	10391
R-HSA-4570464	SUMOylation of RNA binding proteins	0.999999999999694	-3.05511313818939e-13	48	0	0	207	10391
R-HSA-964827	Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-5627083	RHO GTPases regulate CFTR trafficking	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-77285	Beta oxidation of myristoyl-CoA to lauroyl-CoA	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-3359462	Defective AMN causes hereditary megaloblastic anemia 1	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-379398	Enzymatic degradation of Dopamine by monoamine oxidase	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-193681	Ceramide signalling	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-110330	Recognition and association of DNA glycosylase with site containing an affected purine	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-5624958	ARL13B-mediated ciliary trafficking of INPP5E	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-2892245	POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-428359	Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-111446	Activation of BIM and translocation to mitochondria	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-427589	Type II Na+/Pi cotransporters	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-73927	Depurination	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-351200	Interconversion of polyamines	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-3304347	Loss of Function of SMAD4 in Cancer	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-1614603	Cysteine formation from homocysteine	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-5250971	Toxicity of botulinum toxin type C (BoNT/C)	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-111458	Formation of apoptosome	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-3359463	Defective CUBN causes hereditary megaloblastic anemia 1	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-5250992	Toxicity of botulinum toxin type E (BoNT/E)	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-175567	Integration of viral DNA into host genomic DNA	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-3249367	STAT6-mediated induction of chemokines	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-162699	Synthesis of dolichyl-phosphate mannose	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-3296197	Hydroxycarboxylic acid-binding receptors	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-5250958	Toxicity of botulinum toxin type B (BoNT/B)	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-5688031	Defective pro-SFTPB causes pulmonary surfactant metabolism dysfunction 1 (SMDP1) and respiratory distress syndrome (RDS)	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-265473	Trafficking of dietary sterols	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-198745	Signalling to STAT3	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-190374	FGFR1c and Klotho ligand binding and activation	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-444411	Rhesus glycoproteins mediate ammonium transport.	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-350864	Regulation of thyroid hormone activity	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-163282	Mitochondrial transcription initiation	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-139910	Activation of BMF and translocation to mitochondria	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-110331	Cleavage of the damaged purine	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-1234162	Oxygen-dependent asparagine hydroxylation of Hypoxia-inducible Factor Alpha	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-392023	Adrenaline signalling through Alpha-2 adrenergic receptor	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-180897	Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-5250989	Toxicity of botulinum toxin type G (BoNT/G)	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-217271	FMO oxidises nucleophiles	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-1307965	betaKlotho-mediated ligand binding	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-8875791	MET activates STAT3	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-844455	The NLRP1 inflammasome	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-379397	Enzymatic degradation of dopamine by COMT	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-165181	Inhibition of TSC complex formation by PKB	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-8853336	Signaling by plasma membrane FGFR1 fusions	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-1483248	Synthesis of PIPs at the ER membrane	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-352238	Breakdown of the nuclear lamina	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-5635851	GLI proteins bind promoters of Hh responsive genes to promote transcription	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-1299308	Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK)	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-977442	GABA A (rho) receptor activation	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-5653890	Lactose synthesis	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-3311021	SMAD4 MH2 Domain Mutants in Cancer	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-177539	Autointegration results in viral DNA circles	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-77108	Utilization of Ketone Bodies	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-5339700	TCF7L2 mutants don't bind CTBP	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-5602680	MyD88 deficiency (TLR5)	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-844615	The AIM2 inflammasome	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-73843	5-Phosphoribose 1-diphosphate biosynthesis	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-1296067	Potassium transport channels	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-5658034	HHAT G278V abrogates palmitoylation of Hh-Np	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-1368071	NR1D1 (REV-ERBA) represses gene expression	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-2395516	Electron transport from NADPH to Ferredoxin	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-5357572	Lysosomal glycogen catabolism	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-173599	Formation of the active cofactor, UDP-glucuronate	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-1299503	TWIK related potassium channel (TREK)	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-170145	Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-6806664	Metabolism of vitamin K	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-880009	Interconversion of 2-oxoglutarate and 2-hydroxyglutarate	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-380615	Serotonin clearance from the synaptic cleft	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-5602571	TRAF3 deficiency - HSE	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-77305	Beta oxidation of palmitoyl-CoA to myristoyl-CoA	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-8849472	PTK6 Down-Regulation	0.999999999999731	-2.69351003699962e-13	3	0	0	207	10391
R-HSA-504046	RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription	1.00000000000039	3.91393114672636e-13	150	0	0	207	10391
R-HSA-5654743	Signaling by FGFR4	1.00000000000068	6.8294876566258e-13	41	0	0	207	10391
R-HSA-5620924	Intraflagellar transport	1.00000000000068	6.8294876566258e-13	41	0	0	207	10391
R-HSA-5696400	Dual Incision in GG-NER	1.00000000000068	6.8294876566258e-13	41	0	0	207	10391
R-HSA-749476	RNA Polymerase III Abortive And Retractive Initiation	1.00000000000068	6.8294876566258e-13	41	0	0	207	10391
R-HSA-110313	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template	1.00000000000068	6.8294876566258e-13	41	0	0	207	10391
R-HSA-74158	RNA Polymerase III Transcription	1.00000000000068	6.8294876566258e-13	41	0	0	207	10391
R-HSA-159236	Transport of Mature mRNA derived from an Intron-Containing Transcript	1.00000000000072	7.20875996805188e-13	76	0	0	207	10391
R-HSA-176409	APC/C:Cdc20 mediated degradation of mitotic proteins	1.00000000000072	7.20875996805188e-13	76	0	0	207	10391
R-HSA-5693565	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	1.00000000000072	7.20875996805188e-13	76	0	0	207	10391
R-HSA-210745	Regulation of gene expression in beta cells	1.00000000000072	7.22505868098728e-13	21	0	0	207	10391
R-HSA-5654689	PI-3K cascade:FGFR1	1.00000000000072	7.22505868098728e-13	21	0	0	207	10391
R-HSA-2028269	Signaling by Hippo	1.00000000000072	7.22505868098728e-13	21	0	0	207	10391
R-HSA-5654688	SHC-mediated cascade:FGFR1	1.00000000000072	7.22505868098728e-13	21	0	0	207	10391
R-HSA-1181150	Signaling by NODAL	1.00000000000072	7.22505868098728e-13	21	0	0	207	10391
R-HSA-69618	Mitotic Spindle Checkpoint	1.00000000000072	7.22505868098728e-13	21	0	0	207	10391
R-HSA-2022870	Chondroitin sulfate biosynthesis	1.00000000000072	7.22505868098728e-13	21	0	0	207	10391
R-HSA-6804115	TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain	1.00000000000072	7.22505868098728e-13	21	0	0	207	10391
R-HSA-3000480	Scavenging by Class A Receptors	1.00000000000072	7.22505868098728e-13	21	0	0	207	10391
R-HSA-6807004	Negative regulation of MET activity	1.00000000000072	7.22505868098728e-13	21	0	0	207	10391
R-HSA-5651801	PCNA-Dependent Long Patch Base Excision Repair	1.00000000000072	7.22505868098728e-13	21	0	0	207	10391
R-HSA-196741	Cobalamin (Cbl, vitamin B12) transport and metabolism	1.00000000000072	7.22505868098728e-13	21	0	0	207	10391
R-HSA-2024096	HS-GAG degradation	1.00000000000072	7.22505868098728e-13	21	0	0	207	10391
R-HSA-166786	Creation of C4 and C2 activators	1.00000000000072	7.22505868098728e-13	21	0	0	207	10391
R-HSA-1810476	RIP-mediated NFkB activation via ZBP1	1.00000000000072	7.22505868098728e-13	21	0	0	207	10391
R-HSA-8849932	SALM protein interactions at the synapses	1.00000000000072	7.22505868098728e-13	21	0	0	207	10391
R-HSA-6803204	TP53 Regulates Transcription of Genes Involved in Cytochrome C Release	1.00000000000072	7.22505868098728e-13	21	0	0	207	10391
R-HSA-198933	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	1.00000000000113	1.12587326315726e-12	135	0	0	207	10391
R-HSA-167169	HIV Transcription Elongation	1.00000000000128	1.28355021541051e-12	50	0	0	207	10391
R-HSA-167200	Formation of HIV-1 elongation complex containing HIV-1 Tat	1.00000000000128	1.28355021541051e-12	50	0	0	207	10391
R-HSA-73893	DNA Damage Bypass	1.00000000000128	1.28355021541051e-12	50	0	0	207	10391
R-HSA-167246	Tat-mediated elongation of the HIV-1 transcript	1.00000000000128	1.28355021541051e-12	50	0	0	207	10391
R-HSA-5654736	Signaling by FGFR1	1.00000000000128	1.28355021541051e-12	50	0	0	207	10391
R-HSA-450408	AUF1 (hnRNP D0) binds and destabilizes mRNA	1.00000000000193	1.93119862626996e-12	57	0	0	207	10391
R-HSA-6799198	Complex I biogenesis	1.00000000000193	1.93119862626996e-12	57	0	0	207	10391
R-HSA-69002	DNA Replication Pre-Initiation	1.00000000000228	2.28133555615986e-12	86	0	0	207	10391
R-HSA-68874	M/G1 Transition	1.00000000000228	2.28133555615986e-12	86	0	0	207	10391
R-HSA-5663220	RHO GTPases Activate Formins	1.00000000000249	2.48508838234267e-12	117	0	0	207	10391
R-HSA-114604	GPVI-mediated activation cascade	1.00000000000282	2.81735659033518e-12	54	0	0	207	10391
R-HSA-69613	p53-Independent G1/S DNA damage checkpoint	1.00000000000282	2.81735659033518e-12	54	0	0	207	10391
R-HSA-1638091	Heparan sulfate/heparin (HS-GAG) metabolism	1.00000000000282	2.81735659033518e-12	54	0	0	207	10391
R-HSA-169911	Regulation of Apoptosis	1.00000000000282	2.81735659033518e-12	54	0	0	207	10391
R-HSA-189200	Hexose transport	1.00000000000282	2.81735659033518e-12	54	0	0	207	10391
R-HSA-69601	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	1.00000000000282	2.81735659033518e-12	54	0	0	207	10391
R-HSA-69610	p53-Independent DNA Damage Response	1.00000000000282	2.81735659033518e-12	54	0	0	207	10391
R-HSA-6781823	Formation of TC-NER Pre-Incision Complex	1.00000000000282	2.81735659033518e-12	54	0	0	207	10391
R-HSA-425397	Transport of vitamins, nucleosides, and related molecules	1.000000000003	2.99598690044598e-12	40	0	0	207	10391
R-HSA-109703	PKB-mediated events	1.000000000003	2.99598690044598e-12	40	0	0	207	10391
R-HSA-167287	HIV elongation arrest and recovery	1.000000000003	2.99598690044598e-12	40	0	0	207	10391
R-HSA-5654741	Signaling by FGFR3	1.000000000003	2.99598690044598e-12	40	0	0	207	10391
R-HSA-8864260	Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors	1.000000000003	2.99598690044598e-12	40	0	0	207	10391
R-HSA-167290	Pausing and recovery of HIV elongation	1.000000000003	2.99598690044598e-12	40	0	0	207	10391
R-HSA-156590	Glutathione conjugation	1.000000000003	2.99598690044598e-12	40	0	0	207	10391
R-HSA-5675221	Negative regulation of MAPK pathway	1.000000000003	2.99598690044598e-12	40	0	0	207	10391
R-HSA-168276	NS1 Mediated Effects on Host Pathways	1.000000000003	2.99598690044598e-12	40	0	0	207	10391
R-HSA-418360	Platelet calcium homeostasis	1.00000000000301	3.00871123723276e-12	31	0	0	207	10391
R-HSA-5654733	Negative regulation of FGFR4 signaling	1.00000000000301	3.00871123723276e-12	31	0	0	207	10391
R-HSA-73772	RNA Polymerase I Promoter Escape	1.00000000000301	3.00871123723276e-12	31	0	0	207	10391
R-HSA-5654687	Downstream signaling of activated FGFR1	1.00000000000301	3.00871123723276e-12	31	0	0	207	10391
R-HSA-168333	NEP/NS2 Interacts with the Cellular Export Machinery	1.00000000000301	3.00871123723276e-12	31	0	0	207	10391
R-HSA-168271	Transport of Ribonucleoproteins into the Host Nucleus	1.00000000000301	3.00871123723276e-12	31	0	0	207	10391
R-HSA-70614	Amino acid synthesis and interconversion (transamination)	1.00000000000301	3.00871123723276e-12	31	0	0	207	10391
R-HSA-5339562	Uptake and actions of bacterial toxins	1.00000000000301	3.00871123723276e-12	31	0	0	207	10391
R-HSA-1839124	FGFR1 mutant receptor activation	1.00000000000301	3.00871123723276e-12	31	0	0	207	10391
R-HSA-75067	Processing of Capped Intronless Pre-mRNA	1.00000000000301	3.00871123723276e-12	31	0	0	207	10391
R-HSA-2022928	HS-GAG biosynthesis	1.00000000000301	3.00871123723276e-12	31	0	0	207	10391
R-HSA-180786	Extension of Telomeres	1.00000000000301	3.00871123723276e-12	31	0	0	207	10391
R-HSA-170822	Regulation of Glucokinase by Glucokinase Regulatory Protein	1.00000000000301	3.00871123723276e-12	31	0	0	207	10391
R-HSA-6804758	Regulation of TP53 Activity through Acetylation	1.00000000000301	3.00871123723276e-12	31	0	0	207	10391
R-HSA-6811434	COPI-dependent Golgi-to-ER retrograde traffic	1.0000000000032	3.20091117077752e-12	83	0	0	207	10391
R-HSA-195253	Degradation of beta-catenin by the destruction complex	1.0000000000032	3.20091117077752e-12	83	0	0	207	10391
R-HSA-157579	Telomere Maintenance	1.0000000000032	3.20091117077752e-12	83	0	0	207	10391
R-HSA-2559586	DNA Damage/Telomere Stress Induced Senescence	1.00000000000328	3.28452036160309e-12	80	0	0	207	10391
R-HSA-6784531	tRNA processing in the nucleus	1.00000000000372	3.72414580166422e-12	60	0	0	207	10391
R-HSA-68827	CDT1 association with the CDC6:ORC:origin complex	1.00000000000372	3.72414580166422e-12	60	0	0	207	10391
R-HSA-5387390	Hh mutants abrogate ligand secretion	1.00000000000372	3.72414580166422e-12	60	0	0	207	10391
R-HSA-5676590	NIK-->noncanonical NF-kB signaling	1.00000000000372	3.72414580166422e-12	60	0	0	207	10391
R-HSA-174113	SCF-beta-TrCP mediated degradation of Emi1	1.00000000000373	3.7296369410501e-12	56	0	0	207	10391
R-HSA-4641257	Degradation of AXIN	1.00000000000373	3.7296369410501e-12	56	0	0	207	10391
R-HSA-381038	XBP1(S) activates chaperone genes	1.00000000000373	3.7296369410501e-12	56	0	0	207	10391
R-HSA-69541	Stabilization of p53	1.00000000000373	3.7296369410501e-12	56	0	0	207	10391
R-HSA-8854050	FBXL7 down-regulates AURKA during mitotic entry and in early mitosis	1.00000000000373	3.7296369410501e-12	56	0	0	207	10391
R-HSA-1222499	Response of Mtb to phagocytosis	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-5619110	Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-162585	Uncoating of the HIV Virion	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-162589	Reverse Transcription of HIV RNA	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-1299287	Tandem pore domain halothane-inhibited K+ channel (THIK)	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-211957	Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-5467333	APC truncation mutants are not K63 polyubiquitinated	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-168330	Viral RNP Complexes in the Host Cell Nucleus	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-1222352	Latent infection of Homo sapiens with Mycobacterium tuberculosis	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-5619058	Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR)	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-112122	ALKBH2 mediated reversal of alkylation damage	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-140180	COX reactions	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-2466712	Biosynthesis of A2E, implicated in retinal degradation	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-171286	Synthesis and processing of ENV and VPU	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-164516	Minus-strand DNA synthesis	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-5602415	UNC93B1 deficiency - HSE	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-8853333	Signaling by FGFR2 fusions	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-1300645	Acrosome Reaction	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-5083633	Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-2033515	t(4;14) translocations of FGFR3	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-5083629	Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-2023837	Signaling by FGFR2 amplification mutants	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-5250982	Toxicity of tetanus toxin (TeNT)	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-3248023	Regulation by TREX1	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-1839128	FGFR4 mutant receptor activation	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-5602410	TLR3 deficiency - HSE	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-169131	Inhibition of PKR	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-389542	NADPH regeneration	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-2142696	Synthesis of Hepoxilins (HX) and Trioxilins (TrX)	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-1222449	Mtb iron assimilation by chelation	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-3359454	Defective TCN2 causes hereditary megaloblastic anemia	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-5083628	Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-164525	Plus-strand DNA synthesis	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-3359457	Defective GIF causes intrinsic factor deficiency	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-6809583	Retinoid metabolism disease events	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-2978092	Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-5340573	WNT ligand secretion is abrogated by the PORCN inhibitor LGK974	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-5657655	MGMT-mediated DNA damage reversal	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-3359474	Defective MMACHC causes methylmalonic aciduria and homocystinuria type cblC	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-1299344	TWIK-related spinal cord K+ channel (TRESK)	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-163316	Mitochondrial transcription termination	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-2534343	Interaction With Cumulus Cells	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-1855231	Synthesis of IPs in the ER lumen	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-5263617	Metabolism of ingested MeSeO2H into MeSeH	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-2408552	Methylation of MeSeH for excretion	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-975574	Reactions specific to the hybrid N-glycan synthesis pathway	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-1839120	Signaling by FGFR1 amplification mutants	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-1483196	PI and PC transport between ER and Golgi membranes	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-1483076	Synthesis of CL	1.00000000000401	4.01221070256419e-12	1	0	0	207	10391
R-HSA-174403	Glutathione synthesis and recycling	1.00000000000413	4.12735943735908e-12	16	0	0	207	10391
R-HSA-5686938	Regulation of TLR by endogenous ligand	1.00000000000413	4.12735943735908e-12	16	0	0	207	10391
R-HSA-159418	Recycling of bile acids and salts	1.00000000000413	4.12735943735908e-12	16	0	0	207	10391
R-HSA-163615	PKA activation	1.00000000000413	4.12735943735908e-12	16	0	0	207	10391
R-HSA-1834941	STING mediated induction of host immune responses	1.00000000000413	4.12735943735908e-12	16	0	0	207	10391
R-HSA-1170546	Prolactin receptor signaling	1.00000000000413	4.12735943735908e-12	16	0	0	207	10391
R-HSA-110312	Translesion synthesis by REV1	1.00000000000413	4.12735943735908e-12	16	0	0	207	10391
R-HSA-8866910	TFAP2 (AP-2) family regulates transcription of growth factors and their receptors	1.00000000000413	4.12735943735908e-12	16	0	0	207	10391
R-HSA-5637812	Signaling by EGFRvIII in Cancer	1.00000000000413	4.12735943735908e-12	16	0	0	207	10391
R-HSA-2559584	Formation of Senescence-Associated Heterochromatin Foci (SAHF)	1.00000000000413	4.12735943735908e-12	16	0	0	207	10391
R-HSA-5213460	RIPK1-mediated regulated necrosis	1.00000000000413	4.12735943735908e-12	16	0	0	207	10391
R-HSA-5637810	Constitutive Signaling by EGFRvIII	1.00000000000413	4.12735943735908e-12	16	0	0	207	10391
R-HSA-1433559	Regulation of KIT signaling	1.00000000000413	4.12735943735908e-12	16	0	0	207	10391
R-HSA-918233	TRAF3-dependent IRF activation pathway	1.00000000000413	4.12735943735908e-12	16	0	0	207	10391
R-HSA-5654219	Phospholipase C-mediated cascade: FGFR1	1.00000000000413	4.12735943735908e-12	16	0	0	207	10391
R-HSA-446353	Cell-extracellular matrix interactions	1.00000000000413	4.12735943735908e-12	16	0	0	207	10391
R-HSA-5684264	MAP3K8 (TPL2)-dependent MAPK1/3 activation	1.00000000000413	4.12735943735908e-12	16	0	0	207	10391
R-HSA-190242	FGFR1 ligand binding and activation	1.00000000000413	4.12735943735908e-12	16	0	0	207	10391
R-HSA-354194	GRB2:SOS provides linkage to MAPK signaling for Integrins	1.00000000000413	4.12735943735908e-12	16	0	0	207	10391
R-HSA-162710	Synthesis of glycosylphosphatidylinositol (GPI)	1.00000000000413	4.12735943735908e-12	16	0	0	207	10391
R-HSA-372708	p130Cas linkage to MAPK signaling for integrins	1.00000000000413	4.12735943735908e-12	16	0	0	207	10391
R-HSA-5218859	Regulated Necrosis	1.00000000000413	4.12735943735908e-12	16	0	0	207	10391
R-HSA-1295596	Spry regulation of FGF signaling	1.00000000000413	4.12735943735908e-12	16	0	0	207	10391
R-HSA-997269	Inhibition of adenylate cyclase pathway	1.00000000000415	4.15441148559208e-12	15	0	0	207	10391
R-HSA-2691230	Signaling by NOTCH1 HD Domain Mutants in Cancer	1.00000000000415	4.15441148559208e-12	15	0	0	207	10391
R-HSA-5358752	T41 mutants of beta-catenin aren't phosphorylated	1.00000000000415	4.15441148559208e-12	15	0	0	207	10391
R-HSA-975577	N-Glycan antennae elongation	1.00000000000415	4.15441148559208e-12	15	0	0	207	10391
R-HSA-69183	Processive synthesis on the lagging strand	1.00000000000415	4.15441148559208e-12	15	0	0	207	10391
R-HSA-3371568	Attenuation phase	1.00000000000415	4.15441148559208e-12	15	0	0	207	10391
R-HSA-2046104	alpha-linolenic (omega3) and linoleic (omega6) acid metabolism	1.00000000000415	4.15441148559208e-12	15	0	0	207	10391
R-HSA-3322077	Glycogen synthesis	1.00000000000415	4.15441148559208e-12	15	0	0	207	10391
R-HSA-4839743	phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex	1.00000000000415	4.15441148559208e-12	15	0	0	207	10391
R-HSA-3772470	Negative regulation of TCF-dependent signaling by WNT ligand antagonists	1.00000000000415	4.15441148559208e-12	15	0	0	207	10391
R-HSA-5358751	S45 mutants of beta-catenin aren't phosphorylated	1.00000000000415	4.15441148559208e-12	15	0	0	207	10391
R-HSA-2691232	Constitutive Signaling by NOTCH1 HD Domain Mutants	1.00000000000415	4.15441148559208e-12	15	0	0	207	10391
R-HSA-4419969	Depolymerisation of the Nuclear Lamina	1.00000000000415	4.15441148559208e-12	15	0	0	207	10391
R-HSA-170670	Adenylate cyclase inhibitory pathway	1.00000000000415	4.15441148559208e-12	15	0	0	207	10391
R-HSA-428540	Activation of Rac	1.00000000000415	4.15441148559208e-12	15	0	0	207	10391
R-HSA-5358508	Mismatch Repair	1.00000000000415	4.15441148559208e-12	15	0	0	207	10391
R-HSA-391903	Eicosanoid ligand-binding receptors	1.00000000000415	4.15441148559208e-12	15	0	0	207	10391
R-HSA-205043	NRIF signals cell death from the nucleus	1.00000000000415	4.15441148559208e-12	15	0	0	207	10391
R-HSA-5358747	S33 mutants of beta-catenin aren't phosphorylated	1.00000000000415	4.15441148559208e-12	15	0	0	207	10391
R-HSA-3134975	Regulation of innate immune responses to cytosolic DNA	1.00000000000415	4.15441148559208e-12	15	0	0	207	10391
R-HSA-8875360	InlB-mediated entry of Listeria monocytogenes into host cell	1.00000000000415	4.15441148559208e-12	15	0	0	207	10391
R-HSA-5339716	Misspliced GSK3beta mutants stabilize beta-catenin	1.00000000000415	4.15441148559208e-12	15	0	0	207	10391
R-HSA-5358749	S37 mutants of beta-catenin aren't phosphorylated	1.00000000000415	4.15441148559208e-12	15	0	0	207	10391
R-HSA-173623	Classical antibody-mediated complement activation	1.00000000000415	4.15441148559208e-12	15	0	0	207	10391
R-HSA-193807	Synthesis of bile acids and bile salts via 27-hydroxycholesterol	1.00000000000415	4.15441148559208e-12	15	0	0	207	10391
R-HSA-5654228	Phospholipase C-mediated cascade; FGFR4	1.00000000000415	4.15441148559208e-12	15	0	0	207	10391
R-HSA-69298	Association of licensing factors with the pre-replicative complex	1.00000000000415	4.15441148559208e-12	15	0	0	207	10391
R-HSA-2046106	alpha-linolenic acid (ALA) metabolism	1.00000000000415	4.15441148559208e-12	15	0	0	207	10391
R-HSA-68884	Mitotic Telophase/Cytokinesis	1.00000000000415	4.15441148559208e-12	15	0	0	207	10391
R-HSA-430039	mRNA decay by 5' to 3' exoribonuclease	1.00000000000415	4.15441148559208e-12	15	0	0	207	10391
R-HSA-1236974	ER-Phagosome pathway	1.0000000000043	4.30423356367591e-12	85	0	0	207	10391
R-HSA-1475029	Reversible hydration of carbon dioxide	1.00000000000445	4.45275641846715e-12	12	0	0	207	10391
R-HSA-1234158	Regulation of gene expression by Hypoxia-inducible Factor	1.00000000000445	4.45275641846715e-12	12	0	0	207	10391
R-HSA-5578768	Physiological factors	1.00000000000445	4.45275641846715e-12	12	0	0	207	10391
R-HSA-879518	Transport of organic anions	1.00000000000445	4.45275641846715e-12	12	0	0	207	10391
R-HSA-73621	Pyrimidine catabolism	1.00000000000445	4.45275641846715e-12	12	0	0	207	10391
R-HSA-2468052	Establishment of Sister Chromatid Cohesion	1.00000000000445	4.45275641846715e-12	12	0	0	207	10391
R-HSA-1474151	Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation	1.00000000000445	4.45275641846715e-12	12	0	0	207	10391
R-HSA-451308	Activation of Ca-permeable Kainate Receptor	1.00000000000445	4.45275641846715e-12	12	0	0	207	10391
R-HSA-3656237	Defective EXT2 causes exostoses 2	1.00000000000445	4.45275641846715e-12	12	0	0	207	10391
R-HSA-844456	The NLRP3 inflammasome	1.00000000000445	4.45275641846715e-12	12	0	0	207	10391
R-HSA-2033514	FGFR3 mutant receptor activation	1.00000000000445	4.45275641846715e-12	12	0	0	207	10391
R-HSA-71064	Lysine catabolism	1.00000000000445	4.45275641846715e-12	12	0	0	207	10391
R-HSA-389359	CD28 dependent Vav1 pathway	1.00000000000445	4.45275641846715e-12	12	0	0	207	10391
R-HSA-1433617	Regulation of signaling by NODAL	1.00000000000445	4.45275641846715e-12	12	0	0	207	10391
R-HSA-451306	Ionotropic activity of Kainate Receptors	1.00000000000445	4.45275641846715e-12	12	0	0	207	10391
R-HSA-2022857	Keratan sulfate degradation	1.00000000000445	4.45275641846715e-12	12	0	0	207	10391
R-HSA-1839130	Signaling by activated point mutants of FGFR3	1.00000000000445	4.45275641846715e-12	12	0	0	207	10391
R-HSA-209822	Glycoprotein hormones	1.00000000000445	4.45275641846715e-12	12	0	0	207	10391
R-HSA-8851680	Butyrophilin (BTN) family interactions	1.00000000000445	4.45275641846715e-12	12	0	0	207	10391
R-HSA-73817	Purine ribonucleoside monophosphate biosynthesis	1.00000000000445	4.45275641846715e-12	12	0	0	207	10391
R-HSA-203615	eNOS activation	1.00000000000445	4.45275641846715e-12	12	0	0	207	10391
R-HSA-190373	FGFR1c ligand binding and activation	1.00000000000445	4.45275641846715e-12	12	0	0	207	10391
R-HSA-622323	Presynaptic nicotinic acetylcholine receptors	1.00000000000445	4.45275641846715e-12	12	0	0	207	10391
R-HSA-1236977	Endosomal/Vacuolar pathway	1.00000000000445	4.45275641846715e-12	12	0	0	207	10391
R-HSA-4641265	Repression of WNT target genes	1.00000000000445	4.45275641846715e-12	12	0	0	207	10391
R-HSA-5689877	Josephin domain DUBs	1.00000000000445	4.45275641846715e-12	12	0	0	207	10391
R-HSA-975110	TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling	1.00000000000445	4.45275641846715e-12	12	0	0	207	10391
R-HSA-1296346	Tandem pore domain potassium channels	1.00000000000445	4.45275641846715e-12	12	0	0	207	10391
R-HSA-2160916	Hyaluronan uptake and degradation	1.00000000000445	4.45275641846715e-12	12	0	0	207	10391
R-HSA-211979	Eicosanoids	1.00000000000445	4.45275641846715e-12	12	0	0	207	10391
R-HSA-3656253	Defective EXT1 causes exostoses 1, TRPS2 and CHDS	1.00000000000445	4.45275641846715e-12	12	0	0	207	10391
R-HSA-3371511	HSF1 activation	1.00000000000445	4.45275641846715e-12	12	0	0	207	10391
R-HSA-6803207	TP53 Regulates Transcription of Caspase Activators and Caspases	1.00000000000445	4.45275641846715e-12	12	0	0	207	10391
R-HSA-176974	Unwinding of DNA	1.00000000000445	4.45275641846715e-12	12	0	0	207	10391
R-HSA-179419	APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint	1.00000000000451	4.5053351161048e-12	74	0	0	207	10391
R-HSA-69300	Removal of licensing factors from origins	1.00000000000451	4.5053351161048e-12	74	0	0	207	10391
R-HSA-192105	Synthesis of bile acids and bile salts	1.00000000000513	5.12492357436315e-12	34	0	0	207	10391
R-HSA-389958	Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding	1.00000000000513	5.12492357436315e-12	34	0	0	207	10391
R-HSA-159227	Transport of the SLBP independent Mature mRNA	1.00000000000513	5.12492357436315e-12	34	0	0	207	10391
R-HSA-73847	Purine metabolism	1.00000000000513	5.12492357436315e-12	34	0	0	207	10391
R-HSA-165054	Rev-mediated nuclear export of HIV RNA	1.00000000000513	5.12492357436315e-12	34	0	0	207	10391
R-HSA-390522	Striated Muscle Contraction	1.00000000000513	5.12492357436315e-12	34	0	0	207	10391
R-HSA-5656169	Termination of translesion DNA synthesis	1.00000000000513	5.12492357436315e-12	34	0	0	207	10391
R-HSA-5694530	Cargo concentration in the ER	1.00000000000513	5.12492357436315e-12	34	0	0	207	10391
R-HSA-5654727	Negative regulation of FGFR2 signaling	1.00000000000513	5.12492357436315e-12	34	0	0	207	10391
R-HSA-162791	Attachment of GPI anchor to uPAR	1.00000000000523	5.23343799102277e-12	7	0	0	207	10391
R-HSA-1912399	Pre-NOTCH Processing in the Endoplasmic Reticulum	1.00000000000523	5.23343799102277e-12	7	0	0	207	10391
R-HSA-163767	PP2A-mediated dephosphorylation of key metabolic factors	1.00000000000523	5.23343799102277e-12	7	0	0	207	10391
R-HSA-3656225	Defective CHST6 causes MCDC1	1.00000000000523	5.23343799102277e-12	7	0	0	207	10391
R-HSA-3656244	Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)	1.00000000000523	5.23343799102277e-12	7	0	0	207	10391
R-HSA-435368	Zinc efflux and compartmentalization by the SLC30 family	1.00000000000523	5.23343799102277e-12	7	0	0	207	10391
R-HSA-5603029	IkBA variant leads to EDA-ID	1.00000000000523	5.23343799102277e-12	7	0	0	207	10391
R-HSA-171319	Telomere Extension By Telomerase	1.00000000000523	5.23343799102277e-12	7	0	0	207	10391
R-HSA-111471	Apoptotic factor-mediated response	1.00000000000523	5.23343799102277e-12	7	0	0	207	10391
R-HSA-5576894	Phase 1 - inactivation of fast Na+ channels	1.00000000000523	5.23343799102277e-12	7	0	0	207	10391
R-HSA-110362	POLB-Dependent Long Patch Base Excision Repair	1.00000000000523	5.23343799102277e-12	7	0	0	207	10391
R-HSA-196843	Vitamin B2 (riboflavin) metabolism	1.00000000000523	5.23343799102277e-12	7	0	0	207	10391
R-HSA-75158	TRAIL  signaling	1.00000000000523	5.23343799102277e-12	7	0	0	207	10391
R-HSA-426496	Post-transcriptional silencing by small RNAs	1.00000000000523	5.23343799102277e-12	7	0	0	207	10391
R-HSA-3656243	Defective ST3GAL3 causes MCT12 and EIEE15	1.00000000000523	5.23343799102277e-12	7	0	0	207	10391
R-HSA-190371	FGFR3b ligand binding and activation	1.00000000000523	5.23343799102277e-12	7	0	0	207	10391
R-HSA-3065678	SUMO is transferred from E1 to E2 (UBE2I, UBC9)	1.00000000000523	5.23343799102277e-12	7	0	0	207	10391
R-HSA-164843	2-LTR circle formation	1.00000000000523	5.23343799102277e-12	7	0	0	207	10391
R-HSA-196791	Vitamin D (calciferol) metabolism	1.00000000000523	5.23343799102277e-12	7	0	0	207	10391
R-HSA-73943	Reversal of alkylation damage by DNA dioxygenases	1.00000000000523	5.23343799102277e-12	7	0	0	207	10391
R-HSA-429593	Inositol transporters	1.00000000000523	5.23343799102277e-12	7	0	0	207	10391
R-HSA-433692	Proton-coupled monocarboxylate transport	1.00000000000523	5.23343799102277e-12	7	0	0	207	10391
R-HSA-442720	CREB phosphorylation through the activation of Adenylate Cyclase	1.00000000000523	5.23343799102277e-12	7	0	0	207	10391
R-HSA-3595172	Defective CHST3 causes SEDCJD	1.00000000000523	5.23343799102277e-12	7	0	0	207	10391
R-HSA-3595174	Defective CHST14 causes EDS, musculocontractural type	1.00000000000523	5.23343799102277e-12	7	0	0	207	10391
R-HSA-5649702	APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway	1.00000000000523	5.23343799102277e-12	7	0	0	207	10391
R-HSA-3595177	Defective CHSY1 causes TPBS	1.00000000000523	5.23343799102277e-12	7	0	0	207	10391
R-HSA-2393930	Phosphate bond hydrolysis by NUDT proteins	1.00000000000523	5.23343799102277e-12	7	0	0	207	10391
R-HSA-210744	Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells	1.00000000000523	5.23343799102277e-12	7	0	0	207	10391
R-HSA-182218	Nef Mediated CD8 Down-regulation	1.00000000000523	5.23343799102277e-12	7	0	0	207	10391
R-HSA-5619102	SLC transporter disorders	1.00000000000523	5.23343799102277e-12	7	0	0	207	10391
R-HSA-629587	Highly sodium permeable acetylcholine nicotinic receptors	1.00000000000523	5.23343799102277e-12	7	0	0	207	10391
R-HSA-448706	Interleukin-1 processing	1.00000000000523	5.23343799102277e-12	7	0	0	207	10391
R-HSA-426117	Cation-coupled Chloride cotransporters	1.00000000000523	5.23343799102277e-12	7	0	0	207	10391
R-HSA-4411364	Binding of TCF/LEF:CTNNB1 to target gene promoters	1.00000000000523	5.23343799102277e-12	7	0	0	207	10391
R-HSA-83936	Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane	1.00000000000523	5.23343799102277e-12	7	0	0	207	10391
R-HSA-420597	Nectin/Necl  trans heterodimerization	1.00000000000523	5.23343799102277e-12	7	0	0	207	10391
R-HSA-2660825	Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	1.00000000000523	5.23343799102277e-12	7	0	0	207	10391
R-HSA-174577	Activation of C3 and C5	1.00000000000523	5.23343799102277e-12	7	0	0	207	10391
R-HSA-2660826	Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	1.00000000000523	5.23343799102277e-12	7	0	0	207	10391
R-HSA-68949	Orc1 removal from chromatin	1.0000000000054	5.39627112804948e-12	72	0	0	207	10391
R-HSA-69202	Cyclin E associated events during G1/S transition	1.0000000000054	5.39627112804948e-12	72	0	0	207	10391
R-HSA-73856	RNA Polymerase II Transcription Termination	1.0000000000054	5.39627112804948e-12	72	0	0	207	10391
R-HSA-109688	Cleavage of Growing Transcript in the Termination Region	1.0000000000054	5.39627112804948e-12	72	0	0	207	10391
R-HSA-69052	Switching of origins to a post-replicative state	1.0000000000054	5.39627112804948e-12	72	0	0	207	10391
R-HSA-1482839	Acyl chain remodelling of PE	1.00000000000607	6.06863887958172e-12	29	0	0	207	10391
R-HSA-390918	Peroxisomal lipid metabolism	1.00000000000607	6.06863887958172e-12	29	0	0	207	10391
R-HSA-164952	The role of Nef in HIV-1 replication and disease pathogenesis	1.00000000000607	6.06863887958172e-12	29	0	0	207	10391
R-HSA-5621480	Dectin-2 family	1.00000000000607	6.06863887958172e-12	29	0	0	207	10391
R-HSA-5218920	VEGFR2 mediated vascular permeability	1.00000000000607	6.06863887958172e-12	29	0	0	207	10391
R-HSA-5654732	Negative regulation of FGFR3 signaling	1.00000000000607	6.06863887958172e-12	29	0	0	207	10391
R-HSA-72086	mRNA Capping	1.00000000000607	6.06863887958172e-12	29	0	0	207	10391
R-HSA-389957	Prefoldin mediated transfer of substrate  to CCT/TriC	1.00000000000607	6.06863887958172e-12	29	0	0	207	10391
R-HSA-5601884	PIWI-interacting RNA (piRNA) biogenesis	1.00000000000607	6.06863887958172e-12	29	0	0	207	10391
R-HSA-2032785	YAP1- and WWTR1 (TAZ)-stimulated gene expression	1.00000000000607	6.06863887958172e-12	29	0	0	207	10391
R-HSA-901042	Calnexin/calreticulin cycle	1.00000000000627	6.27228483019913e-12	27	0	0	207	10391
R-HSA-5654716	Downstream signaling of activated FGFR4	1.00000000000627	6.27228483019913e-12	27	0	0	207	10391
R-HSA-211981	Xenobiotics	1.00000000000627	6.27228483019913e-12	27	0	0	207	10391
R-HSA-76066	RNA Polymerase III Transcription Initiation From Type 2 Promoter	1.00000000000627	6.27228483019913e-12	27	0	0	207	10391
R-HSA-400685	Sema4D in semaphorin signaling	1.00000000000627	6.27228483019913e-12	27	0	0	207	10391
R-HSA-1482788	Acyl chain remodelling of PC	1.00000000000627	6.27228483019913e-12	27	0	0	207	10391
R-HSA-3238698	WNT ligand biogenesis and trafficking	1.00000000000627	6.27228483019913e-12	27	0	0	207	10391
R-HSA-180024	DARPP-32 events	1.00000000000627	6.27228483019913e-12	27	0	0	207	10391
R-HSA-8849471	PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases	1.00000000000627	6.27228483019913e-12	27	0	0	207	10391
R-HSA-6783589	Interleukin-6 family signaling	1.00000000000627	6.27228483019913e-12	27	0	0	207	10391
R-HSA-167160	RNA Pol II CTD phosphorylation and interaction with CE during HIV infection	1.00000000000627	6.27228483019913e-12	27	0	0	207	10391
R-HSA-77075	RNA Pol II CTD phosphorylation and interaction with CE	1.00000000000627	6.27228483019913e-12	27	0	0	207	10391
R-HSA-1834949	Cytosolic sensors of pathogen-associated DNA	1.0000000000064	6.40110567425476e-12	68	0	0	207	10391
R-HSA-174154	APC/C:Cdc20 mediated degradation of Securin	1.0000000000064	6.40110567425476e-12	68	0	0	207	10391
R-HSA-202427	Phosphorylation of CD3 and TCR zeta chains	1.00000000000687	6.86820453719675e-12	25	0	0	207	10391
R-HSA-983170	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	1.00000000000687	6.86820453719675e-12	25	0	0	207	10391
R-HSA-5654708	Downstream signaling of activated FGFR3	1.00000000000687	6.86820453719675e-12	25	0	0	207	10391
R-HSA-933542	TRAF6 mediated NF-kB activation	1.00000000000687	6.86820453719675e-12	25	0	0	207	10391
R-HSA-167242	Abortive elongation of HIV-1 transcript in the absence of Tat	1.00000000000687	6.86820453719675e-12	25	0	0	207	10391
R-HSA-1606322	ZBP1(DAI) mediated induction of type I IFNs	1.00000000000687	6.86820453719675e-12	25	0	0	207	10391
R-HSA-429947	Deadenylation of mRNA	1.00000000000687	6.86820453719675e-12	25	0	0	207	10391
R-HSA-179409	APC-Cdc20 mediated degradation of Nek2A	1.00000000000687	6.86820453719675e-12	25	0	0	207	10391
R-HSA-5654700	FRS-mediated FGFR2 signaling	1.00000000000687	6.86820453719675e-12	25	0	0	207	10391
R-HSA-5674400	Constitutive Signaling by AKT1 E17K in Cancer	1.00000000000687	6.86820453719675e-12	25	0	0	207	10391
R-HSA-5696397	Gap-filling DNA repair synthesis and ligation in GG-NER	1.00000000000687	6.86820453719675e-12	25	0	0	207	10391
R-HSA-5673000	RAF activation	1.00000000000687	6.86820453719675e-12	25	0	0	207	10391
R-HSA-182971	EGFR downregulation	1.00000000000687	6.86820453719675e-12	25	0	0	207	10391
R-HSA-162588	Budding and maturation of HIV virion	1.00000000000687	6.86820453719675e-12	25	0	0	207	10391
R-HSA-202670	ERKs are inactivated	1.00000000000753	7.52672893378333e-12	13	0	0	207	10391
R-HSA-432047	Passive transport by Aquaporins	1.00000000000753	7.52672893378333e-12	13	0	0	207	10391
R-HSA-264870	Caspase-mediated cleavage of cytoskeletal proteins	1.00000000000753	7.52672893378333e-12	13	0	0	207	10391
R-HSA-211227	Activation of DNA fragmentation factor	1.00000000000753	7.52672893378333e-12	13	0	0	207	10391
R-HSA-190372	FGFR3c ligand binding and activation	1.00000000000753	7.52672893378333e-12	13	0	0	207	10391
R-HSA-2564830	Cytosolic iron-sulfur cluster assembly	1.00000000000753	7.52672893378333e-12	13	0	0	207	10391
R-HSA-5658623	FGFRL1 modulation of FGFR1 signaling	1.00000000000753	7.52672893378333e-12	13	0	0	207	10391
R-HSA-190375	FGFR2c ligand binding and activation	1.00000000000753	7.52672893378333e-12	13	0	0	207	10391
R-HSA-112308	Depolarization of the Presynaptic Terminal Triggers the Opening of Calcium Channels	1.00000000000753	7.52672893378333e-12	13	0	0	207	10391
R-HSA-375281	Hormone ligand-binding receptors	1.00000000000753	7.52672893378333e-12	13	0	0	207	10391
R-HSA-140342	Apoptosis induced DNA fragmentation	1.00000000000753	7.52672893378333e-12	13	0	0	207	10391
R-HSA-6804116	TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest	1.00000000000753	7.52672893378333e-12	13	0	0	207	10391
R-HSA-5357786	TNFR1-induced proapoptotic signaling	1.00000000000753	7.52672893378333e-12	13	0	0	207	10391
R-HSA-74217	Purine salvage	1.00000000000753	7.52672893378333e-12	13	0	0	207	10391
R-HSA-5210891	Uptake and function of anthrax toxins	1.00000000000753	7.52672893378333e-12	13	0	0	207	10391
R-HSA-198323	AKT phosphorylates targets in the cytosol	1.00000000000753	7.52672893378333e-12	13	0	0	207	10391
R-HSA-1502540	Signaling by Activin	1.00000000000753	7.52672893378333e-12	13	0	0	207	10391
R-HSA-2892247	POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation	1.00000000000753	7.52672893378333e-12	13	0	0	207	10391
R-HSA-2408517	SeMet incorporation into proteins	1.00000000000753	7.52672893378333e-12	13	0	0	207	10391
R-HSA-5607763	CLEC7A (Dectin-1) induces NFAT activation	1.00000000000753	7.52672893378333e-12	13	0	0	207	10391
R-HSA-933543	NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10	1.00000000000753	7.52672893378333e-12	13	0	0	207	10391
R-HSA-2197563	NOTCH2 intracellular domain regulates transcription	1.00000000000753	7.52672893378333e-12	13	0	0	207	10391
R-HSA-3134963	DEx/H-box helicases activate type I IFN and inflammatory cytokines production	1.00000000000753	7.52672893378333e-12	13	0	0	207	10391
R-HSA-5668599	RHO GTPases Activate NADPH Oxidases	1.00000000000753	7.52672893378333e-12	13	0	0	207	10391
R-HSA-175474	Assembly Of The HIV Virion	1.00000000000753	7.52672893378333e-12	13	0	0	207	10391
R-HSA-171007	p38MAPK events	1.00000000000753	7.52672893378333e-12	13	0	0	207	10391
R-HSA-425561	Sodium/Calcium exchangers	1.00000000000753	7.52672893378333e-12	13	0	0	207	10391
R-HSA-75892	Platelet Adhesion to exposed collagen	1.00000000000753	7.52672893378333e-12	13	0	0	207	10391
R-HSA-5654227	Phospholipase C-mediated cascade; FGFR3	1.00000000000753	7.52672893378333e-12	13	0	0	207	10391
R-HSA-391160	Signal regulatory protein (SIRP) family interactions	1.00000000000753	7.52672893378333e-12	13	0	0	207	10391
R-HSA-977441	GABA A receptor activation	1.00000000000753	7.52672893378333e-12	13	0	0	207	10391
R-HSA-5626467	RHO GTPases activate IQGAPs	1.00000000000753	7.52672893378333e-12	13	0	0	207	10391
R-HSA-879415	Advanced glycosylation endproduct receptor signaling	1.00000000000753	7.52672893378333e-12	13	0	0	207	10391
R-HSA-381033	ATF6 (ATF6-alpha) activates chaperones	1.00000000000753	7.52672893378333e-12	13	0	0	207	10391
R-HSA-350054	Notch-HLH transcription pathway	1.00000000000753	7.52672893378333e-12	13	0	0	207	10391
R-HSA-1663150	The activation of arylsulfatases	1.00000000000753	7.52672893378333e-12	13	0	0	207	10391
R-HSA-3270619	IRF3-mediated induction of type I IFN	1.00000000000753	7.52672893378333e-12	13	0	0	207	10391
R-HSA-8866907	Activation of the TFAP2 (AP-2) family of transcription factors	1.00000000000753	7.52672893378333e-12	13	0	0	207	10391
R-HSA-211999	CYP2E1 reactions	1.00000000000753	7.52672893378333e-12	13	0	0	207	10391
R-HSA-190239	FGFR3 ligand binding and activation	1.00000000000753	7.52672893378333e-12	13	0	0	207	10391
R-HSA-212165	Epigenetic regulation of gene expression	1.00000000000789	7.88830830026268e-12	152	0	0	207	10391
R-HSA-75815	Ubiquitin-dependent degradation of Cyclin D	1.00000000000799	7.98798282209832e-12	52	0	0	207	10391
R-HSA-69229	Ubiquitin-dependent degradation of Cyclin D1	1.00000000000799	7.98798282209832e-12	52	0	0	207	10391
R-HSA-350562	Regulation of ornithine decarboxylase (ODC)	1.00000000000799	7.98798282209832e-12	52	0	0	207	10391
R-HSA-167152	Formation of HIV elongation complex in the absence of HIV Tat	1.00000000000799	7.98798282209832e-12	52	0	0	207	10391
R-HSA-171306	Packaging Of Telomere Ends	1.00000000000799	7.98798282209832e-12	52	0	0	207	10391
R-HSA-69017	CDK-mediated phosphorylation and removal of Cdc6	1.00000000000799	7.98798282209832e-12	52	0	0	207	10391
R-HSA-8851907	MET activates PI3K/AKT signaling	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-1566977	Fibronectin matrix formation	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-5674499	Negative feedback regulation of MAPK pathway	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-5339717	Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-2142770	Synthesis of 15-eicosatetraenoic acid derivatives	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-211916	Vitamins	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-5579029	Metabolic disorders of biological oxidation enzymes	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-428808	Na+-dependent glucose transporters	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-68616	Assembly of the ORC complex at the origin of replication	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-3000484	Scavenging by Class F Receptors	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-3134973	LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-193144	Estrogen biosynthesis	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-189483	Heme degradation	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-5693548	Sensing of DNA Double Strand Breaks	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-3065679	SUMO is proteolytically processed	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-446199	Synthesis of Dolichyl-phosphate	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-2142712	Synthesis of 12-eicosatetraenoic acid derivatives	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-500753	Pyrimidine biosynthesis	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-193670	p75NTR negatively regulates cell cycle via SC1	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-1482798	Acyl chain remodeling of CL	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-8857538	PTK6 promotes HIF1A stabilization	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-176417	Phosphorylation of Emi1	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-442717	CREB phosphorylation through the activation of CaMKK	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-187015	Activation of TRKA receptors	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-5660668	CLEC7A/inflammasome pathway	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-77288	mitochondrial fatty acid beta-oxidation of unsaturated fatty acids	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-947581	Molybdenum cofactor biosynthesis	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-6799990	Metal sequestration by antimicrobial proteins	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-193993	Mineralocorticoid biosynthesis	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-390247	Beta-oxidation of very long chain fatty acids	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-3323169	Defects in biotin (Btn) metabolism	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-8849470	PTK6 Regulates Cell Cycle	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-6793080	rRNA modification in the mitochondrion	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-177135	Conjugation of benzoate with glycine	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-205025	NADE modulates death signalling	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-166662	Lectin pathway of complement activation	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-111957	Cam-PDE 1 activation	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-1237112	Methionine salvage pathway	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-6782861	Synthesis of wybutosine at G37 of tRNA(Phe)	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-2187335	The retinoid cycle in cones (daylight vision)	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-190370	FGFR1b ligand binding and activation	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-6798163	Choline catabolism	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-6806942	MET Receptor Activation	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-388479	Vasopressin-like receptors	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-5626978	TNFR1-mediated ceramide production	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-5336415	Uptake and function of diphtheria toxin	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-5368598	Negative regulation of TCF-dependent signaling by DVL-interacting proteins	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-5624138	Trafficking of myristoylated proteins to the cilium	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-5676934	Protein repair	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-3371599	Defective HLCS causes multiple carboxylase deficiency	1.00000000000896	8.96338309157164e-12	6	0	0	207	10391
R-HSA-73884	Base Excision Repair	1.00000000000899	8.99019902636735e-12	37	0	0	207	10391
R-HSA-5689896	Ovarian tumor domain proteases	1.00000000000899	8.99019902636735e-12	37	0	0	207	10391
R-HSA-73933	Resolution of Abasic Sites (AP sites)	1.00000000000899	8.99019902636735e-12	37	0	0	207	10391
R-HSA-176187	Activation of ATR in response to replication stress	1.00000000000899	8.99019902636735e-12	37	0	0	207	10391
R-HSA-111465	Apoptotic cleavage of cellular proteins	1.000000000009	9.00064168323225e-12	39	0	0	207	10391
R-HSA-6783310	Fanconi Anemia Pathway	1.000000000009	9.00064168323225e-12	39	0	0	207	10391
R-HSA-165159	mTOR signalling	1.000000000009	9.00064168323225e-12	39	0	0	207	10391
R-HSA-174084	Autodegradation of Cdh1 by Cdh1:APC/C	1.00000000000903	9.03339418211684e-12	64	0	0	207	10391
R-HSA-73728	RNA Polymerase I Promoter Opening	1.00000000000903	9.03339418211684e-12	64	0	0	207	10391
R-HSA-983695	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	1.00000000000921	9.21342594453851e-12	44	0	0	207	10391
R-HSA-5668914	Diseases of metabolism	1.00000000000921	9.21342594453851e-12	44	0	0	207	10391
R-HSA-159231	Transport of Mature mRNA Derived from an Intronless Transcript	1.00000000000921	9.21342594453851e-12	44	0	0	207	10391
R-HSA-376172	DSCAM interactions	1.00000000000968	9.68124754156936e-12	11	0	0	207	10391
R-HSA-196780	Biotin transport and metabolism	1.00000000000968	9.68124754156936e-12	11	0	0	207	10391
R-HSA-2485179	Activation of the phototransduction cascade	1.00000000000968	9.68124754156936e-12	11	0	0	207	10391
R-HSA-975144	IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation	1.00000000000968	9.68124754156936e-12	11	0	0	207	10391
R-HSA-73614	Pyrimidine salvage reactions	1.00000000000968	9.68124754156936e-12	11	0	0	207	10391
R-HSA-446107	Type I hemidesmosome assembly	1.00000000000968	9.68124754156936e-12	11	0	0	207	10391
R-HSA-5625970	RHO GTPases activate KTN1	1.00000000000968	9.68124754156936e-12	11	0	0	207	10391
R-HSA-1980150	Signaling by NOTCH4	1.00000000000968	9.68124754156936e-12	11	0	0	207	10391
R-HSA-2514853	Condensation of Prometaphase Chromosomes	1.00000000000968	9.68124754156936e-12	11	0	0	207	10391
R-HSA-418889	Ligand-independent caspase activation via DCC	1.00000000000968	9.68124754156936e-12	11	0	0	207	10391
R-HSA-8851805	MET activates RAS signaling	1.00000000000968	9.68124754156936e-12	11	0	0	207	10391
R-HSA-69416	Dimerization of procaspase-8	1.00000000000968	9.68124754156936e-12	11	0	0	207	10391
R-HSA-174414	Processive synthesis on the C-strand of the telomere	1.00000000000968	9.68124754156936e-12	11	0	0	207	10391
R-HSA-3296469	Defects in cobalamin (B12) metabolism	1.00000000000968	9.68124754156936e-12	11	0	0	207	10391
R-HSA-71182	Phenylalanine and tyrosine catabolism	1.00000000000968	9.68124754156936e-12	11	0	0	207	10391
R-HSA-193048	Androgen biosynthesis	1.00000000000968	9.68124754156936e-12	11	0	0	207	10391
R-HSA-174490	Membrane binding and targetting of GAG proteins	1.00000000000968	9.68124754156936e-12	11	0	0	207	10391
R-HSA-5661231	Metallothioneins bind metals	1.00000000000968	9.68124754156936e-12	11	0	0	207	10391
R-HSA-5655291	Signaling by FGFR4 in disease	1.00000000000968	9.68124754156936e-12	11	0	0	207	10391
R-HSA-351906	Apoptotic cleavage of cell adhesion  proteins	1.00000000000968	9.68124754156936e-12	11	0	0	207	10391
R-HSA-1839122	Signaling by activated point mutants of FGFR1	1.00000000000968	9.68124754156936e-12	11	0	0	207	10391
R-HSA-3371378	Regulation by c-FLIP	1.00000000000968	9.68124754156936e-12	11	0	0	207	10391
R-HSA-68689	CDC6 association with the ORC:origin complex	1.00000000000968	9.68124754156936e-12	11	0	0	207	10391
R-HSA-1059683	Interleukin-6 signaling	1.00000000000968	9.68124754156936e-12	11	0	0	207	10391
R-HSA-5685939	HDR through MMEJ (alt-NHEJ)	1.00000000000968	9.68124754156936e-12	11	0	0	207	10391
R-HSA-75072	mRNA Editing	1.00000000000968	9.68124754156936e-12	11	0	0	207	10391
R-HSA-5690714	CD22 mediated BCR regulation	1.00000000000968	9.68124754156936e-12	11	0	0	207	10391
R-HSA-5218900	CASP8 activity is inhibited	1.00000000000968	9.68124754156936e-12	11	0	0	207	10391
R-HSA-200425	Import of palmitoyl-CoA into the mitochondrial matrix	1.00000000000968	9.68124754156936e-12	11	0	0	207	10391
R-HSA-5602498	MyD88 deficiency (TLR2/4)	1.00000000000968	9.68124754156936e-12	11	0	0	207	10391
R-HSA-77588	SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs	1.00000000000968	9.68124754156936e-12	11	0	0	207	10391
R-HSA-174495	Synthesis And Processing Of GAG, GAGPOL Polyproteins	1.00000000000968	9.68124754156936e-12	11	0	0	207	10391
R-HSA-2470946	Cohesin Loading onto Chromatin	1.00000000000968	9.68124754156936e-12	11	0	0	207	10391
R-HSA-937039	IRAK1 recruits IKK complex	1.00000000000968	9.68124754156936e-12	11	0	0	207	10391
R-HSA-8875555	MET activates RAP1 and RAC1	1.00000000000968	9.68124754156936e-12	11	0	0	207	10391
R-HSA-71288	Creatine metabolism	1.00000000000968	9.68124754156936e-12	11	0	0	207	10391
R-HSA-629594	Highly calcium permeable postsynaptic nicotinic acetylcholine receptors	1.00000000000968	9.68124754156936e-12	11	0	0	207	10391
R-HSA-381183	ATF6 (ATF6-alpha) activates chaperone genes	1.00000000000968	9.68124754156936e-12	11	0	0	207	10391
R-HSA-5660526	Response to metal ions	1.00000000000968	9.68124754156936e-12	11	0	0	207	10391
R-HSA-189451	Heme biosynthesis	1.00000000000968	9.68124754156936e-12	11	0	0	207	10391
R-HSA-1980148	Signaling by NOTCH3	1.00000000000968	9.68124754156936e-12	11	0	0	207	10391
R-HSA-2022923	Dermatan sulfate biosynthesis	1.00000000000968	9.68124754156936e-12	11	0	0	207	10391
R-HSA-5603041	IRAK4 deficiency (TLR2/4)	1.00000000000968	9.68124754156936e-12	11	0	0	207	10391
R-HSA-8866652	Synthesis of active ubiquitin: roles of E1 and E2 enzymes	1.00000000001033	1.03274723386398e-11	30	0	0	207	10391
R-HSA-5654696	Downstream signaling of activated FGFR2	1.00000000001033	1.03274723386398e-11	30	0	0	207	10391
R-HSA-5683826	Surfactant metabolism	1.00000000001033	1.03274723386398e-11	30	0	0	207	10391
R-HSA-111996	Ca-dependent events	1.00000000001033	1.03274723386398e-11	30	0	0	207	10391
R-HSA-110314	Recognition of DNA damage by PCNA-containing replication complex	1.00000000001033	1.03274723386398e-11	30	0	0	207	10391
R-HSA-427413	NoRC negatively regulates rRNA expression	1.00000000001084	1.08437951482939e-11	108	0	0	207	10391
R-HSA-72202	Transport of Mature Transcript to Cytoplasm	1.00000000001125	1.12491738317863e-11	88	0	0	207	10391
R-HSA-674695	RNA Polymerase II Pre-transcription Events	1.00000000001125	1.12491738317863e-11	88	0	0	207	10391
R-HSA-5689901	Metalloprotease DUBs	1.00000000001134	1.13360709166286e-11	38	0	0	207	10391
R-HSA-5655302	Signaling by FGFR1 in disease	1.00000000001134	1.13360709166286e-11	38	0	0	207	10391
R-HSA-76009	Platelet Aggregation (Plug Formation)	1.00000000001134	1.13360709166286e-11	38	0	0	207	10391
R-HSA-167243	Tat-mediated HIV elongation arrest and recovery	1.00000000001134	1.13360709166286e-11	38	0	0	207	10391
R-HSA-167238	Pausing and recovery of Tat-mediated HIV elongation	1.00000000001134	1.13360709166286e-11	38	0	0	207	10391
R-HSA-2467813	Separation of Sister Chromatids	1.00000000001182	1.18221402895162e-11	168	0	0	207	10391
R-HSA-73777	RNA Polymerase I Chain Elongation	1.00000000001222	1.22196458103997e-11	92	0	0	207	10391
R-HSA-201722	Formation of the beta-catenin:TCF transactivating complex	1.00000000001222	1.22196458103997e-11	92	0	0	207	10391
R-HSA-211733	Regulation of activated PAK-2p34 by proteasome mediated degradation	1.00000000001229	1.22857825611349e-11	51	0	0	207	10391
R-HSA-1236978	Cross-presentation of soluble exogenous antigens (endosomes)	1.00000000001229	1.22857825611349e-11	51	0	0	207	10391
R-HSA-1793185	Chondroitin sulfate/dermatan sulfate metabolism	1.00000000001229	1.22857825611349e-11	51	0	0	207	10391
R-HSA-5687128	MAPK6/MAPK4 signaling	1.00000000001299	1.29885349783653e-11	90	0	0	207	10391
R-HSA-109704	PI3K Cascade	1.00000000001304	1.30388647247548e-11	79	0	0	207	10391
R-HSA-6781827	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	1.00000000001304	1.30388647247548e-11	79	0	0	207	10391
R-HSA-3214858	RMTs methylate histone arginines	1.00000000001304	1.30388647247548e-11	79	0	0	207	10391
R-HSA-6807878	COPI-mediated anterograde transport	1.00000000001304	1.30388647247548e-11	79	0	0	207	10391
R-HSA-606279	Deposition of new CENPA-containing nucleosomes at the centromere	1.0000000000136	1.35953822137416e-11	73	0	0	207	10391
R-HSA-774815	Nucleosome assembly	1.0000000000136	1.35953822137416e-11	73	0	0	207	10391
R-HSA-174178	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	1.0000000000136	1.35953822137416e-11	73	0	0	207	10391
R-HSA-174184	Cdc20:Phospho-APC/C mediated degradation of Cyclin A	1.0000000000136	1.35953822137416e-11	73	0	0	207	10391
R-HSA-388841	Costimulation by the CD28 family	1.0000000000136	1.35953822137416e-11	73	0	0	207	10391
R-HSA-68877	Mitotic Prometaphase	1.0000000000137	1.36960329302861e-11	111	0	0	207	10391
R-HSA-5250941	Negative epigenetic regulation of rRNA expression	1.0000000000137	1.36960329302861e-11	111	0	0	207	10391
R-HSA-73854	RNA Polymerase I Promoter Clearance	1.0000000000137	1.36960329302861e-11	111	0	0	207	10391
R-HSA-8856688	Golgi-to-ER retrograde transport	1.0000000000137	1.36960329302861e-11	111	0	0	207	10391
R-HSA-73857	RNA Polymerase II Transcription	1.00000000001445	1.445269593487e-11	160	0	0	207	10391
R-HSA-5658442	Regulation of RAS by GAPs	1.00000000001518	1.51832983011864e-11	70	0	0	207	10391
R-HSA-211897	Cytochrome P450 - arranged by substrate type	1.00000000001518	1.51832983011864e-11	70	0	0	207	10391
R-HSA-5693571	Nonhomologous End-Joining (NHEJ)	1.00000000001518	1.51832983011864e-11	70	0	0	207	10391
R-HSA-427359	SIRT1 negatively regulates rRNA Expression	1.00000000001518	1.51832983011864e-11	70	0	0	207	10391
R-HSA-3371453	Regulation of HSF1-mediated heat shock response	1.00000000001518	1.51832983011864e-11	70	0	0	207	10391
R-HSA-1428517	The citric acid (TCA) cycle and respiratory electron transport	1.00000000001605	1.60494242431782e-11	170	0	0	207	10391
R-HSA-4615885	SUMOylation of DNA replication proteins	1.00000000001636	1.63599000800878e-11	46	0	0	207	10391
R-HSA-70153	Glucose transport	1.00000000001636	1.63599000800878e-11	46	0	0	207	10391
R-HSA-1660662	Glycosphingolipid metabolism	1.00000000001636	1.63599000800878e-11	46	0	0	207	10391
R-HSA-6811442	Intra-Golgi and retrograde Golgi-to-ER traffic	1.0000000000167	1.66970017895996e-11	180	0	0	207	10391
R-HSA-5696395	Formation of Incision Complex in GG-NER	1.00000000001729	1.72926126270594e-11	43	0	0	207	10391
R-HSA-168325	Viral Messenger RNA Synthesis	1.00000000001729	1.72926126270594e-11	43	0	0	207	10391
R-HSA-983189	Kinesins	1.00000000001729	1.72926126270594e-11	43	0	0	207	10391
R-HSA-1461957	Beta defensins	1.00000000001729	1.72926126270594e-11	43	0	0	207	10391
R-HSA-5655253	Signaling by FGFR2 in disease	1.00000000001729	1.72926126270594e-11	43	0	0	207	10391
R-HSA-194068	Bile acid and bile salt metabolism	1.00000000001729	1.72926126270594e-11	43	0	0	207	10391
R-HSA-3928662	EPHB-mediated forward signaling	1.00000000001806	1.80590292282502e-11	42	0	0	207	10391
R-HSA-2426168	Activation of gene expression by SREBF (SREBP)	1.00000000001806	1.80590292282502e-11	42	0	0	207	10391
R-HSA-168253	Host Interactions with Influenza Factors	1.00000000001806	1.80590292282502e-11	42	0	0	207	10391
R-HSA-6782315	tRNA modification in the nucleus and cytosol	1.00000000001806	1.80590292282502e-11	42	0	0	207	10391
R-HSA-73864	RNA Polymerase I Transcription	1.00000000001855	1.8551177880528e-11	113	0	0	207	10391
R-HSA-3214847	HATs acetylate histones	1.0000000000194	1.93960402818594e-11	143	0	0	207	10391
R-HSA-187577	SCF(Skp2)-mediated degradation of p27/p21	1.00000000001966	1.96561952697163e-11	61	0	0	207	10391
R-HSA-5610785	GLI3 is processed to GLI3R by the proteasome	1.00000000001966	1.96561952697163e-11	61	0	0	207	10391
R-HSA-8852276	The role of GTSE1 in G2/M progression after G2 checkpoint	1.00000000001966	1.96561952697163e-11	61	0	0	207	10391
R-HSA-5607761	Dectin-1 mediated noncanonical NF-kB signaling	1.00000000001966	1.96561952697163e-11	61	0	0	207	10391
R-HSA-5610783	Degradation of GLI2 by the proteasome	1.00000000001966	1.96561952697163e-11	61	0	0	207	10391
R-HSA-176408	Regulation of APC/C activators between G1/S and early anaphase	1.00000000001982	1.98217419951812e-11	81	0	0	207	10391
R-HSA-6790901	rRNA modification in the nucleus and cytosol	1.00000000001985	1.98509502768769e-11	63	0	0	207	10391
R-HSA-72187	mRNA 3'-end processing	1.00000000001985	1.98509502768769e-11	63	0	0	207	10391
R-HSA-1226099	Signaling by FGFR in disease	1.00000000001985	1.98509502768769e-11	63	0	0	207	10391
R-HSA-162599	Late Phase of HIV Life Cycle	1.0000000000205	2.0504439317476e-11	139	0	0	207	10391
R-HSA-3214815	HDACs deacetylate histones	1.00000000002108	2.10784469992301e-11	94	0	0	207	10391
R-HSA-5250924	B-WICH complex positively regulates rRNA expression	1.00000000002108	2.10784469992301e-11	94	0	0	207	10391
R-HSA-75153	Apoptotic execution  phase	1.00000000002162	2.16209657062497e-11	53	0	0	207	10391
R-HSA-349425	Autodegradation of the E3 ubiquitin ligase COP1	1.00000000002162	2.16209657062497e-11	53	0	0	207	10391
R-HSA-191859	snRNP Assembly	1.00000000002162	2.16209657062497e-11	53	0	0	207	10391
R-HSA-180534	Vpu mediated degradation of CD4	1.00000000002162	2.16209657062497e-11	53	0	0	207	10391
R-HSA-1461973	Defensins	1.00000000002162	2.16209657062497e-11	53	0	0	207	10391
R-HSA-72165	mRNA Splicing - Minor Pathway	1.00000000002162	2.16209657062497e-11	53	0	0	207	10391
R-HSA-194441	Metabolism of non-coding RNA	1.00000000002162	2.16209657062497e-11	53	0	0	207	10391
R-HSA-163200	Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.	1.00000000002186	2.18558209012475e-11	125	0	0	207	10391
R-HSA-2299718	Condensation of Prophase Chromosomes	1.00000000002197	2.19735302156655e-11	75	0	0	207	10391
R-HSA-5654738	Signaling by FGFR2	1.00000000002197	2.19735302156655e-11	75	0	0	207	10391
R-HSA-212300	PRC2 methylates histones and DNA	1.00000000002197	2.19735302156655e-11	75	0	0	207	10391
R-HSA-73886	Chromosome Maintenance	1.00000000002236	2.23565562270312e-11	110	0	0	207	10391
R-HSA-381070	IRE1alpha activates chaperones	1.00000000002237	2.23738796043e-11	58	0	0	207	10391
R-HSA-5362768	Hh mutants that don't undergo autocatalytic processing are degraded by ERAD	1.00000000002237	2.23738796043e-11	58	0	0	207	10391
R-HSA-68867	Assembly of the pre-replicative complex	1.00000000002276	2.27631180996244e-11	69	0	0	207	10391
R-HSA-204005	COPII (Coat Protein 2) Mediated Vesicle Transport	1.00000000002276	2.27631180996244e-11	69	0	0	207	10391
R-HSA-6796648	TP53 Regulates Transcription of DNA Repair Genes	1.00000000002276	2.27631180996244e-11	69	0	0	207	10391
R-HSA-70268	Pyruvate metabolism	1.00000000002296	2.29566711140287e-11	28	0	0	207	10391
R-HSA-354192	Integrin alphaIIb beta3 signaling	1.00000000002296	2.29566711140287e-11	28	0	0	207	10391
R-HSA-380972	Energy dependent regulation of mTOR by LKB1-AMPK	1.00000000002296	2.29566711140287e-11	28	0	0	207	10391
R-HSA-76071	RNA Polymerase III Transcription Initiation From Type 3 Promoter	1.00000000002296	2.29566711140287e-11	28	0	0	207	10391
R-HSA-76061	RNA Polymerase III Transcription Initiation From Type 1 Promoter	1.00000000002296	2.29566711140287e-11	28	0	0	207	10391
R-HSA-5576893	Phase 2 - plateau phase	1.00000000002296	2.29566711140287e-11	28	0	0	207	10391
R-HSA-111933	Calmodulin induced events	1.00000000002296	2.29566711140287e-11	28	0	0	207	10391
R-HSA-917729	Endosomal Sorting Complex Required For Transport (ESCRT)	1.00000000002296	2.29566711140287e-11	28	0	0	207	10391
R-HSA-2022854	Keratan sulfate biosynthesis	1.00000000002296	2.29566711140287e-11	28	0	0	207	10391
R-HSA-264876	Insulin processing	1.00000000002296	2.29566711140287e-11	28	0	0	207	10391
R-HSA-211976	Endogenous sterols	1.00000000002296	2.29566711140287e-11	28	0	0	207	10391
R-HSA-111997	CaM pathway	1.00000000002296	2.29566711140287e-11	28	0	0	207	10391
R-HSA-75876	Synthesis of very long-chain fatty acyl-CoAs	1.00000000002296	2.29566711140287e-11	28	0	0	207	10391
R-HSA-6803529	FGFR2 alternative splicing	1.00000000002296	2.29566711140287e-11	28	0	0	207	10391
R-HSA-6811436	COPI-independent Golgi-to-ER retrograde traffic	1.00000000002296	2.29566711140287e-11	28	0	0	207	10391
R-HSA-5357769	Caspase activation via extrinsic apoptotic signalling pathway	1.00000000002296	2.29566711140287e-11	28	0	0	207	10391
R-HSA-1266695	Interleukin-7 signaling	1.00000000002296	2.29566711140287e-11	28	0	0	207	10391
R-HSA-1855204	Synthesis of IP3 and IP4 in the cytosol	1.00000000002296	2.29566711140287e-11	28	0	0	207	10391
R-HSA-174800	Chylomicron-mediated lipid transport	1.00000000002296	2.29566711140287e-11	28	0	0	207	10391
R-HSA-73779	RNA Polymerase II Transcription Pre-Initiation And Promoter Opening	1.00000000002328	2.32827607399983e-11	47	0	0	207	10391
R-HSA-167162	RNA Polymerase II HIV Promoter Escape	1.00000000002328	2.32827607399983e-11	47	0	0	207	10391
R-HSA-73776	RNA Polymerase II Promoter Escape	1.00000000002328	2.32827607399983e-11	47	0	0	207	10391
R-HSA-112043	PLC beta mediated events	1.00000000002328	2.32827607399983e-11	47	0	0	207	10391
R-HSA-167161	HIV Transcription Initiation	1.00000000002328	2.32827607399983e-11	47	0	0	207	10391
R-HSA-75953	RNA Polymerase II Transcription Initiation	1.00000000002328	2.32827607399983e-11	47	0	0	207	10391
R-HSA-76042	RNA Polymerase II Transcription Initiation And Promoter Clearance	1.00000000002328	2.32827607399983e-11	47	0	0	207	10391
R-HSA-5610780	Degradation of GLI1 by the proteasome	1.00000000002462	2.46247608541864e-11	62	0	0	207	10391
R-HSA-69242	S Phase	1.00000000002478	2.47793551919624e-11	130	0	0	207	10391
R-HSA-69615	G1/S DNA Damage Checkpoints	1.00000000002493	2.49260375442964e-11	67	0	0	207	10391
R-HSA-5358346	Hedgehog ligand biogenesis	1.00000000002493	2.49260375442964e-11	67	0	0	207	10391
R-HSA-1632852	Macroautophagy	1.00000000002493	2.49260375442964e-11	67	0	0	207	10391
R-HSA-1234176	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	1.00000000002493	2.49260375442964e-11	67	0	0	207	10391
R-HSA-2500257	Resolution of Sister Chromatid Cohesion	1.00000000002709	2.70938577778923e-11	103	0	0	207	10391
R-HSA-168928	RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways	1.00000000002741	2.74062149885477e-11	84	0	0	207	10391
R-HSA-69306	DNA Replication	1.00000000002784	2.78434856577156e-11	109	0	0	207	10391
R-HSA-5250913	Positive epigenetic regulation of rRNA expression	1.00000000002784	2.78434856577156e-11	109	0	0	207	10391
R-HSA-72306	tRNA processing	1.00000000002784	2.78434856577156e-11	109	0	0	207	10391
